{"title": "Hoda Anton-Culver", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2021-07-10", "cleaned_text": "Medicine School of Medicine School of Medicine Director, Genetic Epidemiology Research Institute Ph.D., University of St. Andrews , Scotland, 1968 Phone: (949) 824-7416 Email: Email: [hantoncu@uci.edu](mailto:hantoncu@uci.edu) University of California, Irvine 301 Med Surge II Mail Code: 7560 Irvine, CA 92697 301 Med Surge II Mail Code: 7560 Irvine, CA 92697 Research Interests Precision Medicine, Cancer Epidemiology, Genetic Epidemiology, Disease Prevention, Translational Epidemiology Websites Academic Distinctions Multiple Professional Achievement Awards in cancer genetics from the National Cancer Institute (NCI). University of California, Irvine Alumni Association Lauds & Laurels Award University of California, Irvine Alumni Association Lauds & Laurels Award Research Abstract Dr. Anton-Culver's research is in the broad scientific areas of cancer epidemiology and cancer genetics. Her research focuses on cancer epidemiology with special emphasis on etiology, molecular genetic characterization, evaluation of genetic-phenotype correlation, and genotype-environment interaction using large populations of cancer patients, their relatives, and unaffected controls. Dr Anton-Culver's research theme takes advantage of population genetics, to predict the proportion of cancers that can be attributed to genetic variation and exposure to environmental risk factors in the population. She developed and has been successful in implementing this research theme in the understanding of several cancers, particularly breast, colorectal, ovarian, and prostate cancers. Gene-environment interactions are important components in several cancers in human populations and the knowledge generated from this research will help in planning of cancer prevention and control. Dr. Anton-Culver is the Founding Director of one of only 22 Organized Research Units (ORU) at UC Irvine; namely the Genetic Epidemiology Research Institute (GERI). This research institute brings together a multidisciplinary team of exceptional scientists from complementary fields, including epidemiology, developmental and cell biology, molecular biology and biochemistry, evolutionary biology, genetics, immunology, statistics, bioinformatics, and environmental and behavioral sciences. With the revolutionary progress being made in all of the component sciences, the Institute concentrates on the following four primary goals: 1) To combine epidemiologic approaches with basic science methods to test hypotheses related to genetic bases of the etiology and progression of disease. 2) To facilitate research to apply newly discovered molecular biological processes and genetic characteristics in health and disease in well-characterized human populations. 3) To provide epidemiological information that will influence our understanding of the basic processes leading to disease, such as environmental and lifestyle factors, and to test their effects as modifiers of genetic predisposition. 4) Use latest advances in information sciences and communication technology to allow for efficient data mining and pattern recognition for genetic epidemiological data. Current Research Study Examples: The \"Hereditary Breast Cancer: Genetic and Molecular Studies\" (U01 CA58860-12, Anton-Culver) has also been renewed for an additional five years. The competitive renewal application will maintain and followup the existing family resource of 1270 breast and 262 ovarian cancer probands, further characterize BRCA mutations in breast and ovarian cancer families and explore the associated functions of BRCA1 missense mutations. In addition, the investigators will determine whether there is molecular genetic evidence for the aggregation of breast and colorectal cancer in a subgroup of the existing high risk breast cancer families. There is strong familial and molecular genetic evidence of an association between breast and ovarian cancer and also a familial association between breast and colon cancer. Further, preliminary results show mutations in MSH2 and MLH1 in breast cancer families where there is colon cancer in first or second degree relatives. The candidate genes (such as mismatch repair genes) relevant to the tumor spectrum in these families in addition to BRCA1 and BRCA2 will be examined and possible new genetic alterations will be explored. The data generated from the proposed study will have yield novel and important information to the scientific and clinical community as well as for subjects from breast cancer families possessing the diverse spectrum of tumors as is often observed in familial breast cancer. The \"Breast and Other Cancers in the California Teacher's Cohort\" (NCI, Bernstein) has also received recent approval. A cohort of 133,000 California school teachers had been established by a collaborative group of epidemiological investigators with the goal of evaluating unresolved issues related to breast cancer risk factors. UCI investigators Anton-Culver and Lin are assessing modification of breast cancer risk by other risk factors in women with and without a family history of breast and other cancers. Specifically, the study will: a) evaluate the modifying effects of reproductive and hormonal factors (age at onset of menarche, age at first full-term pregnancy, weight, oral contraceptive use, and use of hormone replacement therapy); b) evaluate the modifying effects of dietary risk and physical activity; and c) assess whether risk modification in women with a family history of breast or other cancers is related to age at onset of breast cancer. Additionally, this research will conduct a validation study of self-reported family history of cancer by cancer type and by family relationships of affected individuals. A major focus will be breast and ovarian cancer, but long-range goals of the CTS cohort will include familial and genetic studies of other cancers including malignant melanoma, endometrial cancer, and colorectal cancer. This will allow investigators to evaluate the validity of family history data collected from self-reports by the cancer type and family relationship (degree of closeness to the proband) in a sample of the CTS cohort who reported in the baseline questionnaire a positive family history of breast cancer in at least one first-degree relative. Comparisons will be made between data provided by the baseline questionnaire. The ATHENA Breast Health Network: This groundbreaking project will initially involve 150,000 women throughout California who will be screened for breast cancer and followed for decades through the five University of California Medical Centers. ATHENA is a University of California system-wide project supported by a $5.3 million University of California grant, and by a $4.8 million grant from the Safeway Foundation. This unique collaboration will revolutionize the delivery of care by integrating research and clinical care in prevention, screening, treatment and management of breast cancer. During the past thirty-two years at UC Irvine, Dr. Anton-Culver has established major research programs in cancer epidemiology and cancer genetics. Under her leadership, the Department of Epidemiology and the Genetic Epidemiology Research Institute are currently engaged in conducting several research studies in cancer epidemiology funded by the National Cancer Institute and other agencies. One study combines techniques in genetic epidemiology and molecular markers to define and characterize inherited breast/ovarian cancer in the population of Orange County. Another focuses on colon and rectum cancers to study the effects of genetic influence on the FCC genes as they interact with diet, physical activity, and other factors that may influence the risk for colorectal cancer. Dr. Anton-Culver is the Founding Director of one of only 22 Organized Research Units (ORU) at UC Irvine; namely the Genetic Epidemiology Research Institute (GERI). This research institute brings together a multidisciplinary team of exceptional scientists from complementary fields, including epidemiology, developmental and cell biology, molecular biology and biochemistry, evolutionary biology, genetics, immunology, statistics, bioinformatics, and environmental and behavioral sciences. With the revolutionary progress being made in all of the component sciences, the Institute concentrates on the following four primary goals: 1) To combine epidemiologic approaches with basic science methods to test hypotheses related to genetic bases of the etiology and progression of disease. 2) To facilitate research to apply newly discovered molecular biological processes and genetic characteristics in health and disease in well-characterized human populations. 3) To provide epidemiological information that will influence our understanding of the basic processes leading to disease, such as environmental and lifestyle factors, and to test their effects as modifiers of genetic predisposition. 4) Use latest advances in information sciences and communication technology to allow for efficient data mining and pattern recognition for genetic epidemiological data. Current Research Study Examples: The \"Hereditary Breast Cancer: Genetic and Molecular Studies\" (U01 CA58860-12, Anton-Culver) has also been renewed for an additional five years. The competitive renewal application will maintain and followup the existing family resource of 1270 breast and 262 ovarian cancer probands, further characterize BRCA mutations in breast and ovarian cancer families and explore the associated functions of BRCA1 missense mutations. In addition, the investigators will determine whether there is molecular genetic evidence for the aggregation of breast and colorectal cancer in a subgroup of the existing high risk breast cancer families. There is strong familial and molecular genetic evidence of an association between breast and ovarian cancer and also a familial association between breast and colon cancer. Further, preliminary results show mutations in MSH2 and MLH1 in breast cancer families where there is colon cancer in first or second degree relatives. The candidate genes (such as mismatch repair genes) relevant to the tumor spectrum in these families in addition to BRCA1 and BRCA2 will be examined and possible new genetic alterations will be explored. The data generated from the proposed study will have yield novel and important information to the scientific and clinical community as well as for subjects from breast cancer families possessing the diverse spectrum of tumors as is often observed in familial breast cancer. The \"Breast and Other Cancers in the California Teacher's Cohort\" (NCI, Bernstein) has also received recent approval. A cohort of 133,000 California school teachers had been established by a collaborative group of epidemiological investigators with the goal of evaluating unresolved issues related to breast cancer risk factors. UCI investigators Anton-Culver and Lin are assessing modification of breast cancer risk by other risk factors in women with and without a family history of breast and other cancers. Specifically, the study will: a) evaluate the modifying effects of reproductive and hormonal factors (age at onset of menarche, age at first full-term pregnancy, weight, oral contraceptive use, and use of hormone replacement therapy); b) evaluate the modifying effects of dietary risk and physical activity; and c) assess whether risk modification in women with a family history of breast or other cancers is related to age at onset of breast cancer. Additionally, this research will conduct a validation study of self-reported family history of cancer by cancer type and by family relationships of affected individuals. A major focus will be breast and ovarian cancer, but long-range goals of the CTS cohort will include familial and genetic studies of other cancers including malignant melanoma, endometrial cancer, and colorectal cancer. This will allow investigators to evaluate the validity of family history data collected from self-reports by the cancer type and family relationship (degree of closeness to the proband) in a sample of the CTS cohort who reported in the baseline questionnaire a positive family history of breast cancer in at least one first-degree relative. Comparisons will be made between data provided by the baseline questionnaire. The ATHENA Breast Health Network: This groundbreaking project will initially involve 150,000 women throughout California who will be screened for breast cancer and followed for decades through the five University of California Medical Centers. ATHENA is a University of California system-wide project supported by a $5.3 million University of California grant, and by a $4.8 million grant from the Safeway Foundation. This unique collaboration will revolutionize the delivery of care by integrating research and clinical care in prevention, screening, treatment and management of breast cancer. During the past thirty-two years at UC Irvine, Dr. Anton-Culver has established major research programs in cancer epidemiology and cancer genetics. Under her leadership, the Department of Epidemiology and the Genetic Epidemiology Research Institute are currently engaged in conducting several research studies in cancer epidemiology funded by the National Cancer Institute and other agencies. One study combines techniques in genetic epidemiology and molecular markers to define and characterize inherited breast/ovarian cancer in the population of Orange County. Another focuses on colon and rectum cancers to study the effects of genetic influence on the FCC genes as they interact with diet, physical activity, and other factors that may influence the risk for colorectal cancer. Publications 123. Milne RL, Goode EL, Garc\u00eda-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, P, Cox A, Brock IW, Elliot G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC, Huang CS, Hou MF, Nordestgaard BG, Bojesen SE, Lanng Barile L, John EM, Hoover RN, Fletcher O, Gibson LJ, dos Santos Silva I, Peto J, Nickels S, Flesch-Janys D, Anton-Culver H, Ziogas A, Sawyer E, Tomlinson I, Kerin M, Miller N, Schmidt MK, Broeks B, Jakubowska A, Lubinski J, Jaworska K, Durda K, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Kraft P, Lindstrom S, Chen X, Beesley Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Khusnutdinova E, Bermisheva M, Prokofieva D, Farahtdinova A, Olson JE, a susceptibility locus for progesterone-receptor-positive, lower grade B, Malats Tollenaar Seynaeve C, Hall P, Czene K, Liu J, Irwanto AK, Kang D, Yoo KY, Noh DY, Couch FJ, Olson JE, Wang X, Fredericksen Z, Nordestgaard BG, Bojesen Beckmann MW, Wang-Gohrke S, Shen Yu JC, Hsu HM, Wu PE, Giles GG, Severi G, Baglietto L, English DR, Cox A, Brock I, Elliott G, Reed MW, Beesley J, Chen X, Investigators K; AOCS Group, Fletcher O, Gibson L, dos Santos Silva I, Peto J, Frank B, Heil J, Meindl A, Chang-Claude J, Hein R, Vrieling A, Flesch-Janys D, Southey MC, Smith L, and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet. 2011 Oct;48(10):698-702. doi: 10.1136/jmedgenet-2011-100303.PMID:21931171 125. Bessonova L, Marshall SF, Ziogas A, Largent J, Bernstein L, Henderson KD, Ma H, West DW, Anton-Culver H. The association of body mass index with mortality in the California Teachers Study. Int J Cancer. 2011 Nov 15;129(10):2492-501. doi: 10.1002/ijc.25905. Epub 2011 Strick R, Peto J, dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, H, BG, J, Zamora Brenner H, M\u00fcller H, Arndt V, Rahman N, Turnbull C, H, Justenhoven C, T; Hein Wang-Gohrke D\u00f6rk T, Sch\u00fcrmann P, Bremer M, Hillemanns P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylk\u00e4s K, Jukkola- Vuorinen A, Grip M, Andrulis I, Knight JA, Mulligan AM, O'Malley FP, Brinton ME, Lissowska P, Czene K, Cox IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Ding SL, Hsu HM, Yu JC, Anton-Culver H, Ziogas A, Ashworth A, Swerdlow A, Jones M, Orr N, Trentham-Dietz A, Egan K, Newcomb P, Titus-Ernstoff L, Easton D, Spurdle AB. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2011 Dec 1;20(23):4693-706. Fasching Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, dos Santos Silva I, Gibson L, Sawyer E, Tomlinson I, Kerin MJ, Chanock S, Lissowska J, RL, P\u00e9rez Hein R, Wang-Gohrke S, D\u00f6rk J, Chenevix-Trench G, Chen X, Peterlongo P, Bonanni B, Bernard L, Manoukian S, Wang X, Cerhan J, Vachon CM, Olson J, Giles GG, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola- Vuorinen A, Grip M, Andrulis I, Knight JA, Glendon G, Mulligan AM, Cox A, Brock IW, Elliott G, SS, Pharoah PP, Dunning AM, Pooley KA, Humphreys MK, Wang J, Kang D, Yoo KY, Noh DY, Sangrajrang S, Gabrieau V, Brennan P, McKay Investigators; Ovarian of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer. 2011 Dec 6;105(12):1934-9. doi: 10.1038/bjc.2011.448. Epub 2011 Oct 27.PMID:22033276 128. O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N, Orr N, dos Santos Silva I, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F; Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), Hall P, Czene K, Irwanto A, Liu J, R, Nickels S, Flesch-Janys D, Tsimiklis H, Makalic E, Schmidt D, Bui M, Hopper JL, Apicella C, Park DJ, Southey M, Broeks Tomlinson I, Kerin Schneeweiss A, Sohn MR, Gonz\u00e1lez-Neira A, Ben\u00edtez J, Anton-Culver H, Ziogas Bernstein Brauch H, Br\u00fcning T; Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network, Wang-Gohrke S, Eilber U, D\u00f6rk T, Bonanni B, Fortuzzi S, Peterlongo P, Couch FJ, Wang X, Stevens K, Lee A, Giles GG, Baglietto L, Severi G, McLean C, Alnaes GG, Kristensen B\u00f8rrensen-Dale AL, John EM, Miron Pylk\u00e4s K, Jukkola-Vuorinen A, Kauppila S, A, Oldenburg RA, van den Ouweland AM, Cox A, Reed MW, Shah M, Jakubowska A, Lubinski J, Jaworska K, Durda Jones M, A, Beesley J, Chen Muir KR, Lophatananon A, Rattanamongkongul S, Chaiwerawattana A, Kang D, Yoo KY, Noh DY, Shen CY, Yu JC, Wu PE, Hsiung CN, Perkins A, Dunning AM, Rahman N, Peto J, Easton DF.Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet. 2012 Jan 22;44(3):312-8. A, Zell JA. Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry. J Bone Joint Surg Am. 2012 Feb 15;94(4):356-63. doi: 10.2106/JBJS.J.01784.PMID:22336975 130. Stevens KN, Fredericksen Z, Vachon Margolin S, Lindblom Nevanlinna H, Greco A, Nickels A, Bartram CR, Schott Engel Weaver J, Pathak HB, Sharma P, Brenner H, M\u00fcller A, Fountzilas G, Gogas HJ, Swann RL, Ben\u00edtez J, Burwinkel B, Marm\u00e9 F, C, Sawyer E, Tomlinson I, Kerin MJ, Peto J, Johnson N, Fletcher O, Dos Santos Silva I, Fasching PA, Beckmann MW, Hartmann A, Braaf LM, Park DJ, Swerdlow Orr N, H, Ziogas A, Bernstein L, Dur CC, Shen CY, Yu JC, Hsu HM, Hsiung CN, Hamann D\u00fcnnebier T, Dunning AM, Humphreys MK, Wang Q, Cox A, Cross SS, Reed MW, Hall P, Czene K, Ambrosone CB, Ademuyiwa F, Hwang Eccles AM, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, John EM, Miron A, Aln\u00e6s GG, Kristensen V, B\u00f8rresen-Dale AL, Giles Severi G, Kosel ML, Pankratz Slager S, Olson a Cancer Res. 2012 Apr 1;72(7):1795-803. 10.1158/0008-5472.CAN-11-3364. 13.PMID:22331459 131. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen Menon MC, Risch H, Wu AH, Berchuck A; Ovarian Cancer Association Consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis Oncol. Barleben A, S, Stamos MJ, Zell JA. Population-based evaluation of adenosquamous carcinoma of and rectum. Dis Colon Rectum. May;55(5):509-14. doi: van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N, Milne RL, Zamora U, Hein R, Nickels S, Flesch-Janys D, Wang-Gohrke S, John EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Chenevix-Trench G, Beesley J, Chen X; Investigators kConFab; Australian Ovarian Cancer Study Group, Menegaux F, Cordina-Duverger E, Shen CY, Yu JC, Wu PE, Hou MF, Andrulis IL, Selander T, N, Ashworth A, Swerdlow A, Severi G, Baglietto L, Giles G, Southey M, Marm\u00e9 F, Schneeweiss A, Sohn C, Burwinkel PA, Schulz-Wendtland R, Ekici AB, Beckmann MW, Fletcher O, N, Idos Peto Nevanlinna H, Muranen TA, Aittom\u00e4ki P, Peterlongo P, Manoukian S, Bernard L, Couch FJ, Olson JE, Wang X, Fredericksen Z, Alnaes GG, Kristensen J, Sherman ME, Hall P, Liu J, Czene K, Kang D, Yoo KY, Noh DY, a locus for hormone receptor positive breast cancer. Hum Mutat. 2012 Jul;33(7):1123-32. doi: 10.1002/humu.22089. Epub 2012 A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Gu\u00e9nel MP, Ben\u00edtez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, M\u00fcller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Andrulis G, Mulligan AM, Figueroa Seynaeve C, Coll\u00e9e M, Hall P, Humpreys K, Czene K, Liu J, Cox A, Brock IW, Cross SS, Reed MW, Ahmed S, Ghoussaini M, Pharoah PD, Kang D, Yoo Noh Durda K, Zlowocka E, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Yu JC, Hsu HM, Hou MF, Orr N, Schoemaker M, Ashworth A, Swerdlow A, Trentham-Dietz A, Newcomb PA, Titus L, Egan KM, Chenevix-Trench G, Antoniou AC, Humphreys MK, DF, Dunning AM.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).PLoS One. 2012;7(8):e42380. Epub van R, Dunning AM, Czene K, Liu J, Chang-Claude J, Wang-Gohrke S, Eilber U, Nickels S, D\u00f6rk T, Schiekel M, Bremer M, S, Couch FJ, Stevens KN, Olson JE, Kosel M, Cross SS, Balasubramanian SP, Reed MW, Miron A, John EM, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Kauppila S, Schmidt MK.The Nguyen Nguyen VQ, Ziogas A, Hohmann S, Stamos MJ. Outcomes of 23.PMID:22727608 137. Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC, P, Truong T, Laurent-Puig P, C, Ovarian Study Lambrechts D, Smeets A, Paridaens R, Weltens C, Flesch-Janys D, Buck K, Behrens S, Peterlongo P, Bernard L, Manoukian S, Radice P, Couch FJ, Vachon C, Wang X, Olson J, Giles G, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Mulligan AM, Weerasooriya N, A, Tilanus-Linthorst MM, Hall P, Czene K, Liu J, Li J, Cox A, Cross SS, Brock IW, Reed MW, Pharoah P, Blows FM, Dunning Swerdlow A, Jones M, Schoemaker M, DF, Humphreys M, Wang Q, Peto a susceptibility locus for estrogen receptor-positive breast from Anton-Culver Fasching PA, Anton-Culver Lambrechts M, Cox A, Giles GG, B, Lindblom A, Couch FJ, Mannermaa A, G, John EM, D\u00f6rk T, Flyger H, Dunning AM, Wang Q, Hien Figueroa Kosma Kristensen VN, Miron A, Bogdanova N, Shah M, Blomqvist C, Broeks A, Sherman M, Phillips KA, Li J, Liu J, Glendon G, Seynaeve C, Ekici AB, Leunen K, Kriege M, Cross SS, Baglietto L, Sohn C, Wang X, Kataja V, B\u00f8rresen-Dale A, Easton DF, Schmidt MK, Bojesen SE.CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.J Clin Oncol. 2012 Dec 10;30(35):4308-16. TH, Ziogas A, Meyskens FL Jr, Anton-Culver H.A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.Pigment Cell Melanoma Res. Epub K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee Larson Anton-Culver H, Antonenkova N, Antoniou AC, Cancer LA, Brooks-Wilson A, Brown R, Butzow R, Cai Q, Campbell I, Chang- Claude J, Chanock S, Chenevix-Trench G, Cheng JQ, Cicek Coetzee GA; Consortium of Investigators of Modifiers of BRCA1/2, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Despierre E, Doherty D\u00fcrst Easton J, Goodman MT, Gore M, G\u00f3rski B, Gronwald J, Hall P, Halle MK, S, Lancaster JM, Le ND, Leminen A, Levine DA, Liang D, Lim BK, Lin J, Lissowska J, Lu KH, Lubinski J, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson SH, Orlow I, Paul J, Pearce CL, Pejovic T, Pelttari Sutphen R, Teo SH, KL, Tessier DC, Thompson PJ, Tworoger SS, van Altena Vierkant RA, Winterhoff B, Woo YL, Wu AH, Xiang YB, Yang HP, Zheng W, Ziogas A, Zulkifli F, Iversen Sellers TA, Gayther SA.Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.Nat Commun. 2013;4:1627. doi: 10.1038/ncomms2613.PMID:23535648 142. JM, M; PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Omar SZ, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, T, AN, Moes- Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubinski J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Garcia-Closas M, Bois Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA; Australian Ovarian Cancer Study Group; Australian Cancer Study, Schildkraut JM, Sellers TA, A, Chenevix-Trench G, SA, Pharoah PD, Laird PW, Goode EL, Pearce CL.Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for doi: CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Goode RA, Larson MC, EV, Olson SH, Rodriguez-Rodriguez Yang H, Garcia-Closas M, U, Gentry-Maharaj A, Webb PM; Ovarian Cancer Association Consortium. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. doi: 10.1530/ERC-12-0395. Print 2013 Apr.PMID:23404857 145. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, H\u00e4berle L, Vrieling A, Gaudet M, Figueroa J, Schoof AB, Idos S, Peto J, Humphreys MK, Wang Lanng Clarke CA, Brenner H, M\u00fcller H, Paridaens R, Flesch-Janys D, Obi N, Wang-Gohrke S, Couch FJ, Olson JE, Vachon CM, Giles GG, Severi G, Baglietto L, Offit K, John EM, Miron A, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Chanock SJ, Lissowska J, Liu A, Cramp H, Connley D, Balasubramanian S, Dunning AM, Shah M, Trentham-Dietz A, Newcomb P, Titus L, Egan K, Cahoon EK, Rajaraman P, Sigurdson AJ, Doody Chang-Claude of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 2013;9(3):e1003284. Beckmann K, Illig T, Seibold P, Behrens S, Humphreys K, Li J, Liu J, Olson JE, Wang X, Hankinson SE, Truong T, Menegaux F, Dos Santos Silva I, Johnson N; GENICA Network, Chen ST, Yu JC, Ziogas A, Kataja V, Kosma VM, Mannermaa A, Anton-Culver H, Shen CY, Brauch H, Peto J, Gu\u00e9nel P, Kraft P, Couch FJ, Easton DF, Hall P, Chang-Claude J.A genome-wide association study to genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.Breast Cancer Res Treat. Ramus SJ, Phelan EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, Bacot F, Vincent D, Cunningham JM, Dennis J, Dicks E; Australian Cancer Study; Australian Ovarian Cancer Study Group, Aben Brooks-Wilson A, Brown R, Butzow R, Campbell I, Carney ME, Carvalho RS, Chang-Claude J, Chen YA, Chen Z, Chow WH, Cicek MS, Coetzee G, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Despierre E, Doherty JA, D\u00f6rk T, du Bois A, D\u00fcrst M, Eccles D, Edwards R, Ekici D, Flanagan J, Gao YT, Garcia-Closas M, Gentry-Maharaj A, Giles G, Gjyshi A, Gore M, Gronwald J, Guo Q, Halle MK, Harter P, Hein A, J, Lambrechts D, Lambrechts S, Le ND, Lee N, Lee J, Leminen A, Lim BK, Lissowska J, Lubinski J, Lundvall L, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson S, Orlow I, Paul J, Pejovic T, Pelttari LM, Permuth-Wey J, Pike MC, Poole EM, Qu X, Risch HA, Rodriguez- Rodriguez L, W, MC, Spellman KL, Thompson PJ, Timorek A, Tworoger SS, van Altena AM, van den Berg Vergote Vierkant E, Winterhoff B, Woo YL, Wu AH, Yang HP, Zheng W, Ziogas A, Zulkifli F, Goodman MT, Hall P, Easton JM, TA.GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet. 2013 K, JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wang Q, Dennis J, McGuffog L, Barrowdale D, Lee A, Healey S, Lush M, Tessier DC, Vincent D, Bacot F; Australian Cancer Study; Australian Ovarian Cancer Study; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab); Gene Environment Interaction and Breast Cancer (GENICA); Swedish Breast Cancer Study (SWE-BRCA); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Vergote Lambrechts S, Despierre E, Risch HA, Gonz\u00e1lez-Neira A, Rossing MA, Pita G, Doherty JA, Alvarez N, Larson MC, Fridley BL, Gu\u00e9nel P, Teoman A, Milne RL, Garcia JJ, Cox A, Shridhar V, Burwinkel B, Marme F, Hein R, Sawyer EJ, IL, GG, Brenner H, Simard PA, Carney Radice P, Wilkens LR, Swerdlow H, Bunker CH, Kristensen V, Ness RB, Muir K, Edwards R, Meindl A, Heitz F, Matsuo K, du Bois A, Wu AH, Harter P, Teo SH, Schwaab I, Shu XO, Blot W, Hosono S, Kang D, Nakanishi T, Hartman Yatabe U, Karlan SK, Gaborieau V, Jensen A, Eccles D, H\u00f8gdall E, Shen CY, Brown J, Woo YL, Shah M, Azmi MA, Luben Vierkant RA, Nordestgaard BG, Flyger H, Vachon C, Olson JE, Wang X, Levine DA, Rudolph A, Weber RP, Flesch-Janys D, Iversen E, Nickels S, Schildkraut JM, Silva Idos S, Cramer DW, Gibson L, Fletcher O, Schoot SS, Liu J, Bandera EV, Li J, Olson SH, Humphreys K, Orlow Rodriguez-Rodriguez MP, Cook LS, Balasubramanian SP, Kelemen LE, Schneeweiss A, ND, Sohn A, Tomlinson I, Kerin MJ, Miller N, Cybulski C, Henderson BE, Menkiszak J, Schumacher F, Wentzensen N, Le Marchand L, Yang HP, Mulligan AM, Glendon G, Engelholm SA, Knight JA, H\u00f8gdall CK, Apicella C, Gore M, Tsimiklis H, Song H, Southey MC, Jager A, Brown Kriege Whittemore AS, Baglietto C, W, M\u00fcller H, Arndt V, Labr\u00e8che F, Gao YT, Goldberg MS, Yang G, Dumont M, McLaughlin JR, Hartmann A, Ekici AB, Beckmann MW, Phelan CM, Lux MP, Permuth-Wey J, Peissel B, Sellers TA, Ficarazzi F, Barile M, A, Ashworth A, Gentry-Maharaj A, SJ, N, H, Tajima K, Tseng CC, DO, van den Berg D, Yip CH, Ikram MK, Teh YC, Cai H, Lu W, Signorello LB, Cai Q, Noh DY, Yoo KY, Miao H, Iau PT, Teo YY, McKay J, Shapiro C, Ademuyiwa F, Fountzilas G, Hsiung CN, Yu JC, Hou MF, Healey CS, Luccarini C, Peock S, Stoppa-Lyonnet D, Peterlongo P, Rebbeck TR, Piedmonte M, Singer CF, Friedman E, Thomassen M, Offit K, Hansen TV, Neuhausen SL, Szabo J, Narod Caldes T, Imyanitov EN, Tihomirova Os TA, Evans DG, Frost D, Fineberg E, Barwell J, Walker L, Kennedy MJ, Platte R, Davidson R, Ellis SD, Cole T, Bressac-de Paillerets B, Buecher B, Damiola F, Faivre D, Giannini G, Bernard L, Dolcetti R, Manoukian S, Arnold N, Engel C, Deissler H, Rhiem K, Niederacher D, Plendl M, Gerdes AM, Ejlertsen B, Foretova L, Savage SA, Lester J, Soucy P, Kuchenbaecker KB, Olswold C, Cunningham JM, Slager S, Pankratz VS, Dicks E, Lakhani SR, Couch Hall P, Monteiro AN, Gayther SA, Pharoah PD, Reddel Antoniou AC, Chenevix-Trench variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013 Apr;45(4):371-84, 384e1-2. doi: 10.1038/ng.2566.PMID:23535731 149. Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM; for Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, Carney ME, Goodman MT, Moysich K, Hogdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Vierkant RA, Weber Aben Berchuck Doherty JA, Iversen E, McGuire V, Moorman PG, Pharoah P, Pike H, Sieh JM, Kjaer SK; Ovarian Cancer Association Consortium.Combined and interactive effects of environmental and GWAS-identified risk factors Whittemore AS, Karlan BY, SB, Fasching PA, Campbell I, Goodman MT, Pejovic T, Bean Y, Lurie G, Eccles D, Hein A, Beckmann MW, Ekici AB, Paul J, R, Bois Lundvall L, Olson SH, Orlow I, Eilber U, Dansonka-Mieszkowska A, Rzepecka IK, Ziolkowska-Seta M, Despierre E, Lambrechts S, Vergote I, Walsh C, Lester J, Sieh W, McGuire V, Rothstein JH, Ziogas A, Lubinski SA, SJ, A, Berchuck A, D, Terry KL, Vitonis AF, Doherty JA, Johnatty SE, Defazio A, Song H, Tyrer J, Sellers TA, Phelan CM, Kalli KR, Cunningham JM, Fridley BL, Goode EL.Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer Ziogas A, Anton-Culver H.Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013 Jun;148(6):516-23. Ziogas A, Anton-Culver H.Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013 Jun;121(6):1226-34. doi: 10.1097/AOG.0b013e3182922a17.PMID:23812456 153. Kent TJ, Montoya MJ, Ziogas A, Anton-Culver H.Multilevel socioeconomic effects on quality of life in adolescent and young adult survivors of leukemia and lymphoma.Qual Life Res. 2013 Aug;22(6):1339-51. doi: 10.1007/s11136-012-0254-z. Epub 2012 Aug 26.PMID:22922952 154. Meyer KB, O'Reilly M, Michailidou K, Carlebur S, Edwards SL, French JD, Prathalingham R, Dennis J, Bolla MK, Wang Q, de Santiago I, Hopper JL, Tsimiklis H, Apicella C, Southey MC, MP, Ekici AB, Beckmann MW, Peto J, Dos Santos Silva I, Fletcher O, Johnson N, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme Gu\u00e9nel JI, Benitez H, Muranen TA, Aittom\u00e4ki K, Blomqvist Matsuo K, Ito H, Iwata H, Yatabe Y, D\u00f6rk T, Helbig Ovarian Cancer Study Group, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Lambrechts D, Thienpont B, Christiaens MR, Smeets P, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Bernard L, Couch FJ, Olson JE, Wang X, Purrington K, Giles GG, Severi G, Baglietto L, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labr\u00e8che F, Dumont M, Teo SH, CH, Phuah SY, Kristensen V, Grenaker Deming-Halverson S, M, Long J, Winqvist R, Pylk\u00e4s K, Vuorinen Kauppila den Ouweland AM, van Deurzen CH, Hall P, Li J, Liu J, Humphreys K, Shu XO, Lu W, Gao YT, Cai H, Cox A, Reed MW, Blot W, Signorello LB, Cai Q, Pharoah PD, Ghoussaini M, Harrington P, Tyrer J, Kang D, Choi JY, Park SK, Noh DY, Hartman M, Hui M, Lim Buhari K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Vachon C, Slager S, Fostira F, Pilarski R, Shen CY, Hsiung CN, Wu PE, Hou MF, Swerdlow A, Ashworth A, Ponder AM, Easton DF. functional variants differentially bind 5;93(6):1046-60. 10.1016/j.ajhg.2013.10.026. Smith EC, Ziogas A, Anton-Culver H.Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults.Cancer. 2012 Dec 15;118(24):6179-87. doi: 10.1002/cncr.27684. Epub Bandera EV, Orlow I, Terry K, Goodman MT, Thompson PJ, Cook LS, Rossing MA, Ness RB, Narod SA, Kupryjanczyk J, Lu K, Butzow R, D\u00f6rk T, Pejovic T, CH, Bogdanova N, Runnebaum IB, Eccles Heitz F, Levine DA, Kjaer SK, Cramer D, Flanagan JM, Phelan CM, Brown R, Massuger LF, Song H, Doherty JA, Krakstad C, Liang D, Odunsi K, Berchuck A, Jensen A, Lubinski J, Nevanlinna H, Bean YT, Lurie G, Ziogas A, Walsh C, Despierre E, Brinton L, Hein A, Rudolph A, Dansonka-Mieszkowska A, Olson SH, Harter P, Tyrer Cybulski C, Lin J, Sucheston L, Edwards R, McGuire V, Lester J, du Bois A, Lundvall L, Wang-Gohrke van Gentry-Maharaj A, the NF-?B pathway: genetic association with IL1A and TNFSF10. Cancer Res. Feb 1;74(3):852-61. doi: 10.1158/0008-5472.CAN-13-1051. Epub 2013 Nov 22. PMID:24272484 J, Ziogas A, Randall LM, Anton-Culver H. High-volume ovarian cancer care: survival impact and disparities in access advanced-stage disease. Oncol. B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kj\u00e6r SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson Menon U, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.J Natl Cancer Inst. 2014 Feb;106(2):djt431. Karnes W, Stamos Zell JA. Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV MJ, Sender LS, Morris RA, Ziogas A, Anton-Culver H.Attitudes Toward Cancer Clinical Trial Participation in Young Adults with a History of Cancer and a Healthy College Student Sample: A Preliminary Investigation.J Adolesc Young Adult Oncol. 2014 Mar 1;3(1):20-27.PMID:24669355 161. Milne Herranz J, Michailidou JP, Zamora MP, Arias-Perez JI, Gonz\u00e1lez- Neira A, Pita Alonso MR, Wang Q, Bolla MK, Czene K, Eriksson M, Humphreys K, Darabi H, Li J, Anton-Culver H, Neuhausen SL, Ziogas A, Ashworth A, Orr N, Schoemaker M, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Wang X, Olson JE, Vachon C, Purrington K, Winqvist R, Pylk\u00e4s K, Jukkola- Vuorinen A, Grip M, Dunning AM, Shah M, Gu\u00e9nel P, Truong T, Sanchez M, Mulot C, Brenner Tollenaar RA, Seynaeve C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Dumont M, Soucy P, D\u00f6rk T, Bogdanova L, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Radice P, Peterlongo P, Peissel B, Mariani G, Baglietto L, Sawyer E, Tomlinson I, Kerin Miller N, Marme F, assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer Mol Hartmann LC, Lawrenson K, Wang C, Tyrer J, Song H, deFazio A, Johnatty SE, Doherty JA, Phelan CM, Sellers TA, Ramirez SM, Vitonis AF, Terry KL, Van Den Berg D, AH, Berchuck A, Gentry-Maharaj A, Ramus SJ, Diergaarde Shen Lubilski J, Ziogas A, Rothstein JH, McGuire V, Sieh W, Lester J, Walsh C, Vergote I, Lambrechts S, Despierre E, Garcia-Closas B, Rzepecka IK, Dansonka-Mieszkowska A, Seibold P, Rudolph A, I, Lundvall L, Olson SH, Hogdall Bois Harter Paul J, Ekici AB, Beckmann MW, Hein A, Eccles D, Lurie G, Hays LE, Bean YT, Pejovic T, Goodman MT, Campbell I, Fasching PA, Whittemore AS, Culver HA, J, DA, LE, Knutson KL, Goode EL.Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.Cancer Immunol Res. 10.1158/2326-6066.CIR-13-0136. Smoak C, Bohr T, K, Disease: A Confirmatory Study.Br J Med Med Res. Apr 21;4(12):2388-2417. PMID:24977122 164. Davanipour Z, Sobel E, (sCJD): A Confirmatory Case-Control Study. Br J Med Med Res. 2014 Apr 30;4(12):2322-2333.PMID:25089261 165. Earp MA, Kelemen G; Australian Cancer Study; Australian Ovarian Cancer Study Group, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts S, Doherty JA, Rossing MA, Chang- Claude J, Rudolph A, Friel G, Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Goodman MT, Carney ME, Thompson PJ, Runnebaum IB, D\u00fcrst M, Hillemanns R, CH, F, RP, RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, Walsh C, Lester J, Jensen A, Kj\u00e6r SK, H\u00f8gdall CK, H\u00f8gdall E, Lundvall L, Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA, Bisogna M, Schildkraut JM, Iversen ES, Weber RP, Berchuck EM, Tworoger N, Brinton J, Garcia-Closas M, Dicks E, DF, Song H, Tyrer JP, Pharoah PD, Eccles W, Rothstein JH, Flanagan JM, Paul J, Brown R, Phelan CM, Risch HA, McLaughlin JR, Narod SA, Ziogas A, A, Ovarian Cancer Association Consortium.Genome-wide association study of subtype-specific epithelial ovarian cancer risk Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang- Claude J, Martin NG, Montgomery GW, Kristensen V, Goodfellow Renner W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold J, L, Reed MW, Cross SS, Deming-Halverson S, Shrubsole M, Cai Q, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, R\u00fcdiger T, W\u00f6lfing HU, K, Blomqvist C, Irwanto Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A, Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM, Couch FJ. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Carcinogenesis. 2014 May;35(5):1012-9. doi: 10.1093/carcin/bgt404. PG, SE, Strong LC, Ziogas A, Griffin CA, Kasten CH, Finkelstein DM. Long-term risk of medical conditions associated with breast cancer treatment.Breast Cancer Res Treat. 2014 May;145(1):233-43. doi: 10.1007/s10549-014-2928-4. Epub 2014 Apr 3.PMID:24696430 168. Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, M, Miller N, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Gu\u00e9nel BG, H, Milne R, Zamora MP, Arias Perez JI, Benitez J, Bernstein L, Anton-Culver H, Ziogas A, Clarke Dur C, Brenner H, M\u00fcller Arndt C, Ko YD; GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Nevanlinna H, Muranen TA, Aittom\u00e4ki K, Blomqvist kConFab Investigators; Australian Ovarian Cancer Study Group, Wu AH, Van den Berg D, Tseng CC, Lambrechts D, Smeets D, Neven P, Wildiers H, Chang-Claude Rudolph A, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Pensotti V, Couch FJ, Olson JE, Wang X, Fredericksen Z, Pankratz VS, Giles GG, Severi G, Baglietto L, Haiman C, Simard J, Goldberg MS, Labr\u00e8che F, Dumont M, Soucy P, K, Jukkola- Vuorinen A, Grip M, Andrulis Knight AM, Devillee P, Figueroa J, Chanock ME, Hall P, Schoof N, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Liu J, Cox A, Brock IW, Reed SS, Blot W, Signorello PD, Dunning AM, Shah M, Kang D, Noh DY, Park SK, Choi JY, Hartman M, Miao H, Lim WY, Tang A, Hamann F\u00f6rsti A, J, Slager S, Toland AE, Vachon C, Yannoukakos D, Shen CY, Yu JC, Huang CS, Hou MF, Gonz\u00e1lez-Neira A, Tessier DC, Vincent D, Bacot F, Luccarini C, A, Peto J, dos Santos Silva I, Fletcher O.Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.Breast Cancer Res. 2014 May 26;16(3):R51. 169. RE, Chang J, Ziogas A, Anton-Culver H, Vieira VM.Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.Gynecol Oncol. 2014 Jul;134(1):60-7. doi: 10.1016/j.ygyno.2014.03.561. Pearce Schildkraut J, Menon U, Kjaer SK, Levine DA, Gronwald Culver HA, Whittemore AS, Karlan BY, SB, PA, Campbell I, Goodman MT, Pejovic T, Bean YT, Hays LE, Lurie G, Eccles D, Hein A, Beckmann MW, Ekici AB, Paul J, R, Bois Lundvall L, Olson SH, I, U, Dansonka- Mieszkowska Rzepecka M, Despierre E, Lambrechts S, Vergote I, Walsh CS, Lester J, Sieh W, McGuire V, Rothstein JH, Ziogas A, Lubinski Maharaj A, Berchuck A, Wu Den Berg D, KL, Vitonis AF, Ramirez SM, Rider DN, Knutson KL, Sellers TA, Phelan CM, Doherty JA, Johnatty SE, deFazio A, Song H, Tyrer J, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa HA, McLaughlin JR, Siddiqui N, Glasspool R, Paul J, Carty K, Gronwald J, J, A, Aben Olson SH, Orlow Nevanlinna MW, A, Ekici AB, Doherty JA, Wu AH, Pearce CL, Pike MC, Stram D, Chang-Claude J, IB, RP, Kelley JL, Modugno F, Ness RB, Karlan BY, Walsh C, Lester J, Orsulic S, Fridley BL, Vierkant RA, Cunningham JM, Wu X, Lu K, Liang D, Hildebrandt MA, Weber RP, Iversen ES, Tworoger SS, Poole EM, Salvesen HB, Krakstad M, Wentzensen N, Brinton LA, Lissowska J, Garcia-Closas JH, Anton-Culver JM, Berchuck A, Pharoah PD, Sellers TA, Brooks-Wilson A, Cook LS, Le ND.Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian Bojesen SE, Andrulis IL, Cox A, Hall P, Carpenter J, Yannoukakos D, Haiman CA, Fasching PA, Mannermaa BG, Nielsen SF, Flyger H, Wang X, Olswold C, Olson JE, Mulligan AM, Knight JA, Tchatchou S, Reed MW, Cross SS, Liu J, Li J, Humphreys K, Clarke C, Scott R; ABCTB Investigators, Fostira F, Fountzilas G, Konstantopoulou I, Henderson BE, Schumacher F, Le Marchand Ekici Hartmann Ovarian Cancer Study kConFab Balleine Arias Perez JI, Pilar Zamora M, Men\u00e9ndez P, Ashworth A, Jones M, Orr T, Bugert P, Toland CB, Labr\u00e8che F, MS, Dumont M, A, Lee E, Dite GS, Apicella C, Southey L, Mclean C, Milne RL, Baglietto L, dos Santos Silva I, Fletcher O, Johnson N, Van'T Veer LJ, Cornelissen S, F\u00f6rsti A, Torres D, R\u00fcdiger T, Rudolph A, Flesch-Janys D, Nickels S, Weltens C, Floris G, Moisse M, Dennis J, Wang Q, Dunning AM, Shah M, Brown J, Simard J, Anton-Culver H, Neuhausen SL, Hopper JL, Bogdanova J, Devillee P, Brauch M, B, Marmee F, Eccles DM, Giles GG, Peto S, Vachon CM, Couch FJ.Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.Hum Mol Genet. 2014 Nov 15;23(22):6034-46. WT, Dillon PM, Busman KJ, From Anton-Culver Marrett S, H, JS, Begg CB, Berwick M; Genes, Environment, and Melanoma (GEM) Group.Comparison of features and survival Ziogas Anton-Culver H, Bristow RE. Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a Clin Oncol. PMID:25385738 175. Spurdle FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher S, Steinemann D, Preisler-Adams S, Kast K, Varon-Mateeva R, Ellis S, Frost D, Platte R, Perkins J, Evans DG, Izatt L, Eeles R, Adlard J, Davidson R, Cole Scuvera G, Manoukian S, Bonanni B, Mariette SL, Toland AE, Nevanlinna H, Montagna M, Garber J, Godwin AK, Osorio A, Factor RE, Terry MB, Rebbeck TR, Karlan BY, Southey M, Rashid MU, Tung N, Pharoah PD, Blows FM, Dunning AM, Provenzano E, Hall Schmidt Seibold J, VS, John EM, Whittemore AS, West DW, Hamann U, Torres D, Ulmer HU, Durcan L, Jones L, Peto J, dos-Santos-Silva I, Fletcher O, Johnson N, Dwek M, Swann R, Bane AL, Glendon G, Mulligan AM, Giles GG, Milne RL, Baglietto L, McLean C, Carpenter J, Clarke C, Scott R, Brauch H, Br\u00fcning T, Ko YD, Cox A, Cross SS, Reed MW, Lubinski J, Jaworska-Bieniek Durda N, Park-Simon TW, Hillemanns P, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Burwinkel B, Marme F, Surovy H, K, Jukkola-Vuorinen A, Grip M, Lindblom A, Margolin S, Joseph V, Robson M, Rau-Murthy R, Gonz\u00e1lez-Neira A, Arias JI, Zamora mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res. 2014 doi: 10.1186/s13058-014-0474-y.PMID:25857409 176. Kuchenbaecker Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, Coetzee S, Hazelett D, Miron A, Southey M, Terry MB, Goldgar DE, Buys SS, Janavicius R, Dorfling CM, van Rensburg Neuhausen J\u00f8nson Ejlertsen B, Barrowdale Dennis L, Ottini L, Fostira F, Konstantopoulou I, Garber J, Frost D, Perkins J, Platte R, Ellis S; EMBRACE, Godwin AK, Schmutzler Stoppa-Lyonnet K, De Leeneer K, Kirk J, Rodriguez GC, Piedmonte M, O'Malley DM, de la Hoya Tung N, Hamann U, Isaccs C, Tischkowitz Kauff N, Vijai J, Aghajanian CA, Pfeiler G, Berger A, Singer CF, Tea MK, Phelan CM, Greene MH, Mai PL, Rennert G, Mulligan AM, Tchatchou C, Lester J; Australian Cancer Study (Ovarian Cancer Investigators); Australian Ovarian Cancer Study Group, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Van Nieuwenhuysen Vergote Lambrechts S, Dicks E, Doherty JA, Wicklund KG, Rossing MA, Rudolph A, Chang-Claude J, Wang-Gohrke R, F, JL, RP, RB, du Bois A, Heitz F, Schwaab I, Harter P, Matsuo K, Hosono S, A, Kjaer SK, Hogdall MA, Cunningham JM, Vierkant RA, Bruinsma F, Giles GG, Liang D, Hildebrandt MA, Wu X, Levine DA, Bisogna M, Berchuck A, Iversen ES, Schildkraut JM, Concannon Tworoger SS, Cybulski C, Yang H, Lissowska J, Brinton LA, Wentzensen N, Hogdall C, Lundvall L, Nedergaard L, Baker H, Song H, Eccles D, McNeish I, Paul J, Carty K, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Ji BT, Zheng W, Shu XO, Gao YT, Rosen B, Risch HA, McLaughlin JR, Narod SA, Monteiro AN, Chen A, Lin HY, Permuth-Wey J, Sellers TA, Tsai YY, Chen Z, Ziogas A, Anton-Culver H, Gentry-Maharaj A, Menon U, Harrington P, Lee AW, Wu AH, Pearce CL, Coetzee G, Pike MC, Dansonka-Mieszkowska of of BRCA1 and BRCA2.Identification of six new susceptibility loci ovarian Genet. HL, Chang SS, Ziogas A, Neuhausen SL, Wang SS, Bernstein L, Anton-Culver H.Human Nail Clippings as a Source of DNA for Genetic Studies. Open J Epidemiol. 2015 Feb 1;5(1):41-50.PMID:26180661 178. McEligot AJ, Ziogas A, Pfeiffer CM, Fazili Z, H.The association between circulating total folate and folate vitamers with overall survival 2015;67(3):442-8. doi: 10.1080/01635581.2015.1002623. Epub 2015 3.PMID:25647689 Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Wicklund KG, Odunsi Schwaab I, Heitz F, du Bois A, Orsulic S, Lester J, Walsh C, Karlan BY, Hogdall E, Kjaer SK, Jensen A, BL, Southey MC, Giles GG, Bruinsma F, Wu X, Hildebrandt MA, Lu K, Liang D, Bisogna M, Levine DA, Weber RP, Schildkraut JM, Iversen ES, Berchuck A, Terry KL, Cramer Bean Pejovic T, Kellar M, Le ND, Cook LS, Kelemen J, Yang H, Nedergaard L, Lundvall L, Hogdall C, Song H, Campbell IG, Eccles D, Glasspool R, Siddiqui N, Carty K, Paul J, McNeish IA, Sieh W, McGuire V, Rothstein JH, Whittemore AS, McLaughlin JR, Risch HA, Ziogas A, Menon MA, Ness RB, Pharoah PD, Stram Wu AH, Pearce CL.Evaluating the ovarian 2014 Ziogas A, Tewari KS, Anton-Culver H, Bristow RE. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California. Am J Obstet Gynecol. 2015 doi: 10.1016/j.ajog.2014.10.1104. Epub Ziogas A, Campos B, Chavez LR, Anton-Culver H. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol. Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen M, Peto F, A, Verhoef S, SJ, Brinton L, Lissowska Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Men\u00e9ndez P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox Cross Reed Khusnutdinova RK, Sutter C, Yang R, Sch\u00fcrmann P, Bremer M, Christiansen H, Park- Simon TW, Hillemanns P, Gu\u00e9nel P, Truong T, Menegaux Sanchez M, P, Manoukian S, EJ, Tomlinson I, Kerin MJ, N, IL, Knight Glendon G, Marie Mulligan A, Chenevix- Trench G, Balleine R, Giles GG, Milne RL, McLean C, Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AM, Koppert LB, Carpenter J, Clarke C, Scott Kosma J, Robson M, Rau-Murthy R, Dwek M, Swann R, Annie Perkins K, Goldberg MS, Labr\u00e8che F, Dumont M, Eccles DM, Tapper WJ, Rafiq S, EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S, Zheng W, Halverson SL, Gonz\u00e1lez-Neira A, Pita G, Rosario Alonso M, \u00c1lvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. Ziogas A, Campos B, Chavez LR, Anton-Culver H. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival. J Am Coll Surg. 2015 May;220(5):940-50. Kanetsky PA, Luo L, A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett RP, S, Study Group.Inherited genetic variants associated with occurrence of Ziogas A, Tewari K, Bristow RE. Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population. Gynecol Oncol. 2015 Jun;137(3):479-84. doi: Alexander A, Groben PA, Parrish E, Kricker A, BK, Anton-Culver H, Gruber SB, From L, Busam KJ, Hao H, Orlow I, Kanetsky Luo Paine Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Doherty JA, D\u00f6rk T, D\u00fcrst M, Easton DF, R, Goodman MT, Gronwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Jakubowska Karlan BY, Kelemen LE, Kellar M, Kiemeney S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Sucheston L, Teo SH, Terry KL, PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant Vergote Walsh N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, H, Ziogas A, Pharoah PD, Sellers TA, Phelan CM.Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS One. 2015 Jun 19;10(6):e0128106. doi: 10.1371/journal.pone.0128106. RE, Gillen DL, Bai L, Vieira VM.Spatial analysis of advanced-stage ovarian cancer mortality in California. Am J Obstet Gynecol. Jul;213(1):43.e1-8. doi: Lawrenson K, Karst A, Drapkin R, Ramus SJ; Ovarian Cancer Association Consortium, The Consortium of Investigators of Modifiers of BRCA1/2, Couch FJ, Offit K, Chenevix-Trench G, PD, Noushmehr H, Gayther SA; Ovarian Cancer Association Consortium The Consortium of Investigators of Modifiers of BRCA1/2.Cell-type-specific enrichment of risk-associated regulatory elements at ovarian Mol Hodeib M, Liu F, Ziogas A, Dilley S, Randall LM, Anton-Culver H, Bristow RE. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Gynecol Oncol. Beesley J, Michailidou K, Nord S, Kar S, Humphreys K, Thompson D, Ghoussaini M, Bolla MK, Dennis J, Wang Q, Canisius S, Scott CG, Apicella C, Hopper JL, Southey H, Engel C, Meindl A, Schmutzler RK; German Consortium of Hereditary Breast and Ovarian Cancer, Arnold N, Brauch H, Hamann U, Chang- Claude J, Khan S, Nevanlinna H, Ito H, Matsuo K, Bogdanova NV, D\u00f6rk A, Floris G, Lambrechts D, Rudolph A, Peterlongo P, Radice P, Couch FJ, Vachon C, Giles GG, McLean C, Milne RL, Dugu\u00e9 PA, Haiman CA, Maskarinec G, Woolcott C, Henderson BE, Goldberg MS, Simard J, Teo SH, Mariapun S, Helland \u00c5, Haakensen Winqvist R, Andrulis M, M, Li J, Gao YT, XO, A, Cross SS, Luben R, Khaw Choi JY, Kang D, Hartman WY, Kabisch M, Torres D, Jakubowska J, McKay J, Sangrajrang S, Toland AE, Swerdlow A, Borresen-Dale in 10q21.2 Risk Locus Jun 11.PMID:26073781 192. Kelemen LE, K, Tyrer J, Li Q, Lee JM, Seo JH, Phelan CM, Beesley J, Chen X, Spindler Aben KK, Anton-Culver H, Antonenkova N; Australian Cancer Study; Australian Ovarian Cancer Study Group; Ovarian Cancer Association Consortium.Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat Genet. Aug;47(8):888-97. doi: Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE; Australian Ovarian Cancer Study Group, Fasching PA, D, HA, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Goodman MT, Ness RB, Moysich K, Heitz F, du Bois A, Harter P, Schwaab I, Matsuo K, Hosono MC, Rodriguez-Rodriguez LA, Lissowska J, H\u00f8gdall E, Lundvall L, Whittemore W, J, Sutphen R, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Webb PM; Ovarian Cancer Association Consortium.Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.Br J Cancer. 2015 Sep 1;113(5):817-26. doi: 7.PMID:26151456 SM, Lee J, Goodman D, Ziogas A, Kelly R, Larsen KM, Alvarez A, Tannous C, Strope J, Lynch W, Anton-Culver H. Clinical Implementation of a Breast Cancer Risk Assessment Program in a Multiethnic Patient Population: Which Risk Model to Use?Breast J. 2015 Sep-Oct;21(5):562-4. doi: 10.1111/tbj.12461. Epub 2015 Jul 31. abstract available.PMID: 26227105 195. Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth- Wey J, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois D\u00f6rk Harter P, Hasmad Hogdall E, Hosono S, Iversen Ji BT, Karlan BY, Kellar M, Kiemeney LA, Krakstad S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Thomsen KB, Ness RB, Nevanlinna Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Palmieri Weber R, Paul J, Pearce Pejovic Pelttari LM, Pike MC, Poole Teo SH, Terry KL, PJ, Tangen IL, Tworoger SS, van Altena AM, Vergote I, Walsh Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Amankwah E, Berchuck A; Georgia Chenevix-Trench Gayther SA, Pharoah PD, Sellers TA, Phelan CM. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). J Genet Genome Res. 2015;2(2). pii: 017. Epub 2015 Sep Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N; Australian Ovarian Cancer Study Baker Bandera Bean Y, Beckmann Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix- Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka- Mieszkowska A, Dennis J, Dicks E, Doherty JA, D\u00f6rk T, du Bois A, D\u00fcrst M, Eccles D, Easton GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt E, Hogdall C, Hosono S, Iversen ES, Jakubowska A, James P, Jensen A, Ji BT, Karlan BY, Kruger Kjaer S, Kelemen Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, Moysich SA, Nedergaard L, Ness RB, Azmi MA, Odunsi K, Olson SH, Orlow I, Orsulic RP, Pearce CL, Pejovic T, Pelttari LM, Risch HA, Tangen IL, Teo SH, Terry KL, PJ, Timorek A, Tsai YY, Tworoger SS, van AM, Van Nieuwenhuysen E, Vergote Vierkant RA, Wang-Gohrke AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Monteiro A, Pharoah PD, Gayther SA, Freedman ML.Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Commun. 2015 Sep 22;6:8234. doi: 10.1038/ncomms9234.PMID:26391404 197. Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix- Trench G; Australian Cancer Study; Australian Ovarian Cancer Study Baker Bandera Brooks-Wilson A, Butzow R, Campbell I, Carty K, Chang-Claude J, Chen YA, Chen Z, Cook LS, Cramer D, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Dicks E, Doherty JA, D\u00f6rk T, du Bois A, D\u00fcrst M, Eccles Gentry-Maharaj GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns E, Hogdall CK, Hosono S, Iversen ES, Jakubowska A, Paul J, Jensen A, Ji BT, Karlan BY, Kjaer SK, Kelemen LE, Kellar M, Kelley LA, C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger L, Matsuo K, McGuire V, McLaughlin JR, McNeish IA, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Odunsi K, Olson SH, Orlow I, Orsulic RP, Pearce CL, Pejovic T, Pelttari LM, Risch HA, Tangen IL, Teo SH, Terry KL, PJ, Timorek A, Tsai YY, Tworoger SS, van AM, Van Nieuwenhuysen E, Vergote Vierkant RA, Wang-Gohrke AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu A, Yang H, Zheng W, Ziogas A, Sellers TA, Monteiro AN, Freedman ML, Gayther SA, Pharoah PD. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer G, Painter JN, Nyholt DR; Australian Ovarian Cancer Study; International Endogene Consortium (IEC), Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Nieuwenhuysen JA, Rossing MA, Wicklund KG, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, F, Moysich KB, Ness RB, Cannioto R, H\u00f8gdall E, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry V, Whittemore AS, Cook Gronwald J, Jakubowska A, Lubinski JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, Mclaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, between endometriosis and ovarian Hum Mol Genet. 2015 Oct 15;24(20):5955-64. doi: 10.1093/hmg/ddv306. Lawrenson ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Bandera EV, Bean Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix-Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Plisiecka-Halasa J, Dennis J, Dicks E, Doherty JA, D\u00f6rk T, du Bois A, Eccles D, Easton DT, Goodman Gronwald J, Harter P, Hasmad HN, Hein A, Heitz P, Hogdall E, Hogdall C, Hosono S, Jakubowska A, Paul J, Jensen A, Karlan BY, Kjaer SK, Kelemen LE, Kellar S, Le ND, Lee AW, Cannioto R, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, L, RB, Azmi MA, Odunsi Olson CL, T, Pelttari Risch HA, Tangen IL, Teo SH, Terry KL, PJ, Timorek A, Tworoger SS, Van Nieuwenhuysen E, Vergote I, Vierkant Wang-Gohrke AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Coetzee GA, Freedman ML, Monteiro ovarian cancer. Carcinogenesis. Nov;36(11):1341-53. 10.1093/carcin/bgv138. Epub 2015 Sep 29.PMID:26424751 S, Chang Y, Hewitt S, Ziogas A.Measuring the quality of surgical decisions for Latina breast cancer patients. Health Expect. 2015 Dec;18(6):2389-400. doi: 10.1111/hex.12207. Epub 2014 May 12.PMID:24813584 201. Johnatty SE, Tyrer JP, Kar S, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Nieuwenhuysen Rossing MA, Doherty JA, Chang-Claude J, Modugno F, Ness RB, Moysich KB, Levine Lissowska J, Wentzensen N, Song H, Rhenius V, Campbell I, Eccles D, Sieh W, Whittemore Spiewankiewicz B, Goodman MT, LR, ME, PJ, Heitz F, du Schwaab I, Harter P, Pisterer J, Hillemanns P; AGO Study Group, Karlan Walsh C, Lester H\u00f8gdall Lundvall L, McNeish I, Paul J, Carty K, Siddiqui N, Glasspool R, Sellers T, Kennedy C, Chiew YE, Berchuck A, MacGregor S, Pharoah PD, Goode EL, deFazio A, Webb PM, Chenevix-Trench G; Australian Ovarian Cancer Study Group. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium. Clin Cancer Res. 2015 Dec 1;21(23):5264-76. doi: 10.1158/1078-0432.CCR-15-0632. Epub 2015 7.PMID:26152742 J, Ziogas A, Bristow RE. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.Gynecol Oncol. 2015 Lawrenson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chen Z, Chen YA, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka- Mieszkowska A, du Bois Despierre JA, D\u00f6rk T, D\u00fcrst M, Easton DF, Gronwald Harrington P, Harter P, Hasmad HN, Hein Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Jim H, Kellar M, Kiemeney LA, Krakstad C, SK, Kupryjanczyk S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Pike Sucheston-Campbell L, Teo SH, Terry KL, PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant Vergote Walsh N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Kelemen LE, Berchuck A; Georgia Chenevix-Trench PD, Sellers TA, Phelan CM. Epithelial- Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Risk. Genet Epidemiol. 2015 Dec;39(8):689-97. doi: 10.1002/gepi.21921. Trench G, Pearce CL; Ovarian Cancer Association Consortium.Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril. 2016 Jan;105(1):35-43.e1-10. I, Reiner AS, Thomas NE, Roy P, Kanetsky PA, Luo L, Paine S, Armstrong BK, Kricker LD, Rosso K, Begg CB, Berwick M; GEM Study Group.Vitamin D receptor polymorphisms and survival in patients with cutaneous a population-based Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Palmieri Moorman PG, J, Iversen ES, BL, Kruger-Kjaer J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Hillemanns P, D\u00fcrst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen P, Stefansson X; Ovarian Study Group, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas at 19p13 are associated to ovarian cancer. Nat Genet. 2016 Jan;48(1):101. doi: 10.1038/ng0116-101b. No abstract available. PMID:26711112 207. Park HL, Ziogas A, Chang J, Desai B, Bessonova L, Garner C, Lee E, Neuhausen SL, Wang SS, Ma H, Clague J, Reynolds P, Lacey JV Jr, Bernstein L, Anton-Culver H. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study. BMC Cancer. 2016 Jan 12;16:14. doi: H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, Ness RB, Pearce CL, Rossing MA, Tworoger SS, Wentzensen N, Bisogna M, Brinton ME, Cunningham JM, Edwards RP, Fogarty ZC, Iversen ES, Kraft HY, Lissowska J, Modugno F, Moysich KB, Olson SH, Pike MC, Poole EM, Rider DN, Terry KL, Thompson PJ, van den Berg D, Vierkant RA, Vitonis AF, Wilkens LR, Wu AH, Yang HP, Ziogas A, CM, Schildkraut JM, Chen YA, Sellers TA, Fridley BL, Goode EL. A targeted genetic association study of epithelial ovarian cancer susceptibility.Oncotarget. 2016 Feb 16;7(7):7381-9. doi: Anton-Culver H, Bandera JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, Menon U, Ness RB, Pearce CL, Pejovic T, Rossing MA, Wentzensen N, Bean Brinton LA, Carney ME, Cunningham JM, Cybulski C, deFazio A, Dicks EM, Edwards RP, Gayther SA, Gentry-Maharaj A, Gore M, Iversen ES, Jensen A, Johnatty SE, Lester J, Lin HY, Lissowska J, Lubinski J, SJ, Song H, Terry KL, Thompson PJ, Tyrer JP, van den Berg DJ, Vierkant RA, Vitonis AF, Walsh C, Wilkens LR, Wu Berchuck EL; Australian Ovarian Cancer Study Group.Investigation of Exomic Variants Associated with Overall Survival in Jensen PM, Nagle CM, H\u00f8gdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, Edwards RP, Goode Song Sieh W, Rothstein J, AH, CL, Pike MC, Lee AW, Chang-Claude J, Jensen A; Ovarian Cancer Association Consortium. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Apr;41:71-9. doi: 10.1016/j.canep.2016.01.012. Epub 2016 Feb 3.PMID: 26851750 211. Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, Hollestelle A, van N, Arun BK, Arver B, Ashworth A; Australian Ovarian Bjorge L, A, Bruinsma CH, Burwinkel B, Butzow R, Buys SS, Caligo MA, J, Chanock SJ, Claes KBM, Coll\u00e9e JM, Cook LS, Couch FJ, Cox A, Cramer D, Cross SS, Cunningham JM, Cybulski C, Czene K, Damiola F, Dansonka- Mieszkowska A, Darabi H, de la Hoya M, deFazio A, Dennis J, Devilee P, Dicks EM, Diez O, Doherty JA, Domchek SM, Dorfling CM, D\u00f6rk T, Silva IDS, du M, Dunning AM, Duran M, Easton D, H, B, AB, Ellis SD; EMBRACE, Engel Eriksson M, Fasching PA, Feliubadalo L, Figueroa J, Flesch-Janys F, Fridley BL, Friebel T, Friedman E, GG, Glasspool R, Glendon G, Godwin AK, Goodman MT, Gore M, Greene MH, Grip M, Gronwald J, Gschwantler Kaulich D, Gu\u00e9nel P, Guzman SR, Haeberle L, Haiman Hall P, SL, S; HEBON, Hein A, Heitz F, Henderson BE, Herzog J, T Hildebrandt MA, H\u00f8gdall CK, H\u00f8gdall E, Hogervorst C, Jakubowska A, Janavicius R, Jaworska K, Jensen A, Jensen UB, Johnson N, A, P, Lazaro C, Le ND, Le Marchand L, Leminen A, Lester J, Levine DA, Li J, Liang D, Lindblom A, Lindor N, Lissowska J, Long J, Lu KH, Lubinski J, Lundvall L, Lurie G, Mai PL, McNeish I, Meindl A, Menegaux F, Men\u00e9ndez P, Menkiszak Olson JE, Olson SH, Oosterwijk JC, Orlow I, Orr N, Orsulic S, Osorio A, Ottini L, Paul J, Pearce CL, Pedersen IS, B, T, Permuth- Wey Peterlongo P, Peto Phelan CM, Piedmonte M, Pike MC, Platte R, Plisiecka- Halasa Scuvera G, Sellers TA, Severi G, Seynaeve CM, Shah M, Shrubsole M, Siddiqui N, Sieh W, Simard J, Singer CF, Sinilnikova OM, Smeets D, Sohn C, Soller M, Song Terry MB, H, Tung N, Tworoger SS, Tyrer JP, Vachon CM, Van 't Veer LJ, van Altena AM, Van Asperen CJ, van den Berg van den Ouweland Wachenfeldt Walsh AH, Wu X, Yang HP, Zaffaroni D, Pilar Zamora M, Zheng Rookus MA, Hooning EL. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol A, Shehata M, Anton-Culver H. A Validation Method to Determine Missing Years of Birth in a Cohort Study of Shipyard Workers Using Social Security Number. J Occup Environ Med. 2016 Jun;58(6):631-5. Pearce CL, Zheng W, Painter JN; AOCS Group & Australian Cancer Study (Ovarian Cancer), Chenevix-Trench Fasching PA, Beckmann MW, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Rudolph A, Moysich KB, Odunsi LM, JL, Heitz F, Karlan BY, Kj\u00e6r SK, H\u00f8gdall Hildebrandt MA, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, J, H\u00f8gdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin A, Menon U, SA, Dansonka-Mieszkowska A, Budzilowska A, Spiewankiewicz B, Webb PM; Ovarian Cancer Association Consortium.Adult body mass index and risk of ovarian cancer by subtype: a 214. Cuellar-Partida G, Lu Y, Dixon SC; Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Nieuwenhuysen Vanderstichele Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Wang-Gohrke S, Goodman MT, KB, Ness RB, Cannioto R, H\u00f8gdall H\u00f8gdall C, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, V, JH, W, Whittemore AS, Cook LS, C, Gronwald J, Jakubowska A, Lubinski JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, I, Gayther G, Risch HA, MacGregor S. Assessing the genetic architecture of epithelial cancer histological subtypes.Hum Genet. Ziogas A. Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. Clinicoecon Outcomes Res. 2016 2;8:397-406. doi: Meijers B, Chang-Claude J, Chenevix-Trench G, Couch FJ, Cox A, Cross SS, Czene K, Dunning AM, Fasching PA, Figueroa J, Fletcher O, H, Galle E, Garc\u00eda- Closas M, Giles GG, Haeberle L, Hall P, Hillemanns P, Hopper JL, Jakubowska A, John EM, Jones M, Khusnutdinova E, Knight JA, Kosma VM, Kristensen V, Lee A, Lindblom A, Lubinski A, Margolin S, Meindl TW, Trentham-Dietz A, Vachon C, Wang Q, Whittemore AS, Ziogas A, van der Kolk L, Nevanlinna T, Bojesen S, Easton DF.Age- Chen Y, Lin HY, Reid Z, Monteiro A, Dennis J, Mendoza- Fandino G; AOCS Study Bandera EV, Bisogna M, Brinton L, Brooks-Wilson A, Cook LS, Cramer DW, Cunningham JM, Cybulski C, D'Aloisio AA, Anne Doherty M, Edwards RP, Fridley BL, Gayther SA, Gentry-Maharaj MT, Gronwald Iversen ES, Jakubowska A, Jensen A, Karlan BY, Kelemen LE, Kjaer SK, Kraft P, Le ND, Levine DA, Lissowska J, Lubinski J, Matsuo K, Menon U, Modugno R, Moysich KB, Nakanishi T, Ness RB, Olson S, Orlow I, Pearce CL, Pejovic T, Poole EM, Ramus SJ, Anne Rossing M, Sandler DP, Shu XO, Song H, Taylor JA, Teo SH, Terry KL, Thompson PJ, Tworoger SS, Webb PM, Wentzensen N, Wilkens LR, Winham S, Woo YL, Wu AH, Yang H, Zheng W, Ziogas A, Phelan CM, Schildkraut JM, Berchuck A, Goode EL, Cancer Association Consortium. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Hum Mol Genet. 2016 Aug 15;25(16):3600-3612. doi: 10.1093/hmg/ddw196. Epub 2016 Kar Amin Al Olama A, Michailidou K, Tyrer J, AS, Wolk A, Monteiro A, Peixoto A, Kierzek A, Cox A, Rudolph A, Gonzalez-Neira A, Wu AH, Lindblom A, Swerdlow A; AOCS Study & Blomqvist C, Phelan C, McLean C, Pearce CL, Vachon C, Cybulski C, Slavov C, Cramer DW, Neal DE, Eccles D, Flesch-Janys D, Edwards DR, Wokozorczyk D, Levine DA, Yannoukakos D, Sawyer EJ, Bandera EV, Poole EM, Goode EL, Khusnutdinova E, H\u00f8gdall Bruinsma F, Song H, Lim HY, McNeish I, Campbell I, Vergote I, Gronwald J, JL, JL, Kupryjanczyk Park JY, Clements JA, Knight JA, Peto J, Cunningham JM, Pow- Sang J, KB, Aly M, MA, Beckmann MW, Moisse M, Sanderson M, Southey MC, Jones M, Lush M, Hildebrandt MA, Hou MF, Schoemaker MJ, Garcia-Closas M, Bogdanova N, Rahman N, Pashayan N, Peterlongo P, Gu\u00e9nel P, Brennan P, Paulo P, Webb PM, Broberg P, Fasching PA, Devilee P, Wang Q, Cai Q, Li Q, Kaneva R, Butzow R, Kopperud Ness R, Milne RL, Travis RC, Benlloch S, Olson SH, McDonnell SK, Tworoger SS, Maia Berndt S, Edwards V, W, W, W, Blot WJ, Kluzniak W, Shu XO, Gao YT, Schumacher F, Freedman Berchuck A, Dunning AM, Simard J, Haiman CA, Spurdle A, Sellers TA, Hunter DJ, Henderson BE, Kraft P, Chanock SJ, Couch FJ, Hall P, of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discov. 2016 Sep;6(9):1052-67. doi: 10.1158/2159-8290.CD-15-1227. Epub 2016 Ziogas A, Anton-Culver H, Clayman RV. Treatment for T1a J, Bray F, Znaor A, Stevens L, Eser S, Silverman B, Nimri O, Pavlou P, Charalambous H, Demetriou A, Ward K, Ziogas A. Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program.Cancer Epidemiol. 2016 G, Lu Y; Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote Vanderstichele Anne Doherty J, Anne Rossing M, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, RB, Cannioto CK, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, V, Whittemore AS, Cook Gronwald J, Jakubowska A, Lubinski JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, I, Gayther Neale RE, Webb PM, MacGregor S. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. Int J Epidemiol. 2016 Oct;45(5):1619-1630. Epub 2016 Sep 4.PMID:27594614 222. Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Edwards RP, Fridley BL, Goode EL, Lurie G, McGuire V, Modugno F, Moysich KB, Olson SH, Pearce CL, Pike MC, Rothstein JH, Sellers TA, Sieh W, Stram Thompson Vierkant RA, Wicklund AH, Ziogas A, Tworoger SS, Schildkraut JM; , on behalf of the Ovarian Cancer Association Consortium. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case- Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.Am J Epidemiol. 2016 Oct 15;184(8):579-589. Epub 2016 MT, Bandera EV, KL, Joseph JM, Aben KK, Anton-Culver Antonenkova A, Bruinsma F, Butzow R, Campbell IG, Carty K, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Despierre E, Dicks E, Doherty JA, du Bois A, D\u00fcrst M, Easton D, Eccles D, Harter P, Hasmad Hein A, Heitz F, Hildebrandt C, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kelley JL, Kiemeney S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Liu S, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Moes-Sosnowska J, Narod SA, Nedergaard L, Nevanlinna H, Nickels S, Olson SH, Orlow I, Weber RP, Paul J, Pejovic T, Pelttari LM, Perkins B, Permuth-Wey J, Pike Teo SH, Thompson PJ, Timorek A, YY, Tworoger SS, Tyrer J, van Altena Vergote Walsh N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Gayther SA, Ramus Sellers TA, Cunningham PP, Ness RB, Odunsi K, Goode EL, Moysich KB. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. 2016 Oct 25;7(43):69097-69110. doi: 10.18632/oncotarget.10215.PMID:27533245 224. Permuth JB, Monteiro AN, Chen Z; AOCS MA, Doherty JA, Chang-Claude H, Pelttari L, Leminen A, Modugno F, Edwards RP, Ness RB, Kelley J, Heitz F, Karlan B, Lester J, Kjaer SK, Jensen A, Giles G, Hildebrandt M, Liang D, Lu KH, Wu X, Levine DA, Bisogna M, Berchuck A, Cramer Terry KL, Tworoger L, Kiemeney LA, Massuger L, Pejovic T, Moffitt M, Le N, Cook LS, Brooks-Wilson A, Kelemen LE, Gronwald J, Lubinski J, Wentzensen E, Hogdall C, Lundvall L, Pharoah PD, Song H, Campbell I, Eccles D, McNeish I, Whittemore A, McGuire V, Sieh W, Rothstein J, Phelan CM, Risch H, Narod S, McLaughlin J, JM, Cheng JQ, Goode EL, Sellers TA.Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. A, L, Ekici AB, Beckmann I, Kerin Yang R, Gu\u00e9nel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Men\u00e9ndez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke H, JM, AB, K; Ovarian Study Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Aln\u00e6s GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip M, Kauppila P, Li J, Brand JS, Humphreys K, Cox A, Reed MW, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres Ulmer HU, R\u00fcdiger A, Ashworth A, Orr N, Jones M, Gonz\u00e1lez-Neira A, Pita G, Alonso MR, \u00c1lvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy P, Eeles Kibel Cybulski C, Cannon-Albright L, Butterbach Park Z, Olama SP, A, A, M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs S, Doherty JA, Rossing MA, S, U, Wang- Gohrke S, Odunsi R, Modugno F, RP, RB, KB, du Bois A, Heitz F, Harter P, Kommoss S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, H\u00f8gdall E, Peissel B, Bonanni B, Bernard L, Liang D, Lu KH, Hildebrandt MA, Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR, Akushevich L, Cramer DW, Schildkraut J, T, SA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire W, Cai H, Shu XO, Teten RT, Sutphen R, McLaughlin JR, Narod SA, Monteiro AN, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa Moes-Sosnowska J Dec;53(12):800-811. Albieri V, Bandera EV, Doherty JA, H\u00f8gdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, Schildkraut A, Olson SH, Kiemeney SA, Phelan CM, Anton-Culver H, AH, Pearce CL, Risch HA, Jensen A; , on behalf of the Ovarian Cancer Association Consortium.Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Kar R, Campbell I, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Doherty JA, D\u00f6rk Fasching PA, Flanagan J, Gentry-Maharaj A, Glasspool R, Goode EL, Goodman MT, Gronwald J, F, Hildebrandt MA, H\u00f8gdall Kjaer SK, Kupryjanczyk J, Lambrechts D, Levine DA, Q, Lissowska J, Lu KH, Lubinski J, Massuger F, Monteiro AN, Moysich KB, Ness RB, H, Paul J, Pearce CL, Pejovic T, Permuth M, W, Song H, Southey M, Terry KL, Tworoger SS, Walsh C, Wentzensen N, Whittemore AS, Wu AH, Yang H, Zheng W, Ziogas A, Freedman ML, Gayther SA, Pharoah PD, Lawrenson K. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility J Etter S, S, Hu Q, Szender JB, Minlikeeva A, Joseph JM, Campbell SP, Chenevix-Trench G, Cramer DW, Dansonka-Mieszkowska A, Dao F, Diergaarde B, Doerk T, Doherty JA, du Bois A, Eccles Engelholm SA, Fasching PA, Gayther A, Glasspool RM, Goodman MT, Gronwald J, Harter P, F, Hillemmanns C, H\u00f8gdall EV, Huzarski Klapdor R, Kluz T, Konopka B, Kj\u00e6r SK, Kupryjanczyk J, Lambrechts D, Lester J, Lubinski J, Levine DA, Lundvall L, McGuire V, McNeish IA, Menon U, Modugno F, Ness RB, Orsulic S, H, Terry KL, Van Nieuwenhuysen E, Vanderstichele A, Vergote I, Walsh CS, Webb PM, Wentzensen N, Whittemore AS, Wu AH, Ziogas A, Odunsi K, Chang-Claude J, Goode EL, Moysich KB; Australian Ovarian Cancer Study. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Arce A, Ziogas A, Taylor T, Wang Z, Yourk V, Liu J, Wu J, McEligot AJ, Anton-Culver H, Meyskens FL. Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light KB, A; Australian Ovarian Cancer Study Group, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Ness RB, Edwards RP, Jensen A, Kj\u00e6r SK, H\u00f8gdall E, Berchuck A, Cramer DW, Terry CL, Wu AH, Pike MC, Webb PM.Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. Br J Cancer. 2017 Apr Bogdanova NV, Hall P, Li J, Khusnutdinova E, Bermisheva M, Kristensen V, Borresen-Dale AL, Investigators N, Peto J, Dos Santos Silva I, Couch FJ, Olson JE, Hillemans P, Park-Simon TW, Brauch H, F, Giles GG, Milne MK, Nevanlinna H. Phelan KB, Tyrer JP, Kar SP, Lawrenson K, Winham A, Riggan S, Beesley J, McGuffog L, Soucy P, Dicks E, Lee A, Barrowdale D, Lecarpentier J, Leslie G, Aalfs CM, Aben A, Bruinsma F, Brunet J, Buecher B, Butzow R, Buys SS, Caldes T, Caligo MA, Campbell I, Cannioto R, Carney ME, Cescon T, Chan SB, Chang-Claude J, Chung WK, Claes KBM, Conner Cook LS, Cook J, Cramer DW, Cunningham JM, D'Aloisio AA, Daly MB, Damiola F, Damirovna SD, Dansonka-Mieszkowska A, Dao F, Davidson R, DeFazio A, Delnatte C, Doheny KF, Diez T, Eeles R, Eilber U, Ejlertsen B, Ekici AB, Ellis S, Elvira M; EMBRACE Study, Eng KH, Engel C, Evans DG, Fasching Ferguson J, Garc\u00eda MJ, Garcia-Barberan V, Gehrig Giles R, Glendon G, Godwin AK, Goldgar DE, Goranova T, Gore M, Greene MH, Gronwald J, Gruber S, Hahnen E, Haiman CA, H\u00e5kansson N, Hamann U, Hansen TVO, Harrington PA, Harris HR, Hauke J; HEBON Study, Hein A, Henderson A, Hildebrandt MAT, P, Hodgson S, H\u00f8gdall A, Jakubowska A, James P, Janavicius R, Jernetz M, Jensen A, Jensen UB, John EM, Johnatty S, Jones ME, Kannisto P, N, Larson MC, Lazaro C, ND, Marchand L, Lee JW, Lele SB, Leminen A, Leroux D, Lester J, Lesueur F, Levine DA, Liang D, Liebrich C, Lilyquist J, Lipworth L, Lissowska J, Lu LFAG, May T, Mazoyer McNeish I, Meijers-Heijboer H, Meindl A, Menon U, Mensenkamp AR, Merritt MA, Milne RL, Mitchell G, Modugno F, Moes-Sosnowska J, Moffitt E, O'Malley DM, Ong KR, Onland-Moret NC; OPAL study Orr A, Palli D, Papi L, Park-Simon Pike MC, Piskorz AM, Poblete SR, Pocza J, Rappaport-Fuerhauser C, Rennert G, Rhiem K, Rice P, Richardson A, Robson M, Rodriguez GC, C, Romm Siddiqui N, Side LE, Sieh W, Singer CF, Sobol H, Song H, Southey AJ, L, Tan YY, Taylor JA, Tea MK, Teixeira MR, Teo SH, Terry KL, Thompson PJ, Thomsen Thull DL, AE, Tone A, Trabert B, RC, Trichopoulou A, Tung N, Tworoger SS, van Altena AM, Van Den Berg D, van der Hout AH, van der Luijt RB, Van Heetvelde M, Van Nieuwenhuysen E, van Rensburg Vanderstichele I, Vierkant RA, Vijai J, Vratimos A, Walker L, Walsh C, Wand D, Wang-Gohrke S, Wappenschmidt B, Webb PM, Weinberg Woo M, Wu X, Wu AH, Yang H, Yannoukakos D, Ziogas A, Zorn AN, Couch FJ, Berchuck A, Chenevix-Trench G, Goode EL, Sellers TA, Gayther SA, Antoniou AC, Pharoah PDP.Identification of 12 new susceptibility loci for different histotypes Nielsen TS, Webb PM, Nagle CM, DeFazio A; Australian Ovarian Cancer Study Group, H\u00f8gdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, Edwards R, Matsuo K, Hosono S, Goode EL, Whittemore Sieh W, Rothstein J, SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike M, AW, Sutphen R, Chang-Claude J, Risch HA, Kjaer SK; Ovarian Cancer Association Consortium. Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer. 2017 Jun 1;140(11):2422-2435. doi: 10.1002/ijc.30600. Epub 2017 Jan 24.PMID:28063166 VM, Villanueva C, Chang J, Ziogas A, Bristow RE. Impact of community disadvantage and air pollution burden on geographic disparities of ovarian cancer survival in California. Environ Res. CB, Berwick M, Thomas NE, Kanetsky PA, Jones LW; GEM Study Group.No association between prediagnosis exercise and survival in patients with high-risk primary melanoma: A population-based study. abstract available.PMID:28397350 236. Liu G, Lee S, Lee AW, Wu AH, Bandera EV, Jensen A, Anne Rossing M, Moysich KB, Chang- Claude J, Doherty J, Gentry-Maharaj A, Kiemeney L, Gayther SA, Modugno F, Massuger U, A, Pharoah PD, Risch H, Leigh Pearce C, Mukherjee B. Robust Tests for Additive Gene-Environment Interaction in Case- Control Studies Using Gene-Environment J Epidemiol. 14. ahead of print]PMID: 28633381 237. Park HL, Chang J, Lal G, Lal K, Ziogas A, Anton-Culver H. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.Clin Breast Cancer. 2017 H, Lee E, Neuhausen SL, Anton-Culver H, Reynolds P, Nelson DO, Ziogas A, Van Den Berg D, Deapen DM, Bernstein L, Schumacher FR. Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Epidemiol P, Diergaarde B, Zsiros E, Kelemen LE, K\u00f6bel M, Steed SJ, Fasching PA, Beckmann MW, Risch HA, Rossing MA, Doherty Chang-Claude J, Goodman MT, D\u00f6rk T, Edwards R, Modugno F, Ness RB, Matsuo K, Mizuno M, Karlan BY, Goode EL, Kj\u00e6r A, Pearce CL, AH, Kupryjanczyk J, Jensen A, Webb PM, Moysich KB; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group.History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiol Kar S, Lindstr\u00f6m S, Hui S, Lema\u00e7on A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, Wang CM; ABCTB Adlard J, Agata S, Ahmed S, Ahsan H, Aittom\u00e4ki K, Al-Ejeh F, Allen J, Ambrosone CI, Andrulis IL, Anton-Culver H, Antonenkova Barkardottir RB, D, Baynes C, MW, H, Paillerets Brewer Broberg P, Brooks-Wilson A, Brunet J, Br\u00fcning T, Burwinkel B, Buys SS, Byun J, Cai Q, Cald\u00e9s T, Caligo MA, Campbell I, Canzian F, Caron A, Chanock SJ, X, TD, Chiquette Christiansen H, Claes KBM, Clarke CL, Conner T, DM, Cook J, Cordina- Duverger E, Cornelissen S, Coupier I, Cox A, Cox DG, Cross SS, Cuk K, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, Davidson R, De Leeneer K, Devilee P, Dicks Dugu\u00e9 PA, Dumont M, Dunning AM, Durcan L, Dwek M, Dworniczak B, Eccles Fasching PA, Faust O, Flyger H, Foulkes WD, Friedman E, Fritschi L, Frost Gammon Gehrig Georgoulias V, Gerdes AM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, Gonz\u00e1lez-Neira A, Goodfellow P, Greene MH, Aln\u00e6s GIG, Grip M, Gronwald J, Grundy A, Gschwantler-Kaulich D, Gu\u00e9nel P, Guo N, U, JM, CS; HEBON, Hein A, Helbig S, Henderson A, Heyworth J, Hicks B, Hillemanns P, Hodgson S, Hogervorst FB, Hollestelle A, Hooning MJ, Hoover B, Hopper JL, Hu C, Huang G, Hulick PJ, Humphreys K, Hunter DJ, Imyanitov EN, Isaacs C, Iwasaki M, Izatt L, Jakubowska A, James P, Janavicius R, Janni W, Jensen UB, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Konstantopoulou D, K, Lasset C, Lazaro C, Le Marchand L, Lecarpentier J, Lee A, Lee E, Lee JW, Lee MH, Lejbkowicz F, Lesueur F, Li J, Lilyquist J, Lincoln A, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Loud JT, Lubinski J, Luccarini Lush M, MacInnis RJ, Maishman T, Makalic E, Kostovska IM, Malone KE, Manoukian S, Manson JE, Margolin S, Martens JWM, Martinez ME, Matsuo K, Mavroudis D, Mazoyer S, McLean C, Meijers-Heijboer H, Men\u00e9ndez P, Meyer J, Miao H, Miller A, Miller N, Mitchell G, Montagna M, Muir K, Mulligan RL, Olswold Oosterwijk JC, Orr N, Osorio A, Pankratz VS, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Lloyd R, Pedersen IS, Peissel B, Peixoto A, Perez JIA, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Pinchev M, Plaseska-Karanfilska D, Poppe B, Porteous ME, Prentice N, Prokofieva D, Pugh E, Pujana MA, Pylk\u00e4s K, Rack B, Radice P, Rahman N, Rantala J, Rappaport-Fuerhauser C, Rennert G, Rennert HS, Rhenius V, Rhiem K, Richardson A, Rodriguez GC, Romero A, Romm J, Rookus MA, Rudolph A, Ruediger T, Saloustros E, Sanders J, DP, Sangrajrang DF, Schoemaker MJ, Sch\u00fcrmann P, Schwentner Scott C, Scott RJ, Seal S, Senter L, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng X, Shimelis H, Shrubsole MJ, Shu XO, Side LE, Singer Spinelli Spurdle RM, Tan YY, Taylor JA, Tejada MI, Tengstr\u00f6m M, Teo SH, Terry MB, Tessier DC, Teul\u00e9 A, Th\u00f6ne K, L, Torres D, Tranchant M, Truong T, Tucker K, Tung N, Tyrer J, Ulmer HU, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, Rensburg EJ, Varesco L, Varon-Mateeva Viel A, Vijai J, Vincent D, Vollenweider J, Walker L, Wang Z, Wang-Gohrke S, Wappenschmidt B, Weinberg CR, AH, Xia L, Yang XR, Yannoukakos D, Zaffaroni D, Zheng W, Zhu B, Ziogas A, Ziv E, Zorn KK, Gago-Dominguez M, Mannermaa A, Olsson H, Teixeira MR, Stone J, Offit K, Ottini L, Park SK, Thomassen M, Hall Antoniou AC, Simard J.Identification of ten variants associated with risk of estrogen-receptor-negative cancer. Nat Genet. Oct Michailidou K, Lindstr\u00f6m S, Dennis J, Beesley J, Hui S, Kar S, Lema\u00e7on A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, Wang Z, Allen J, Keeman R, Eilber U, French JD, Qing Chen X, Fachal McCue K, McCart Reed AE, Ghoussaini M, Carroll JS, Jiang X, Finucane H, Adams M, Adank MA, Ahsan H, Aittom\u00e4ki Q, Cald\u00e9s T, Canzian F, Carracedo A, Carter BD, Castelao JE, Chan TL, David Cheng TY, Seng Chia K, Choi JY, Christiansen H, Clarke CL; NBCS Collaborators, Coll\u00e9e M, Conroy DM, Cordina-Duverger E, Cornelissen Cox DG, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, D\u00f6rk Dos-Santos-Silva I, Dumont M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Elvira M, Engel C, Eriksson M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher H, MS, DE, A, Grip N, SN, Hartikainen JM, Hartman M, Hein A, Heyworth DN, Hollestelle A, MJ, Hoover RN, Hopper JL, Hou MF, Hsiung CN, Huang G, Humphreys K, Ishiguro J, Ito H, Iwasaki M, Iwata H, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang Y, Kerin MJ, Khan S, Khusnutdinova E, Kiiski Kosma VM, Kristensen VN, Kr\u00fcger U, Kwong A, Lambrechts D, Le Marchand L, Lee E, Lee MH, Lee JW, Neng Lee C, Lejbkowicz F, Li J, Lilyquist J, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Lophatananon A, Lubinski J, Luccarini C, Lux MP, Ma ESK, MacInnis RJ, Maishman T, Makalic E, Malone KE, Kostovska IM, Mannermaa A, Manoukian S, Manson JE, Margolin S, Mariapun S, Martinez ME, Matsuo K, Mavroudis D, McKay J, McLean C, Meijers-Heijboer H, Meindl A, Men\u00e9ndez P, Menon U, Meyer J, Miao H, Miller N, Taib NAM, Muir K, Mulligan AM, Mulot C, Neuhausen SF, Noh DY, Nordestgaard BG, Norman A, Olopade OI, Olson JE, Olsson H, Olswold C, Orr N, Pankratz VS, Park SK, Park-Simon TW, Lloyd R, Perez JIA, Peterlongo P, Peto J, Phillips KA, Pinchev M, Plaseska-Karanfilska D, Prentice R, Presneau N, Prokofyeva D, Pugh E, Pylk\u00e4s K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, T, Scott RJ, Scott C, Seal S, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng G, Sherman ME, Shrubsole MJ, Shu XO, Smeets Surowy H, Swerdlow A, Tamimi R, Taylor JA, Tengstr\u00f6m M, Teo SH, Beth Terry M, Tessier DC, Thanasitthichai S, Th\u00f6ne K, Tollenaar RAEM, Tomlinson CC, Tsugane S, Ulmer HU, Ursin G, Untch M, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, van der Kolk L, van der Luijt RB, Vincent D, Vollenweider J, Waisfisz Q, Wang-Gohrke S, Weinberg CR, Wendt AS, Wildiers H, Willett W, Winqvist R, Wolk A, Wu AH, Xia L, Yamaji T, Yang XR, Har Yip C, Yoo KY, Yu JC, Zheng W, Zheng Y, Zhu B, Ziogas A, Ziv E; ABCTB Amos CI, Couch FJ, Pharoah PDP, Chang-Claude J, Hall P, Hunter M, Schmidt Simard J, Kraft P, Easton DF. Association analysis identifies 65 new breast cancer 2017 A, Anton-Culver H. Cancer risk in different generations of Middle Eastern immigrants to California, 1988-2013. Int J Cancer. 2017 Dec Beesley J, Kar S, Lindstr\u00f6m S, Hui S, Lema\u00e7on A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, Wang CM; ABCTB Adlard J, Agata S, Ahmed S, Ahsan H, Aittom\u00e4ki K, Al-Ejeh F, Allen J, Ambrosone CI, Andrulis IL, Anton-Culver H, Antonenkova Barkardottir RB, D, Baynes C, MW, H, Paillerets Brewer Broberg P, Brooks-Wilson A, Brunet J, Br\u00fcning T, Burwinkel B, Buys SS, Byun J, Cai Q, Cald\u00e9s T, Caligo MA, Campbell I, Canzian F, Caron A, Chanock SJ, X, TD, Chiquette Christiansen H, Claes KBM, Clarke CL, Conner T, DM, Cook J, Cordina- Duverger E, Cornelissen S, Coupier I, Cox A, Cox DG, Cross SS, Cuk K, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, Davidson R, De Leeneer K, Devilee P, Dicks Dugu\u00e9 PA, Dumont M, Dunning AM, Durcan L, Dwek M, Dworniczak B, Eccles Fasching PA, Faust O, Flyger H, Foulkes WD, Friedman E, Fritschi L, Frost Gammon Gehrig Georgoulias V, Gerdes AM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, Gonz\u00e1lez-Neira A, Goodfellow P, Greene MH, Aln\u00e6s GIG, Grip M, Gronwald J, Grundy A, Gschwantler-Kaulich D, Gu\u00e9nel P, Guo N, U, JM, CS; HEBON, Hein A, Helbig S, Henderson A, Heyworth J, Hicks B, Hillemanns P, Hodgson S, Hogervorst FB, Hollestelle A, Hooning MJ, Hoover B, Hopper JL, Hu C, Huang G, Hulick PJ, Humphreys K, Hunter DJ, Imyanitov EN, Isaacs C, Iwasaki M, Izatt L, Jakubowska A, James P, Janavicius R, Janni W, Jensen UB, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Konstantopoulou D, K, Lasset C, Lazaro C, Le Marchand L, Lecarpentier J, Lee A, Lee E, Lee JW, Lee MH, Lejbkowicz F, Lesueur F, Li J, Lilyquist J, Lincoln A, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Loud JT, Lubinski J, Luccarini Lush M, MacInnis RJ, Maishman T, Makalic E, Kostovska IM, Malone KE, Manoukian S, Manson JE, Margolin S, Martens JWM, Martinez ME, Matsuo K, Mavroudis D, Mazoyer S, McLean C, Meijers-Heijboer H, Men\u00e9ndez P, Meyer J, Miao H, Miller A, Miller N, Mitchell G, Montagna M, Muir K, Mulligan RL, Olswold Oosterwijk JC, Orr N, Osorio A, Pankratz VS, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Lloyd R, Pedersen IS, Peissel B, Peixoto A, Perez JIA, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Pinchev M, Plaseska-Karanfilska D, Poppe B, Porteous ME, Prentice N, Prokofieva D, Pugh E, Pujana MA, Pylk\u00e4s K, Rack B, Radice P, Rahman N, Rantala J, Rappaport-Fuerhauser C, Rennert G, Rennert HS, Rhenius V, Rhiem K, Richardson A, Rodriguez GC, Romero A, Romm J, Rookus MA, Rudolph A, Ruediger T, Saloustros E, Sanders J, DP, Sangrajrang DF, Schoemaker MJ, Sch\u00fcrmann P, Schwentner Scott C, Scott RJ, Seal S, Senter L, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng X, Shimelis H, Shrubsole MJ, Shu XO, Side LE, Singer Spinelli Spurdle RM, Tan YY, Taylor JA, Tejada MI, Tengstr\u00f6m M, Teo SH, Terry MB, Tessier DC, Teul\u00e9 A, Th\u00f6ne K, L, Torres D, Tranchant M, Truong T, Tucker K, Tung N, Tyrer J, Ulmer HU, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, Rensburg EJ, Varesco L, Varon-Mateeva Viel A, Vijai J, Vincent D, Vollenweider J, Walker L, Wang Z, Wang-Gohrke S, Wappenschmidt B, Weinberg CR, AH, Xia L, Yang XR, Yannoukakos D, Zaffaroni D, Zheng W, Zhu B, Ziogas A, Ziv E, Zorn KK, Gago-Dominguez M, Mannermaa A, Olsson H, Teixeira MR, Stone J, Offit K, Ottini L, Park SK, Thomassen M, Hall M, Schmidt MK, Antoniou AC, Simard J. Identification of ten variants associated with risk of Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kj\u00e6r SK, H\u00f8gdall SA, McLaughlin JR, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Terry KL; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group. Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Prev. A, Ziogas A, Anton-Culver H. Negative Valence Life Events Promote Breast Cancer Development. Clin Breast Cancer. 2017 Nov 1. P, Webb PM, MacGregor S; Ovarian Cancer Association Consortium. Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J F, Ziogas A. An age-dependent interaction between sex and geographical UV index in melanoma risk. J Am LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM; Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM; African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol. 2017 Dec FL, Anton-Culver H, F. Case- Study of the Genetic Variability in Reactive Oxygen Species-Metabolizing Enzymes in Melanoma Risk. Silverman Demetriou A, Yakut C, Nimri O, Pavlou P, \u00d6zg\u00fcr S, Ziogas A, Stevens L, Ward K, Anton Culver H. Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and Izmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program. Turk J Gastroenterol. 2018 Jan;29(1):36-44. doi: Anton-Culver H, Norden-Krichmar T. Identification of a gene expression signature predicting survival in oral cavity squamous cell carcinoma using Monte Carlo cross validation. Oral Oncol. 2018 Mar;78:72-79. doi: CM, Ewing A, Pearce CL, Zheng W; Australian Ovarian Study Group, Chenevix-Trench PA, MW, Rossing MA, Doherty JA, Wicklund KG, Chang- Claude J, Jung AY, Moysich KB, Odunsi Goodman Wilkens LM, F, RB, RP, JL, Heitz F, du Bois A, Harter P, S, Rimel BJ, SK, Hildebrandt MAT, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, J, H\u00f8gdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin A, Menon U, SA, A, Budzilowska A, Rzepecka IK, Webb PM; Ovarian Cancer Association Consortium. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer. 2018 Mar doi: 10.1038/s41416-018-0011-3. [Epub ahead of print] LC, Risch H, Terry KL, M Webb P, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM; Australian Ovarian Cancer Study Group, Anne Rossing M, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM; African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol. 2018 Mar 23. doi: 10.1093/ije/dyy054. Tollenaar Seynaeve C, Hall P, Czene K, Liu J, Irwanto AK, Kang D, Yoo KY, Noh DY, Couch FJ, Olson JE, Wang X, Fredericksen Z, Nordestgaard BG, Bojesen Beckmann MW, Wang-Gohrke S, Shen Yu JC, Hsu HM, Wu PE, Giles GG, Severi G, Baglietto L, English DR, Cox A, Brock I, Elliott G, Reed MW, Beesley J, Chen X, Investigators K; AOCS Group, Fletcher O, Gibson L, dos Santos Silva I, Peto J, Frank B, Heil J, Meindl A, Chang-Claude J, Hein R, Vrieling A, Flesch-Janys D, Southey MC, Smith L, and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet. 2011 Oct;48(10):698-702. doi: 10.1136/jmedgenet-2011-100303.PMID:21931171 125. Bessonova L, Marshall SF, Ziogas A, Largent J, Bernstein L, Henderson KD, Ma H, West DW, Anton-Culver H. The association of body mass index with mortality in the California Teachers Study. Int J Cancer. 2011 Nov 15;129(10):2492-501. doi: 10.1002/ijc.25905. Epub 2011 Strick R, Peto J, dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, H, BG, J, Zamora Brenner H, M\u00fcller H, Arndt V, Rahman N, Turnbull C, H, Justenhoven C, T; Hein Wang-Gohrke D\u00f6rk T, Sch\u00fcrmann P, Bremer M, Hillemanns P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylk\u00e4s K, Jukkola- Vuorinen A, Grip M, Andrulis I, Knight JA, Mulligan AM, O'Malley FP, Brinton ME, Lissowska P, Czene K, Cox IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Ding SL, Hsu HM, Yu JC, Anton-Culver H, Ziogas A, Ashworth A, Swerdlow A, Jones M, Orr N, Trentham-Dietz A, Egan K, Newcomb P, Titus-Ernstoff L, Easton D, Spurdle AB. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2011 Dec 1;20(23):4693-706. Fasching Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, dos Santos Silva I, Gibson L, Sawyer E, Tomlinson I, Kerin MJ, Chanock S, Lissowska J, RL, P\u00e9rez Hein R, Wang-Gohrke S, D\u00f6rk J, Chenevix-Trench G, Chen X, Peterlongo P, Bonanni B, Bernard L, Manoukian S, Wang X, Cerhan J, Vachon CM, Olson J, Giles GG, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola- Vuorinen A, Grip M, Andrulis I, Knight JA, Glendon G, Mulligan AM, Cox A, Brock IW, Elliott G, SS, Pharoah PP, Dunning AM, Pooley KA, Humphreys MK, Wang J, Kang D, Yoo KY, Noh DY, Sangrajrang S, Gabrieau V, Brennan P, McKay Investigators; Ovarian of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer. 2011 Dec 6;105(12):1934-9. doi: 10.1038/bjc.2011.448. Epub 2011 Oct 27.PMID:22033276 128. O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N, Orr N, dos Santos Silva I, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F; Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON), Hall P, Czene K, Irwanto A, Liu J, R, Nickels S, Flesch-Janys D, Tsimiklis H, Makalic E, Schmidt D, Bui M, Hopper JL, Apicella C, Park DJ, Southey M, Broeks Tomlinson I, Kerin Schneeweiss A, Sohn MR, Gonz\u00e1lez-Neira A, Ben\u00edtez J, Anton-Culver H, Ziogas Bernstein Brauch H, Br\u00fcning T; Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network, Wang-Gohrke S, Eilber U, D\u00f6rk T, Bonanni B, Fortuzzi S, Peterlongo P, Couch FJ, Wang X, Stevens K, Lee A, Giles GG, Baglietto L, Severi G, McLean C, Alnaes GG, Kristensen B\u00f8rrensen-Dale AL, John EM, Miron Pylk\u00e4s K, Jukkola-Vuorinen A, Kauppila S, A, Oldenburg RA, van den Ouweland AM, Cox A, Reed MW, Shah M, Jakubowska A, Lubinski J, Jaworska K, Durda Jones M, A, Beesley J, Chen Muir KR, Lophatananon A, Rattanamongkongul S, Chaiwerawattana A, Kang D, Yoo KY, Noh DY, Shen CY, Yu JC, Wu PE, Hsiung CN, Perkins A, Dunning AM, Rahman N, Peto J, Easton DF.Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet. 2012 Jan 22;44(3):312-8. A, Zell JA. Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry. J Bone Joint Surg Am. 2012 Feb 15;94(4):356-63. doi: 10.2106/JBJS.J.01784.PMID:22336975 130. Stevens KN, Fredericksen Z, Vachon Margolin S, Lindblom Nevanlinna H, Greco A, Nickels A, Bartram CR, Schott Engel Weaver J, Pathak HB, Sharma P, Brenner H, M\u00fcller A, Fountzilas G, Gogas HJ, Swann RL, Ben\u00edtez J, Burwinkel B, Marm\u00e9 F, C, Sawyer E, Tomlinson I, Kerin MJ, Peto J, Johnson N, Fletcher O, Dos Santos Silva I, Fasching PA, Beckmann MW, Hartmann A, Braaf LM, Park DJ, Swerdlow Orr N, H, Ziogas A, Bernstein L, Dur CC, Shen CY, Yu JC, Hsu HM, Hsiung CN, Hamann D\u00fcnnebier T, Dunning AM, Humphreys MK, Wang Q, Cox A, Cross SS, Reed MW, Hall P, Czene K, Ambrosone CB, Ademuyiwa F, Hwang Eccles AM, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, John EM, Miron A, Aln\u00e6s GG, Kristensen V, B\u00f8rresen-Dale AL, Giles Severi G, Kosel ML, Pankratz Slager S, Olson a Cancer Res. 2012 Apr 1;72(7):1795-803. 10.1158/0008-5472.CAN-11-3364. 13.PMID:22331459 131. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen Menon MC, Risch H, Wu AH, Berchuck A; Ovarian Cancer Association Consortium. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis Oncol. Barleben A, S, Stamos MJ, Zell JA. Population-based evaluation of adenosquamous carcinoma of and rectum. Dis Colon Rectum. May;55(5):509-14. doi: van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N, Milne RL, Zamora U, Hein R, Nickels S, Flesch-Janys D, Wang-Gohrke S, John EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Chenevix-Trench G, Beesley J, Chen X; Investigators kConFab; Australian Ovarian Cancer Study Group, Menegaux F, Cordina-Duverger E, Shen CY, Yu JC, Wu PE, Hou MF, Andrulis IL, Selander T, N, Ashworth A, Swerdlow A, Severi G, Baglietto L, Giles G, Southey M, Marm\u00e9 F, Schneeweiss A, Sohn C, Burwinkel PA, Schulz-Wendtland R, Ekici AB, Beckmann MW, Fletcher O, N, Idos Peto Nevanlinna H, Muranen TA, Aittom\u00e4ki P, Peterlongo P, Manoukian S, Bernard L, Couch FJ, Olson JE, Wang X, Fredericksen Z, Alnaes GG, Kristensen J, Sherman ME, Hall P, Liu J, Czene K, Kang D, Yoo KY, Noh DY, a locus for hormone receptor positive breast cancer. Hum Mutat. 2012 Jul;33(7):1123-32. doi: 10.1002/humu.22089. Epub 2012 A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Gu\u00e9nel MP, Ben\u00edtez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, M\u00fcller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Andrulis G, Mulligan AM, Figueroa Seynaeve C, Coll\u00e9e M, Hall P, Humpreys K, Czene K, Liu J, Cox A, Brock IW, Cross SS, Reed MW, Ahmed S, Ghoussaini M, Pharoah PD, Kang D, Yoo Noh Durda K, Zlowocka E, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Yu JC, Hsu HM, Hou MF, Orr N, Schoemaker M, Ashworth A, Swerdlow A, Trentham-Dietz A, Newcomb PA, Titus L, Egan KM, Chenevix-Trench G, Antoniou AC, Humphreys MK, DF, Dunning AM.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).PLoS One. 2012;7(8):e42380. Epub van R, Dunning AM, Czene K, Liu J, Chang-Claude J, Wang-Gohrke S, Eilber U, Nickels S, D\u00f6rk T, Schiekel M, Bremer M, S, Couch FJ, Stevens KN, Olson JE, Kosel M, Cross SS, Balasubramanian SP, Reed MW, Miron A, John EM, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Kauppila S, Schmidt MK.The Nguyen Nguyen VQ, Ziogas A, Hohmann S, Stamos MJ. Outcomes of 23.PMID:22727608 137. Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC, P, Truong T, Laurent-Puig P, C, Ovarian Study Lambrechts D, Smeets A, Paridaens R, Weltens C, Flesch-Janys D, Buck K, Behrens S, Peterlongo P, Bernard L, Manoukian S, Radice P, Couch FJ, Vachon C, Wang X, Olson J, Giles G, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Mulligan AM, Weerasooriya N, A, Tilanus-Linthorst MM, Hall P, Czene K, Liu J, Li J, Cox A, Cross SS, Brock IW, Reed MW, Pharoah P, Blows FM, Dunning Swerdlow A, Jones M, Schoemaker M, DF, Humphreys M, Wang Q, Peto a susceptibility locus for estrogen receptor-positive breast from Anton-Culver Fasching PA, Anton-Culver Lambrechts M, Cox A, Giles GG, B, Lindblom A, Couch FJ, Mannermaa A, G, John EM, D\u00f6rk T, Flyger H, Dunning AM, Wang Q, Hien Figueroa Kosma Kristensen VN, Miron A, Bogdanova N, Shah M, Blomqvist C, Broeks A, Sherman M, Phillips KA, Li J, Liu J, Glendon G, Seynaeve C, Ekici AB, Leunen K, Kriege M, Cross SS, Baglietto L, Sohn C, Wang X, Kataja V, B\u00f8rresen-Dale A, Easton DF, Schmidt MK, Bojesen SE.CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer.J Clin Oncol. 2012 Dec 10;30(35):4308-16. TH, Ziogas A, Meyskens FL Jr, Anton-Culver H.A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.Pigment Cell Melanoma Res. Epub K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee Larson Anton-Culver H, Antonenkova N, Antoniou AC, Cancer LA, Brooks-Wilson A, Brown R, Butzow R, Cai Q, Campbell I, Chang- Claude J, Chanock S, Chenevix-Trench G, Cheng JQ, Cicek Coetzee GA; Consortium of Investigators of Modifiers of BRCA1/2, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Despierre E, Doherty D\u00fcrst Easton J, Goodman MT, Gore M, G\u00f3rski B, Gronwald J, Hall P, Halle MK, S, Lancaster JM, Le ND, Leminen A, Levine DA, Liang D, Lim BK, Lin J, Lissowska J, Lu KH, Lubinski J, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson SH, Orlow I, Paul J, Pearce CL, Pejovic T, Pelttari Sutphen R, Teo SH, KL, Tessier DC, Thompson PJ, Tworoger SS, van Altena Vierkant RA, Winterhoff B, Woo YL, Wu AH, Xiang YB, Yang HP, Zheng W, Ziogas A, Zulkifli F, Iversen Sellers TA, Gayther SA.Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.Nat Commun. 2013;4:1627. doi: 10.1038/ncomms2613.PMID:23535648 142. JM, M; PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Omar SZ, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, T, AN, Moes- Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubinski J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Garcia-Closas M, Bois Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA; Australian Ovarian Cancer Study Group; Australian Cancer Study, Schildkraut JM, Sellers TA, A, Chenevix-Trench G, SA, Pharoah PD, Laird PW, Goode EL, Pearce CL.Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for doi: CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Goode RA, Larson MC, EV, Olson SH, Rodriguez-Rodriguez Yang H, Garcia-Closas M, U, Gentry-Maharaj A, Webb PM; Ovarian Cancer Association Consortium. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. doi: 10.1530/ERC-12-0395. Print 2013 Apr.PMID:23404857 145. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, H\u00e4berle L, Vrieling A, Gaudet M, Figueroa J, Schoof AB, Idos S, Peto J, Humphreys MK, Wang Lanng Clarke CA, Brenner H, M\u00fcller H, Paridaens R, Flesch-Janys D, Obi N, Wang-Gohrke S, Couch FJ, Olson JE, Vachon CM, Giles GG, Severi G, Baglietto L, Offit K, John EM, Miron A, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Chanock SJ, Lissowska J, Liu A, Cramp H, Connley D, Balasubramanian S, Dunning AM, Shah M, Trentham-Dietz A, Newcomb P, Titus L, Egan K, Cahoon EK, Rajaraman P, Sigurdson AJ, Doody Chang-Claude of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 2013;9(3):e1003284. Beckmann K, Illig T, Seibold P, Behrens S, Humphreys K, Li J, Liu J, Olson JE, Wang X, Hankinson SE, Truong T, Menegaux F, Dos Santos Silva I, Johnson N; GENICA Network, Chen ST, Yu JC, Ziogas A, Kataja V, Kosma VM, Mannermaa A, Anton-Culver H, Shen CY, Brauch H, Peto J, Gu\u00e9nel P, Kraft P, Couch FJ, Easton DF, Hall P, Chang-Claude J.A genome-wide association study to genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.Breast Cancer Res Treat. Ramus SJ, Phelan EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, Bacot F, Vincent D, Cunningham JM, Dennis J, Dicks E; Australian Cancer Study; Australian Ovarian Cancer Study Group, Aben Brooks-Wilson A, Brown R, Butzow R, Campbell I, Carney ME, Carvalho RS, Chang-Claude J, Chen YA, Chen Z, Chow WH, Cicek MS, Coetzee G, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Despierre E, Doherty JA, D\u00f6rk T, du Bois A, D\u00fcrst M, Eccles D, Edwards R, Ekici D, Flanagan J, Gao YT, Garcia-Closas M, Gentry-Maharaj A, Giles G, Gjyshi A, Gore M, Gronwald J, Guo Q, Halle MK, Harter P, Hein A, J, Lambrechts D, Lambrechts S, Le ND, Lee N, Lee J, Leminen A, Lim BK, Lissowska J, Lubinski J, Lundvall L, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson S, Orlow I, Paul J, Pejovic T, Pelttari LM, Permuth-Wey J, Pike MC, Poole EM, Qu X, Risch HA, Rodriguez- Rodriguez L, W, MC, Spellman KL, Thompson PJ, Timorek A, Tworoger SS, van Altena AM, van den Berg Vergote Vierkant E, Winterhoff B, Woo YL, Wu AH, Yang HP, Zheng W, Ziogas A, Zulkifli F, Goodman MT, Hall P, Easton JM, TA.GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet. 2013 K, JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wang Q, Dennis J, McGuffog L, Barrowdale D, Lee A, Healey S, Lush M, Tessier DC, Vincent D, Bacot F; Australian Cancer Study; Australian Ovarian Cancer Study; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab); Gene Environment Interaction and Breast Cancer (GENICA); Swedish Breast Cancer Study (SWE-BRCA); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Vergote Lambrechts S, Despierre E, Risch HA, Gonz\u00e1lez-Neira A, Rossing MA, Pita G, Doherty JA, Alvarez N, Larson MC, Fridley BL, Gu\u00e9nel P, Teoman A, Milne RL, Garcia JJ, Cox A, Shridhar V, Burwinkel B, Marme F, Hein R, Sawyer EJ, IL, GG, Brenner H, Simard PA, Carney Radice P, Wilkens LR, Swerdlow H, Bunker CH, Kristensen V, Ness RB, Muir K, Edwards R, Meindl A, Heitz F, Matsuo K, du Bois A, Wu AH, Harter P, Teo SH, Schwaab I, Shu XO, Blot W, Hosono S, Kang D, Nakanishi T, Hartman Yatabe U, Karlan SK, Gaborieau V, Jensen A, Eccles D, H\u00f8gdall E, Shen CY, Brown J, Woo YL, Shah M, Azmi MA, Luben Vierkant RA, Nordestgaard BG, Flyger H, Vachon C, Olson JE, Wang X, Levine DA, Rudolph A, Weber RP, Flesch-Janys D, Iversen E, Nickels S, Schildkraut JM, Silva Idos S, Cramer DW, Gibson L, Fletcher O, Schoot SS, Liu J, Bandera EV, Li J, Olson SH, Humphreys K, Orlow Rodriguez-Rodriguez MP, Cook LS, Balasubramanian SP, Kelemen LE, Schneeweiss A, ND, Sohn A, Tomlinson I, Kerin MJ, Miller N, Cybulski C, Henderson BE, Menkiszak J, Schumacher F, Wentzensen N, Le Marchand L, Yang HP, Mulligan AM, Glendon G, Engelholm SA, Knight JA, H\u00f8gdall CK, Apicella C, Gore M, Tsimiklis H, Song H, Southey MC, Jager A, Brown Kriege Whittemore AS, Baglietto C, W, M\u00fcller H, Arndt V, Labr\u00e8che F, Gao YT, Goldberg MS, Yang G, Dumont M, McLaughlin JR, Hartmann A, Ekici AB, Beckmann MW, Phelan CM, Lux MP, Permuth-Wey J, Peissel B, Sellers TA, Ficarazzi F, Barile M, A, Ashworth A, Gentry-Maharaj A, SJ, N, H, Tajima K, Tseng CC, DO, van den Berg D, Yip CH, Ikram MK, Teh YC, Cai H, Lu W, Signorello LB, Cai Q, Noh DY, Yoo KY, Miao H, Iau PT, Teo YY, McKay J, Shapiro C, Ademuyiwa F, Fountzilas G, Hsiung CN, Yu JC, Hou MF, Healey CS, Luccarini C, Peock S, Stoppa-Lyonnet D, Peterlongo P, Rebbeck TR, Piedmonte M, Singer CF, Friedman E, Thomassen M, Offit K, Hansen TV, Neuhausen SL, Szabo J, Narod Caldes T, Imyanitov EN, Tihomirova Os TA, Evans DG, Frost D, Fineberg E, Barwell J, Walker L, Kennedy MJ, Platte R, Davidson R, Ellis SD, Cole T, Bressac-de Paillerets B, Buecher B, Damiola F, Faivre D, Giannini G, Bernard L, Dolcetti R, Manoukian S, Arnold N, Engel C, Deissler H, Rhiem K, Niederacher D, Plendl M, Gerdes AM, Ejlertsen B, Foretova L, Savage SA, Lester J, Soucy P, Kuchenbaecker KB, Olswold C, Cunningham JM, Slager S, Pankratz VS, Dicks E, Lakhani SR, Couch Hall P, Monteiro AN, Gayther SA, Pharoah PD, Reddel Antoniou AC, Chenevix-Trench variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013 Apr;45(4):371-84, 384e1-2. doi: 10.1038/ng.2566.PMID:23535731 149. Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM; for Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, Carney ME, Goodman MT, Moysich K, Hogdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Vierkant RA, Weber Aben Berchuck Doherty JA, Iversen E, McGuire V, Moorman PG, Pharoah P, Pike H, Sieh JM, Kjaer SK; Ovarian Cancer Association Consortium.Combined and interactive effects of environmental and GWAS-identified risk factors Whittemore AS, Karlan BY, SB, Fasching PA, Campbell I, Goodman MT, Pejovic T, Bean Y, Lurie G, Eccles D, Hein A, Beckmann MW, Ekici AB, Paul J, R, Bois Lundvall L, Olson SH, Orlow I, Eilber U, Dansonka-Mieszkowska A, Rzepecka IK, Ziolkowska-Seta M, Despierre E, Lambrechts S, Vergote I, Walsh C, Lester J, Sieh W, McGuire V, Rothstein JH, Ziogas A, Lubinski SA, SJ, A, Berchuck A, D, Terry KL, Vitonis AF, Doherty JA, Johnatty SE, Defazio A, Song H, Tyrer J, Sellers TA, Phelan CM, Kalli KR, Cunningham JM, Fridley BL, Goode EL.Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer Ziogas A, Anton-Culver H.Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013 Jun;148(6):516-23. Ziogas A, Anton-Culver H.Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013 Jun;121(6):1226-34. doi: 10.1097/AOG.0b013e3182922a17.PMID:23812456 153. Kent TJ, Montoya MJ, Ziogas A, Anton-Culver H.Multilevel socioeconomic effects on quality of life in adolescent and young adult survivors of leukemia and lymphoma.Qual Life Res. 2013 Aug;22(6):1339-51. doi: 10.1007/s11136-012-0254-z. Epub 2012 Aug 26.PMID:22922952 154. Meyer KB, O'Reilly M, Michailidou K, Carlebur S, Edwards SL, French JD, Prathalingham R, Dennis J, Bolla MK, Wang Q, de Santiago I, Hopper JL, Tsimiklis H, Apicella C, Southey MC, MP, Ekici AB, Beckmann MW, Peto J, Dos Santos Silva I, Fletcher O, Johnson N, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme Gu\u00e9nel JI, Benitez H, Muranen TA, Aittom\u00e4ki K, Blomqvist Matsuo K, Ito H, Iwata H, Yatabe Y, D\u00f6rk T, Helbig Ovarian Cancer Study Group, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Lambrechts D, Thienpont B, Christiaens MR, Smeets P, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Bernard L, Couch FJ, Olson JE, Wang X, Purrington K, Giles GG, Severi G, Baglietto L, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labr\u00e8che F, Dumont M, Teo SH, CH, Phuah SY, Kristensen V, Grenaker Deming-Halverson S, M, Long J, Winqvist R, Pylk\u00e4s K, Vuorinen Kauppila den Ouweland AM, van Deurzen CH, Hall P, Li J, Liu J, Humphreys K, Shu XO, Lu W, Gao YT, Cai H, Cox A, Reed MW, Blot W, Signorello LB, Cai Q, Pharoah PD, Ghoussaini M, Harrington P, Tyrer J, Kang D, Choi JY, Park SK, Noh DY, Hartman M, Hui M, Lim Buhari K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Vachon C, Slager S, Fostira F, Pilarski R, Shen CY, Hsiung CN, Wu PE, Hou MF, Swerdlow A, Ashworth A, Ponder AM, Easton DF. functional variants differentially bind 5;93(6):1046-60. 10.1016/j.ajhg.2013.10.026. Smith EC, Ziogas A, Anton-Culver H.Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults.Cancer. 2012 Dec 15;118(24):6179-87. doi: 10.1002/cncr.27684. Epub Bandera EV, Orlow I, Terry K, Goodman MT, Thompson PJ, Cook LS, Rossing MA, Ness RB, Narod SA, Kupryjanczyk J, Lu K, Butzow R, D\u00f6rk T, Pejovic T, CH, Bogdanova N, Runnebaum IB, Eccles Heitz F, Levine DA, Kjaer SK, Cramer D, Flanagan JM, Phelan CM, Brown R, Massuger LF, Song H, Doherty JA, Krakstad C, Liang D, Odunsi K, Berchuck A, Jensen A, Lubinski J, Nevanlinna H, Bean YT, Lurie G, Ziogas A, Walsh C, Despierre E, Brinton L, Hein A, Rudolph A, Dansonka-Mieszkowska A, Olson SH, Harter P, Tyrer Cybulski C, Lin J, Sucheston L, Edwards R, McGuire V, Lester J, du Bois A, Lundvall L, Wang-Gohrke van Gentry-Maharaj A, the NF-?B pathway: genetic association with IL1A and TNFSF10. Cancer Res. Feb 1;74(3):852-61. doi: 10.1158/0008-5472.CAN-13-1051. Epub 2013 Nov 22. PMID:24272484 J, Ziogas A, Randall LM, Anton-Culver H. High-volume ovarian cancer care: survival impact and disparities in access advanced-stage disease. Oncol. B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kj\u00e6r SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson Menon U, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.J Natl Cancer Inst. 2014 Feb;106(2):djt431. Karnes W, Stamos Zell JA. Role of primary tumor resection among chemotherapy-treated patients with synchronous stage IV MJ, Sender LS, Morris RA, Ziogas A, Anton-Culver H.Attitudes Toward Cancer Clinical Trial Participation in Young Adults with a History of Cancer and a Healthy College Student Sample: A Preliminary Investigation.J Adolesc Young Adult Oncol. 2014 Mar 1;3(1):20-27.PMID:24669355 161. Milne Herranz J, Michailidou JP, Zamora MP, Arias-Perez JI, Gonz\u00e1lez- Neira A, Pita Alonso MR, Wang Q, Bolla MK, Czene K, Eriksson M, Humphreys K, Darabi H, Li J, Anton-Culver H, Neuhausen SL, Ziogas A, Ashworth A, Orr N, Schoemaker M, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Wang X, Olson JE, Vachon C, Purrington K, Winqvist R, Pylk\u00e4s K, Jukkola- Vuorinen A, Grip M, Dunning AM, Shah M, Gu\u00e9nel P, Truong T, Sanchez M, Mulot C, Brenner Tollenaar RA, Seynaeve C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Dumont M, Soucy P, D\u00f6rk T, Bogdanova L, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Radice P, Peterlongo P, Peissel B, Mariani G, Baglietto L, Sawyer E, Tomlinson I, Kerin Miller N, Marme F, assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer Mol Hartmann LC, Lawrenson K, Wang C, Tyrer J, Song H, deFazio A, Johnatty SE, Doherty JA, Phelan CM, Sellers TA, Ramirez SM, Vitonis AF, Terry KL, Van Den Berg D, AH, Berchuck A, Gentry-Maharaj A, Ramus SJ, Diergaarde Shen Lubilski J, Ziogas A, Rothstein JH, McGuire V, Sieh W, Lester J, Walsh C, Vergote I, Lambrechts S, Despierre E, Garcia-Closas B, Rzepecka IK, Dansonka-Mieszkowska A, Seibold P, Rudolph A, I, Lundvall L, Olson SH, Hogdall Bois Harter Paul J, Ekici AB, Beckmann MW, Hein A, Eccles D, Lurie G, Hays LE, Bean YT, Pejovic T, Goodman MT, Campbell I, Fasching PA, Whittemore AS, Culver HA, J, DA, LE, Knutson KL, Goode EL.Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.Cancer Immunol Res. 10.1158/2326-6066.CIR-13-0136. Smoak C, Bohr T, K, Disease: A Confirmatory Study.Br J Med Med Res. Apr 21;4(12):2388-2417. PMID:24977122 164. Davanipour Z, Sobel E, (sCJD): A Confirmatory Case-Control Study. Br J Med Med Res. 2014 Apr 30;4(12):2322-2333.PMID:25089261 165. Earp MA, Kelemen G; Australian Cancer Study; Australian Ovarian Cancer Study Group, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts S, Doherty JA, Rossing MA, Chang- Claude J, Rudolph A, Friel G, Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Goodman MT, Carney ME, Thompson PJ, Runnebaum IB, D\u00fcrst M, Hillemanns R, CH, F, RP, RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, Walsh C, Lester J, Jensen A, Kj\u00e6r SK, H\u00f8gdall CK, H\u00f8gdall E, Lundvall L, Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA, Bisogna M, Schildkraut JM, Iversen ES, Weber RP, Berchuck EM, Tworoger N, Brinton J, Garcia-Closas M, Dicks E, DF, Song H, Tyrer JP, Pharoah PD, Eccles W, Rothstein JH, Flanagan JM, Paul J, Brown R, Phelan CM, Risch HA, McLaughlin JR, Narod SA, Ziogas A, A, Ovarian Cancer Association Consortium.Genome-wide association study of subtype-specific epithelial ovarian cancer risk Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang- Claude J, Martin NG, Montgomery GW, Kristensen V, Goodfellow Renner W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold J, L, Reed MW, Cross SS, Deming-Halverson S, Shrubsole M, Cai Q, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, R\u00fcdiger T, W\u00f6lfing HU, K, Blomqvist C, Irwanto Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A, Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM, Couch FJ. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Carcinogenesis. 2014 May;35(5):1012-9. doi: 10.1093/carcin/bgt404. PG, SE, Strong LC, Ziogas A, Griffin CA, Kasten CH, Finkelstein DM. Long-term risk of medical conditions associated with breast cancer treatment.Breast Cancer Res Treat. 2014 May;145(1):233-43. doi: 10.1007/s10549-014-2928-4. Epub 2014 Apr 3.PMID:24696430 168. Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, M, Miller N, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Gu\u00e9nel BG, H, Milne R, Zamora MP, Arias Perez JI, Benitez J, Bernstein L, Anton-Culver H, Ziogas A, Clarke Dur C, Brenner H, M\u00fcller Arndt C, Ko YD; GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Nevanlinna H, Muranen TA, Aittom\u00e4ki K, Blomqvist kConFab Investigators; Australian Ovarian Cancer Study Group, Wu AH, Van den Berg D, Tseng CC, Lambrechts D, Smeets D, Neven P, Wildiers H, Chang-Claude Rudolph A, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Pensotti V, Couch FJ, Olson JE, Wang X, Fredericksen Z, Pankratz VS, Giles GG, Severi G, Baglietto L, Haiman C, Simard J, Goldberg MS, Labr\u00e8che F, Dumont M, Soucy P, K, Jukkola- Vuorinen A, Grip M, Andrulis Knight AM, Devillee P, Figueroa J, Chanock ME, Hall P, Schoof N, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Liu J, Cox A, Brock IW, Reed SS, Blot W, Signorello PD, Dunning AM, Shah M, Kang D, Noh DY, Park SK, Choi JY, Hartman M, Miao H, Lim WY, Tang A, Hamann F\u00f6rsti A, J, Slager S, Toland AE, Vachon C, Yannoukakos D, Shen CY, Yu JC, Huang CS, Hou MF, Gonz\u00e1lez-Neira A, Tessier DC, Vincent D, Bacot F, Luccarini C, A, Peto J, dos Santos Silva I, Fletcher O.Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.Breast Cancer Res. 2014 May 26;16(3):R51. 169. RE, Chang J, Ziogas A, Anton-Culver H, Vieira VM.Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.Gynecol Oncol. 2014 Jul;134(1):60-7. doi: 10.1016/j.ygyno.2014.03.561. Pearce Schildkraut J, Menon U, Kjaer SK, Levine DA, Gronwald Culver HA, Whittemore AS, Karlan BY, SB, PA, Campbell I, Goodman MT, Pejovic T, Bean YT, Hays LE, Lurie G, Eccles D, Hein A, Beckmann MW, Ekici AB, Paul J, R, Bois Lundvall L, Olson SH, I, U, Dansonka- Mieszkowska Rzepecka M, Despierre E, Lambrechts S, Vergote I, Walsh CS, Lester J, Sieh W, McGuire V, Rothstein JH, Ziogas A, Lubinski Maharaj A, Berchuck A, Wu Den Berg D, KL, Vitonis AF, Ramirez SM, Rider DN, Knutson KL, Sellers TA, Phelan CM, Doherty JA, Johnatty SE, deFazio A, Song H, Tyrer J, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa HA, McLaughlin JR, Siddiqui N, Glasspool R, Paul J, Carty K, Gronwald J, J, A, Aben Olson SH, Orlow Nevanlinna MW, A, Ekici AB, Doherty JA, Wu AH, Pearce CL, Pike MC, Stram D, Chang-Claude J, IB, RP, Kelley JL, Modugno F, Ness RB, Karlan BY, Walsh C, Lester J, Orsulic S, Fridley BL, Vierkant RA, Cunningham JM, Wu X, Lu K, Liang D, Hildebrandt MA, Weber RP, Iversen ES, Tworoger SS, Poole EM, Salvesen HB, Krakstad M, Wentzensen N, Brinton LA, Lissowska J, Garcia-Closas JH, Anton-Culver JM, Berchuck A, Pharoah PD, Sellers TA, Brooks-Wilson A, Cook LS, Le ND.Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian Bojesen SE, Andrulis IL, Cox A, Hall P, Carpenter J, Yannoukakos D, Haiman CA, Fasching PA, Mannermaa BG, Nielsen SF, Flyger H, Wang X, Olswold C, Olson JE, Mulligan AM, Knight JA, Tchatchou S, Reed MW, Cross SS, Liu J, Li J, Humphreys K, Clarke C, Scott R; ABCTB Investigators, Fostira F, Fountzilas G, Konstantopoulou I, Henderson BE, Schumacher F, Le Marchand Ekici Hartmann Ovarian Cancer Study kConFab Balleine Arias Perez JI, Pilar Zamora M, Men\u00e9ndez P, Ashworth A, Jones M, Orr T, Bugert P, Toland CB, Labr\u00e8che F, MS, Dumont M, A, Lee E, Dite GS, Apicella C, Southey L, Mclean C, Milne RL, Baglietto L, dos Santos Silva I, Fletcher O, Johnson N, Van'T Veer LJ, Cornelissen S, F\u00f6rsti A, Torres D, R\u00fcdiger T, Rudolph A, Flesch-Janys D, Nickels S, Weltens C, Floris G, Moisse M, Dennis J, Wang Q, Dunning AM, Shah M, Brown J, Simard J, Anton-Culver H, Neuhausen SL, Hopper JL, Bogdanova J, Devillee P, Brauch M, B, Marmee F, Eccles DM, Giles GG, Peto S, Vachon CM, Couch FJ.Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.Hum Mol Genet. 2014 Nov 15;23(22):6034-46. WT, Dillon PM, Busman KJ, From Anton-Culver Marrett S, H, JS, Begg CB, Berwick M; Genes, Environment, and Melanoma (GEM) Group.Comparison of features and survival Ziogas Anton-Culver H, Bristow RE. Evaluation of 30-day hospital readmission after surgery for advanced-stage ovarian cancer in a Clin Oncol. PMID:25385738 175. Spurdle FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, Arnold N, Plendl H, Niederacher S, Steinemann D, Preisler-Adams S, Kast K, Varon-Mateeva R, Ellis S, Frost D, Platte R, Perkins J, Evans DG, Izatt L, Eeles R, Adlard J, Davidson R, Cole Scuvera G, Manoukian S, Bonanni B, Mariette SL, Toland AE, Nevanlinna H, Montagna M, Garber J, Godwin AK, Osorio A, Factor RE, Terry MB, Rebbeck TR, Karlan BY, Southey M, Rashid MU, Tung N, Pharoah PD, Blows FM, Dunning AM, Provenzano E, Hall Schmidt Seibold J, VS, John EM, Whittemore AS, West DW, Hamann U, Torres D, Ulmer HU, Durcan L, Jones L, Peto J, dos-Santos-Silva I, Fletcher O, Johnson N, Dwek M, Swann R, Bane AL, Glendon G, Mulligan AM, Giles GG, Milne RL, Baglietto L, McLean C, Carpenter J, Clarke C, Scott R, Brauch H, Br\u00fcning T, Ko YD, Cox A, Cross SS, Reed MW, Lubinski J, Jaworska-Bieniek Durda N, Park-Simon TW, Hillemanns P, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Burwinkel B, Marme F, Surovy H, K, Jukkola-Vuorinen A, Grip M, Lindblom A, Margolin S, Joseph V, Robson M, Rau-Murthy R, Gonz\u00e1lez-Neira A, Arias JI, Zamora mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res. 2014 doi: 10.1186/s13058-014-0474-y.PMID:25857409 176. Kuchenbaecker Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, Coetzee S, Hazelett D, Miron A, Southey M, Terry MB, Goldgar DE, Buys SS, Janavicius R, Dorfling CM, van Rensburg Neuhausen J\u00f8nson Ejlertsen B, Barrowdale Dennis L, Ottini L, Fostira F, Konstantopoulou I, Garber J, Frost D, Perkins J, Platte R, Ellis S; EMBRACE, Godwin AK, Schmutzler Stoppa-Lyonnet K, De Leeneer K, Kirk J, Rodriguez GC, Piedmonte M, O'Malley DM, de la Hoya Tung N, Hamann U, Isaccs C, Tischkowitz Kauff N, Vijai J, Aghajanian CA, Pfeiler G, Berger A, Singer CF, Tea MK, Phelan CM, Greene MH, Mai PL, Rennert G, Mulligan AM, Tchatchou C, Lester J; Australian Cancer Study (Ovarian Cancer Investigators); Australian Ovarian Cancer Study Group, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Van Nieuwenhuysen Vergote Lambrechts S, Dicks E, Doherty JA, Wicklund KG, Rossing MA, Rudolph A, Chang-Claude J, Wang-Gohrke R, F, JL, RP, RB, du Bois A, Heitz F, Schwaab I, Harter P, Matsuo K, Hosono S, A, Kjaer SK, Hogdall MA, Cunningham JM, Vierkant RA, Bruinsma F, Giles GG, Liang D, Hildebrandt MA, Wu X, Levine DA, Bisogna M, Berchuck A, Iversen ES, Schildkraut JM, Concannon Tworoger SS, Cybulski C, Yang H, Lissowska J, Brinton LA, Wentzensen N, Hogdall C, Lundvall L, Nedergaard L, Baker H, Song H, Eccles D, McNeish I, Paul J, Carty K, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Ji BT, Zheng W, Shu XO, Gao YT, Rosen B, Risch HA, McLaughlin JR, Narod SA, Monteiro AN, Chen A, Lin HY, Permuth-Wey J, Sellers TA, Tsai YY, Chen Z, Ziogas A, Anton-Culver H, Gentry-Maharaj A, Menon U, Harrington P, Lee AW, Wu AH, Pearce CL, Coetzee G, Pike MC, Dansonka-Mieszkowska of of BRCA1 and BRCA2.Identification of six new susceptibility loci ovarian Genet. HL, Chang SS, Ziogas A, Neuhausen SL, Wang SS, Bernstein L, Anton-Culver H.Human Nail Clippings as a Source of DNA for Genetic Studies. Open J Epidemiol. 2015 Feb 1;5(1):41-50.PMID:26180661 178. McEligot AJ, Ziogas A, Pfeiffer CM, Fazili Z, H.The association between circulating total folate and folate vitamers with overall survival 2015;67(3):442-8. doi: 10.1080/01635581.2015.1002623. Epub 2015 3.PMID:25647689 Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Wicklund KG, Odunsi Schwaab I, Heitz F, du Bois A, Orsulic S, Lester J, Walsh C, Karlan BY, Hogdall E, Kjaer SK, Jensen A, BL, Southey MC, Giles GG, Bruinsma F, Wu X, Hildebrandt MA, Lu K, Liang D, Bisogna M, Levine DA, Weber RP, Schildkraut JM, Iversen ES, Berchuck A, Terry KL, Cramer Bean Pejovic T, Kellar M, Le ND, Cook LS, Kelemen J, Yang H, Nedergaard L, Lundvall L, Hogdall C, Song H, Campbell IG, Eccles D, Glasspool R, Siddiqui N, Carty K, Paul J, McNeish IA, Sieh W, McGuire V, Rothstein JH, Whittemore AS, McLaughlin JR, Risch HA, Ziogas A, Menon MA, Ness RB, Pharoah PD, Stram Wu AH, Pearce CL.Evaluating the ovarian 2014 Ziogas A, Tewari KS, Anton-Culver H, Bristow RE. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California. Am J Obstet Gynecol. 2015 doi: 10.1016/j.ajog.2014.10.1104. Epub Ziogas A, Campos B, Chavez LR, Anton-Culver H. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines. Obstet Gynecol. Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen M, Peto F, A, Verhoef S, SJ, Brinton L, Lissowska Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Men\u00e9ndez P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox Cross Reed Khusnutdinova RK, Sutter C, Yang R, Sch\u00fcrmann P, Bremer M, Christiansen H, Park- Simon TW, Hillemanns P, Gu\u00e9nel P, Truong T, Menegaux Sanchez M, P, Manoukian S, EJ, Tomlinson I, Kerin MJ, N, IL, Knight Glendon G, Marie Mulligan A, Chenevix- Trench G, Balleine R, Giles GG, Milne RL, McLean C, Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AM, Koppert LB, Carpenter J, Clarke C, Scott Kosma J, Robson M, Rau-Murthy R, Dwek M, Swann R, Annie Perkins K, Goldberg MS, Labr\u00e8che F, Dumont M, Eccles DM, Tapper WJ, Rafiq S, EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S, Zheng W, Halverson SL, Gonz\u00e1lez-Neira A, Pita G, Rosario Alonso M, \u00c1lvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. Ziogas A, Campos B, Chavez LR, Anton-Culver H. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival. J Am Coll Surg. 2015 May;220(5):940-50. Kanetsky PA, Luo L, A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett RP, S, Study Group.Inherited genetic variants associated with occurrence of Ziogas A, Tewari K, Bristow RE. Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population. Gynecol Oncol. 2015 Jun;137(3):479-84. doi: Alexander A, Groben PA, Parrish E, Kricker A, BK, Anton-Culver H, Gruber SB, From L, Busam KJ, Hao H, Orlow I, Kanetsky Luo Paine Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver Wilson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois A, Despierre E, Doherty JA, D\u00f6rk T, D\u00fcrst M, Easton DF, R, Goodman MT, Gronwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall CK, Hogdall E, Hosono S, Jakubowska Karlan BY, Kelemen LE, Kellar M, Kiemeney S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Sucheston L, Teo SH, Terry KL, PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant Vergote Walsh N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, H, Ziogas A, Pharoah PD, Sellers TA, Phelan CM.Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS One. 2015 Jun 19;10(6):e0128106. doi: 10.1371/journal.pone.0128106. RE, Gillen DL, Bai L, Vieira VM.Spatial analysis of advanced-stage ovarian cancer mortality in California. Am J Obstet Gynecol. Jul;213(1):43.e1-8. doi: Lawrenson K, Karst A, Drapkin R, Ramus SJ; Ovarian Cancer Association Consortium, The Consortium of Investigators of Modifiers of BRCA1/2, Couch FJ, Offit K, Chenevix-Trench G, PD, Noushmehr H, Gayther SA; Ovarian Cancer Association Consortium The Consortium of Investigators of Modifiers of BRCA1/2.Cell-type-specific enrichment of risk-associated regulatory elements at ovarian Mol Hodeib M, Liu F, Ziogas A, Dilley S, Randall LM, Anton-Culver H, Bristow RE. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Gynecol Oncol. Beesley J, Michailidou K, Nord S, Kar S, Humphreys K, Thompson D, Ghoussaini M, Bolla MK, Dennis J, Wang Q, Canisius S, Scott CG, Apicella C, Hopper JL, Southey H, Engel C, Meindl A, Schmutzler RK; German Consortium of Hereditary Breast and Ovarian Cancer, Arnold N, Brauch H, Hamann U, Chang- Claude J, Khan S, Nevanlinna H, Ito H, Matsuo K, Bogdanova NV, D\u00f6rk A, Floris G, Lambrechts D, Rudolph A, Peterlongo P, Radice P, Couch FJ, Vachon C, Giles GG, McLean C, Milne RL, Dugu\u00e9 PA, Haiman CA, Maskarinec G, Woolcott C, Henderson BE, Goldberg MS, Simard J, Teo SH, Mariapun S, Helland \u00c5, Haakensen Winqvist R, Andrulis M, M, Li J, Gao YT, XO, A, Cross SS, Luben R, Khaw Choi JY, Kang D, Hartman WY, Kabisch M, Torres D, Jakubowska J, McKay J, Sangrajrang S, Toland AE, Swerdlow A, Borresen-Dale in 10q21.2 Risk Locus Jun 11.PMID:26073781 192. Kelemen LE, K, Tyrer J, Li Q, Lee JM, Seo JH, Phelan CM, Beesley J, Chen X, Spindler Aben KK, Anton-Culver H, Antonenkova N; Australian Cancer Study; Australian Ovarian Cancer Study Group; Ovarian Cancer Association Consortium.Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat Genet. Aug;47(8):888-97. doi: Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE; Australian Ovarian Cancer Study Group, Fasching PA, D, HA, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Goodman MT, Ness RB, Moysich K, Heitz F, du Bois A, Harter P, Schwaab I, Matsuo K, Hosono MC, Rodriguez-Rodriguez LA, Lissowska J, H\u00f8gdall E, Lundvall L, Whittemore W, J, Sutphen R, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Webb PM; Ovarian Cancer Association Consortium.Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.Br J Cancer. 2015 Sep 1;113(5):817-26. doi: 7.PMID:26151456 SM, Lee J, Goodman D, Ziogas A, Kelly R, Larsen KM, Alvarez A, Tannous C, Strope J, Lynch W, Anton-Culver H. Clinical Implementation of a Breast Cancer Risk Assessment Program in a Multiethnic Patient Population: Which Risk Model to Use?Breast J. 2015 Sep-Oct;21(5):562-4. doi: 10.1111/tbj.12461. Epub 2015 Jul 31. abstract available.PMID: 26227105 195. Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth- Wey J, Bunker CH, Butzow R, Campbell IG, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, du Bois D\u00f6rk Harter P, Hasmad Hogdall E, Hosono S, Iversen Ji BT, Karlan BY, Kellar M, Kiemeney LA, Krakstad S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Thomsen KB, Ness RB, Nevanlinna Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Palmieri Weber R, Paul J, Pearce Pejovic Pelttari LM, Pike MC, Poole Teo SH, Terry KL, PJ, Tangen IL, Tworoger SS, van Altena AM, Vergote I, Walsh Wentzensen N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Amankwah E, Berchuck A; Georgia Chenevix-Trench Gayther SA, Pharoah PD, Sellers TA, Phelan CM. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). J Genet Genome Res. 2015;2(2). pii: 017. Epub 2015 Sep Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N; Australian Ovarian Cancer Study Baker Bandera Bean Y, Beckmann Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix- Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka- Mieszkowska A, Dennis J, Dicks E, Doherty JA, D\u00f6rk T, du Bois A, D\u00fcrst M, Eccles D, Easton GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt E, Hogdall C, Hosono S, Iversen ES, Jakubowska A, James P, Jensen A, Ji BT, Karlan BY, Kruger Kjaer S, Kelemen Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, Moysich SA, Nedergaard L, Ness RB, Azmi MA, Odunsi K, Olson SH, Orlow I, Orsulic RP, Pearce CL, Pejovic T, Pelttari LM, Risch HA, Tangen IL, Teo SH, Terry KL, PJ, Timorek A, Tsai YY, Tworoger SS, van AM, Van Nieuwenhuysen E, Vergote Vierkant RA, Wang-Gohrke AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Monteiro A, Pharoah PD, Gayther SA, Freedman ML.Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Commun. 2015 Sep 22;6:8234. doi: 10.1038/ncomms9234.PMID:26391404 197. Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix- Trench G; Australian Cancer Study; Australian Ovarian Cancer Study Baker Bandera Brooks-Wilson A, Butzow R, Campbell I, Carty K, Chang-Claude J, Chen YA, Chen Z, Cook LS, Cramer D, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Dicks E, Doherty JA, D\u00f6rk T, du Bois A, D\u00fcrst M, Eccles Gentry-Maharaj GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns E, Hogdall CK, Hosono S, Iversen ES, Jakubowska A, Paul J, Jensen A, Ji BT, Karlan BY, Kjaer SK, Kelemen LE, Kellar M, Kelley LA, C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger L, Matsuo K, McGuire V, McLaughlin JR, McNeish IA, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Odunsi K, Olson SH, Orlow I, Orsulic RP, Pearce CL, Pejovic T, Pelttari LM, Risch HA, Tangen IL, Teo SH, Terry KL, PJ, Timorek A, Tsai YY, Tworoger SS, van AM, Van Nieuwenhuysen E, Vergote Vierkant RA, Wang-Gohrke AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu A, Yang H, Zheng W, Ziogas A, Sellers TA, Monteiro AN, Freedman ML, Gayther SA, Pharoah PD. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer G, Painter JN, Nyholt DR; Australian Ovarian Cancer Study; International Endogene Consortium (IEC), Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Nieuwenhuysen JA, Rossing MA, Wicklund KG, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, F, Moysich KB, Ness RB, Cannioto R, H\u00f8gdall E, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry V, Whittemore AS, Cook Gronwald J, Jakubowska A, Lubinski JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, Mclaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, between endometriosis and ovarian Hum Mol Genet. 2015 Oct 15;24(20):5955-64. doi: 10.1093/hmg/ddv306. Lawrenson ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Bandera EV, Bean Bruinsma F, Butzow R, Campbell IG, Carty K, Chang-Claude J, Chenevix-Trench G, Chen A, Chen Z, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Plisiecka-Halasa J, Dennis J, Dicks E, Doherty JA, D\u00f6rk T, du Bois A, Eccles D, Easton DT, Goodman Gronwald J, Harter P, Hasmad HN, Hein A, Heitz P, Hogdall E, Hogdall C, Hosono S, Jakubowska A, Paul J, Jensen A, Karlan BY, Kjaer SK, Kelemen LE, Kellar S, Le ND, Lee AW, Cannioto R, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Nevanlinna H, McNeish I, Menon U, Modugno F, L, RB, Azmi MA, Odunsi Olson CL, T, Pelttari Risch HA, Tangen IL, Teo SH, Terry KL, PJ, Timorek A, Tworoger SS, Van Nieuwenhuysen E, Vergote I, Vierkant Wang-Gohrke AS, Wicklund KG, Wilkens LR, Woo YL, Wu X, Wu AH, Yang H, Zheng W, Ziogas A, Coetzee GA, Freedman ML, Monteiro ovarian cancer. Carcinogenesis. Nov;36(11):1341-53. 10.1093/carcin/bgv138. Epub 2015 Sep 29.PMID:26424751 S, Chang Y, Hewitt S, Ziogas A.Measuring the quality of surgical decisions for Latina breast cancer patients. Health Expect. 2015 Dec;18(6):2389-400. doi: 10.1111/hex.12207. Epub 2014 May 12.PMID:24813584 201. Johnatty SE, Tyrer JP, Kar S, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Nieuwenhuysen Rossing MA, Doherty JA, Chang-Claude J, Modugno F, Ness RB, Moysich KB, Levine Lissowska J, Wentzensen N, Song H, Rhenius V, Campbell I, Eccles D, Sieh W, Whittemore Spiewankiewicz B, Goodman MT, LR, ME, PJ, Heitz F, du Schwaab I, Harter P, Pisterer J, Hillemanns P; AGO Study Group, Karlan Walsh C, Lester H\u00f8gdall Lundvall L, McNeish I, Paul J, Carty K, Siddiqui N, Glasspool R, Sellers T, Kennedy C, Chiew YE, Berchuck A, MacGregor S, Pharoah PD, Goode EL, deFazio A, Webb PM, Chenevix-Trench G; Australian Ovarian Cancer Study Group. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium. Clin Cancer Res. 2015 Dec 1;21(23):5264-76. doi: 10.1158/1078-0432.CCR-15-0632. Epub 2015 7.PMID:26152742 J, Ziogas A, Bristow RE. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.Gynecol Oncol. 2015 Lawrenson A, Bunker CH, Butzow R, Campbell IG, Carty K, Chen Z, Chen YA, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Cybulski C, Dansonka- Mieszkowska A, du Bois Despierre JA, D\u00f6rk T, D\u00fcrst M, Easton DF, Gronwald Harrington P, Harter P, Hasmad HN, Hein Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Jim H, Kellar M, Kiemeney LA, Krakstad C, SK, Kupryjanczyk S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lim BK, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Milne RL, Modugno F, Moysich KB, Ness RB, Nevanlinna H, Eilber U, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Paul J, Pearce CL, Pejovic T, Pelttari LM, Permuth-Wey J, Pike Sucheston-Campbell L, Teo SH, Terry KL, PJ, Thomsen L, Tangen IL, Tworoger SS, van Altena AM, Vierkant Vergote Walsh N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Kelemen LE, Berchuck A; Georgia Chenevix-Trench PD, Sellers TA, Phelan CM. Epithelial- Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Risk. Genet Epidemiol. 2015 Dec;39(8):689-97. doi: 10.1002/gepi.21921. Trench G, Pearce CL; Ovarian Cancer Association Consortium.Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril. 2016 Jan;105(1):35-43.e1-10. I, Reiner AS, Thomas NE, Roy P, Kanetsky PA, Luo L, Paine S, Armstrong BK, Kricker LD, Rosso K, Begg CB, Berwick M; GEM Study Group.Vitamin D receptor polymorphisms and survival in patients with cutaneous a population-based Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Palmieri Moorman PG, J, Iversen ES, BL, Kruger-Kjaer J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Hillemanns P, D\u00fcrst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen P, Stefansson X; Ovarian Study Group, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas at 19p13 are associated to ovarian cancer. Nat Genet. 2016 Jan;48(1):101. doi: 10.1038/ng0116-101b. No abstract available. PMID:26711112 207. Park HL, Ziogas A, Chang J, Desai B, Bessonova L, Garner C, Lee E, Neuhausen SL, Wang SS, Ma H, Clague J, Reynolds P, Lacey JV Jr, Bernstein L, Anton-Culver H. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study. BMC Cancer. 2016 Jan 12;16:14. doi: H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, Ness RB, Pearce CL, Rossing MA, Tworoger SS, Wentzensen N, Bisogna M, Brinton ME, Cunningham JM, Edwards RP, Fogarty ZC, Iversen ES, Kraft HY, Lissowska J, Modugno F, Moysich KB, Olson SH, Pike MC, Poole EM, Rider DN, Terry KL, Thompson PJ, van den Berg D, Vierkant RA, Vitonis AF, Wilkens LR, Wu AH, Yang HP, Ziogas A, CM, Schildkraut JM, Chen YA, Sellers TA, Fridley BL, Goode EL. A targeted genetic association study of epithelial ovarian cancer susceptibility.Oncotarget. 2016 Feb 16;7(7):7381-9. doi: Anton-Culver H, Bandera JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, Menon U, Ness RB, Pearce CL, Pejovic T, Rossing MA, Wentzensen N, Bean Brinton LA, Carney ME, Cunningham JM, Cybulski C, deFazio A, Dicks EM, Edwards RP, Gayther SA, Gentry-Maharaj A, Gore M, Iversen ES, Jensen A, Johnatty SE, Lester J, Lin HY, Lissowska J, Lubinski J, SJ, Song H, Terry KL, Thompson PJ, Tyrer JP, van den Berg DJ, Vierkant RA, Vitonis AF, Walsh C, Wilkens LR, Wu Berchuck EL; Australian Ovarian Cancer Study Group.Investigation of Exomic Variants Associated with Overall Survival in Jensen PM, Nagle CM, H\u00f8gdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, Edwards RP, Goode Song Sieh W, Rothstein J, AH, CL, Pike MC, Lee AW, Chang-Claude J, Jensen A; Ovarian Cancer Association Consortium. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Apr;41:71-9. doi: 10.1016/j.canep.2016.01.012. Epub 2016 Feb 3.PMID: 26851750 211. Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, Hollestelle A, van N, Arun BK, Arver B, Ashworth A; Australian Ovarian Bjorge L, A, Bruinsma CH, Burwinkel B, Butzow R, Buys SS, Caligo MA, J, Chanock SJ, Claes KBM, Coll\u00e9e JM, Cook LS, Couch FJ, Cox A, Cramer D, Cross SS, Cunningham JM, Cybulski C, Czene K, Damiola F, Dansonka- Mieszkowska A, Darabi H, de la Hoya M, deFazio A, Dennis J, Devilee P, Dicks EM, Diez O, Doherty JA, Domchek SM, Dorfling CM, D\u00f6rk T, Silva IDS, du M, Dunning AM, Duran M, Easton D, H, B, AB, Ellis SD; EMBRACE, Engel Eriksson M, Fasching PA, Feliubadalo L, Figueroa J, Flesch-Janys F, Fridley BL, Friebel T, Friedman E, GG, Glasspool R, Glendon G, Godwin AK, Goodman MT, Gore M, Greene MH, Grip M, Gronwald J, Gschwantler Kaulich D, Gu\u00e9nel P, Guzman SR, Haeberle L, Haiman Hall P, SL, S; HEBON, Hein A, Heitz F, Henderson BE, Herzog J, T Hildebrandt MA, H\u00f8gdall CK, H\u00f8gdall E, Hogervorst C, Jakubowska A, Janavicius R, Jaworska K, Jensen A, Jensen UB, Johnson N, A, P, Lazaro C, Le ND, Le Marchand L, Leminen A, Lester J, Levine DA, Li J, Liang D, Lindblom A, Lindor N, Lissowska J, Long J, Lu KH, Lubinski J, Lundvall L, Lurie G, Mai PL, McNeish I, Meindl A, Menegaux F, Men\u00e9ndez P, Menkiszak Olson JE, Olson SH, Oosterwijk JC, Orlow I, Orr N, Orsulic S, Osorio A, Ottini L, Paul J, Pearce CL, Pedersen IS, B, T, Permuth- Wey Peterlongo P, Peto Phelan CM, Piedmonte M, Pike MC, Platte R, Plisiecka- Halasa Scuvera G, Sellers TA, Severi G, Seynaeve CM, Shah M, Shrubsole M, Siddiqui N, Sieh W, Simard J, Singer CF, Sinilnikova OM, Smeets D, Sohn C, Soller M, Song Terry MB, H, Tung N, Tworoger SS, Tyrer JP, Vachon CM, Van 't Veer LJ, van Altena AM, Van Asperen CJ, van den Berg van den Ouweland Wachenfeldt Walsh AH, Wu X, Yang HP, Zaffaroni D, Pilar Zamora M, Zheng Rookus MA, Hooning EL. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol A, Shehata M, Anton-Culver H. A Validation Method to Determine Missing Years of Birth in a Cohort Study of Shipyard Workers Using Social Security Number. J Occup Environ Med. 2016 Jun;58(6):631-5. Pearce CL, Zheng W, Painter JN; AOCS Group & Australian Cancer Study (Ovarian Cancer), Chenevix-Trench Fasching PA, Beckmann MW, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Rudolph A, Moysich KB, Odunsi LM, JL, Heitz F, Karlan BY, Kj\u00e6r SK, H\u00f8gdall Hildebrandt MA, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, J, H\u00f8gdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin A, Menon U, SA, Dansonka-Mieszkowska A, Budzilowska A, Spiewankiewicz B, Webb PM; Ovarian Cancer Association Consortium.Adult body mass index and risk of ovarian cancer by subtype: a 214. Cuellar-Partida G, Lu Y, Dixon SC; Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Nieuwenhuysen Vanderstichele Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Wang-Gohrke S, Goodman MT, KB, Ness RB, Cannioto R, H\u00f8gdall H\u00f8gdall C, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, V, JH, W, Whittemore AS, Cook LS, C, Gronwald J, Jakubowska A, Lubinski JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, I, Gayther G, Risch HA, MacGregor S. Assessing the genetic architecture of epithelial cancer histological subtypes.Hum Genet. Ziogas A. Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer. Clinicoecon Outcomes Res. 2016 2;8:397-406. doi: Meijers B, Chang-Claude J, Chenevix-Trench G, Couch FJ, Cox A, Cross SS, Czene K, Dunning AM, Fasching PA, Figueroa J, Fletcher O, H, Galle E, Garc\u00eda- Closas M, Giles GG, Haeberle L, Hall P, Hillemanns P, Hopper JL, Jakubowska A, John EM, Jones M, Khusnutdinova E, Knight JA, Kosma VM, Kristensen V, Lee A, Lindblom A, Lubinski A, Margolin S, Meindl TW, Trentham-Dietz A, Vachon C, Wang Q, Whittemore AS, Ziogas A, van der Kolk L, Nevanlinna T, Bojesen S, Easton DF.Age- Chen Y, Lin HY, Reid Z, Monteiro A, Dennis J, Mendoza- Fandino G; AOCS Study Bandera EV, Bisogna M, Brinton L, Brooks-Wilson A, Cook LS, Cramer DW, Cunningham JM, Cybulski C, D'Aloisio AA, Anne Doherty M, Edwards RP, Fridley BL, Gayther SA, Gentry-Maharaj MT, Gronwald Iversen ES, Jakubowska A, Jensen A, Karlan BY, Kelemen LE, Kjaer SK, Kraft P, Le ND, Levine DA, Lissowska J, Lubinski J, Matsuo K, Menon U, Modugno R, Moysich KB, Nakanishi T, Ness RB, Olson S, Orlow I, Pearce CL, Pejovic T, Poole EM, Ramus SJ, Anne Rossing M, Sandler DP, Shu XO, Song H, Taylor JA, Teo SH, Terry KL, Thompson PJ, Tworoger SS, Webb PM, Wentzensen N, Wilkens LR, Winham S, Woo YL, Wu AH, Yang H, Zheng W, Ziogas A, Phelan CM, Schildkraut JM, Berchuck A, Goode EL, Cancer Association Consortium. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Hum Mol Genet. 2016 Aug 15;25(16):3600-3612. doi: 10.1093/hmg/ddw196. Epub 2016 Kar Amin Al Olama A, Michailidou K, Tyrer J, AS, Wolk A, Monteiro A, Peixoto A, Kierzek A, Cox A, Rudolph A, Gonzalez-Neira A, Wu AH, Lindblom A, Swerdlow A; AOCS Study & Blomqvist C, Phelan C, McLean C, Pearce CL, Vachon C, Cybulski C, Slavov C, Cramer DW, Neal DE, Eccles D, Flesch-Janys D, Edwards DR, Wokozorczyk D, Levine DA, Yannoukakos D, Sawyer EJ, Bandera EV, Poole EM, Goode EL, Khusnutdinova E, H\u00f8gdall Bruinsma F, Song H, Lim HY, McNeish I, Campbell I, Vergote I, Gronwald J, JL, JL, Kupryjanczyk Park JY, Clements JA, Knight JA, Peto J, Cunningham JM, Pow- Sang J, KB, Aly M, MA, Beckmann MW, Moisse M, Sanderson M, Southey MC, Jones M, Lush M, Hildebrandt MA, Hou MF, Schoemaker MJ, Garcia-Closas M, Bogdanova N, Rahman N, Pashayan N, Peterlongo P, Gu\u00e9nel P, Brennan P, Paulo P, Webb PM, Broberg P, Fasching PA, Devilee P, Wang Q, Cai Q, Li Q, Kaneva R, Butzow R, Kopperud Ness R, Milne RL, Travis RC, Benlloch S, Olson SH, McDonnell SK, Tworoger SS, Maia Berndt S, Edwards V, W, W, W, Blot WJ, Kluzniak W, Shu XO, Gao YT, Schumacher F, Freedman Berchuck A, Dunning AM, Simard J, Haiman CA, Spurdle A, Sellers TA, Hunter DJ, Henderson BE, Kraft P, Chanock SJ, Couch FJ, Hall P, of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discov. 2016 Sep;6(9):1052-67. doi: 10.1158/2159-8290.CD-15-1227. Epub 2016 Ziogas A, Anton-Culver H, Clayman RV. Treatment for T1a J, Bray F, Znaor A, Stevens L, Eser S, Silverman B, Nimri O, Pavlou P, Charalambous H, Demetriou A, Ward K, Ziogas A. Cancer burden in four countries of the Middle East Cancer Consortium (Cyprus; Jordan; Israel; Izmir (Turkey)) with comparison to the United States surveillance; epidemiology and end results program.Cancer Epidemiol. 2016 G, Lu Y; Australian Ovarian Cancer Study, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote Vanderstichele Anne Doherty J, Anne Rossing M, Chang-Claude J, Eilber U, Rudolph A, Wang-Gohrke S, Goodman MT, RB, Cannioto CK, Jensen A, Giles GG, Bruinsma F, Kjaer SK, Hildebrandt MA, Liang D, Lu KH, Wu X, Bisogna M, Dao F, Levine DA, Cramer DW, Terry KL, V, Whittemore AS, Cook Gronwald J, Jakubowska A, Lubinski JP, Wentzensen N, Brinton L, Trabert B, Lissowska J, McLaughlin JR, Narod SA, Phelan C, Anton-Culver H, Ziogas A, Eccles D, I, Gayther Neale RE, Webb PM, MacGregor S. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. Int J Epidemiol. 2016 Oct;45(5):1619-1630. Epub 2016 Sep 4.PMID:27594614 222. Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Edwards RP, Fridley BL, Goode EL, Lurie G, McGuire V, Modugno F, Moysich KB, Olson SH, Pearce CL, Pike MC, Rothstein JH, Sellers TA, Sieh W, Stram Thompson Vierkant RA, Wicklund AH, Ziogas A, Tworoger SS, Schildkraut JM; , on behalf of the Ovarian Cancer Association Consortium. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case- Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.Am J Epidemiol. 2016 Oct 15;184(8):579-589. Epub 2016 MT, Bandera EV, KL, Joseph JM, Aben KK, Anton-Culver Antonenkova A, Bruinsma F, Butzow R, Campbell IG, Carty K, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Despierre E, Dicks E, Doherty JA, du Bois A, D\u00fcrst M, Easton D, Eccles D, Harter P, Hasmad Hein A, Heitz F, Hildebrandt C, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kelley JL, Kiemeney S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Liu S, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Moes-Sosnowska J, Narod SA, Nedergaard L, Nevanlinna H, Nickels S, Olson SH, Orlow I, Weber RP, Paul J, Pejovic T, Pelttari LM, Perkins B, Permuth-Wey J, Pike Teo SH, Thompson PJ, Timorek A, YY, Tworoger SS, Tyrer J, van Altena Vergote Walsh N, Whittemore AS, Wicklund KG, Wilkens LR, Wu AH, Wu X, Woo YL, Yang H, Zheng W, Ziogas A, Gayther SA, Ramus Sellers TA, Cunningham PP, Ness RB, Odunsi K, Goode EL, Moysich KB. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. 2016 Oct 25;7(43):69097-69110. doi: 10.18632/oncotarget.10215.PMID:27533245 224. Permuth JB, Monteiro AN, Chen Z; AOCS MA, Doherty JA, Chang-Claude H, Pelttari L, Leminen A, Modugno F, Edwards RP, Ness RB, Kelley J, Heitz F, Karlan B, Lester J, Kjaer SK, Jensen A, Giles G, Hildebrandt M, Liang D, Lu KH, Wu X, Levine DA, Bisogna M, Berchuck A, Cramer Terry KL, Tworoger L, Kiemeney LA, Massuger L, Pejovic T, Moffitt M, Le N, Cook LS, Brooks-Wilson A, Kelemen LE, Gronwald J, Lubinski J, Wentzensen E, Hogdall C, Lundvall L, Pharoah PD, Song H, Campbell I, Eccles D, McNeish I, Whittemore A, McGuire V, Sieh W, Rothstein J, Phelan CM, Risch H, Narod S, McLaughlin J, JM, Cheng JQ, Goode EL, Sellers TA.Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. A, L, Ekici AB, Beckmann I, Kerin Yang R, Gu\u00e9nel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Men\u00e9ndez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke H, JM, AB, K; Ovarian Study Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Aln\u00e6s GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip M, Kauppila P, Li J, Brand JS, Humphreys K, Cox A, Reed MW, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres Ulmer HU, R\u00fcdiger A, Ashworth A, Orr N, Jones M, Gonz\u00e1lez-Neira A, Pita G, Alonso MR, \u00c1lvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy P, Eeles Kibel Cybulski C, Cannon-Albright L, Butterbach Park Z, Olama SP, A, A, M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs S, Doherty JA, Rossing MA, S, U, Wang- Gohrke S, Odunsi R, Modugno F, RP, RB, KB, du Bois A, Heitz F, Harter P, Kommoss S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, H\u00f8gdall E, Peissel B, Bonanni B, Bernard L, Liang D, Lu KH, Hildebrandt MA, Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR, Akushevich L, Cramer DW, Schildkraut J, T, SA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire W, Cai H, Shu XO, Teten RT, Sutphen R, McLaughlin JR, Narod SA, Monteiro AN, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa Moes-Sosnowska J Dec;53(12):800-811. Albieri V, Bandera EV, Doherty JA, H\u00f8gdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, Schildkraut A, Olson SH, Kiemeney SA, Phelan CM, Anton-Culver H, AH, Pearce CL, Risch HA, Jensen A; , on behalf of the Ovarian Cancer Association Consortium.Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Kar R, Campbell I, Carty K, Chang-Claude J, Cook LS, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Doherty JA, D\u00f6rk Fasching PA, Flanagan J, Gentry-Maharaj A, Glasspool R, Goode EL, Goodman MT, Gronwald J, F, Hildebrandt MA, H\u00f8gdall Kjaer SK, Kupryjanczyk J, Lambrechts D, Levine DA, Q, Lissowska J, Lu KH, Lubinski J, Massuger F, Monteiro AN, Moysich KB, Ness RB, H, Paul J, Pearce CL, Pejovic T, Permuth M, W, Song H, Southey M, Terry KL, Tworoger SS, Walsh C, Wentzensen N, Whittemore AS, Wu AH, Yang H, Zheng W, Ziogas A, Freedman ML, Gayther SA, Pharoah PD, Lawrenson K. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility J Etter S, S, Hu Q, Szender JB, Minlikeeva A, Joseph JM, Campbell SP, Chenevix-Trench G, Cramer DW, Dansonka-Mieszkowska A, Dao F, Diergaarde B, Doerk T, Doherty JA, du Bois A, Eccles Engelholm SA, Fasching PA, Gayther A, Glasspool RM, Goodman MT, Gronwald J, Harter P, F, Hillemmanns C, H\u00f8gdall EV, Huzarski Klapdor R, Kluz T, Konopka B, Kj\u00e6r SK, Kupryjanczyk J, Lambrechts D, Lester J, Lubinski J, Levine DA, Lundvall L, McGuire V, McNeish IA, Menon U, Modugno F, Ness RB, Orsulic S, H, Terry KL, Van Nieuwenhuysen E, Vanderstichele A, Vergote I, Walsh CS, Webb PM, Wentzensen N, Whittemore AS, Wu AH, Ziogas A, Odunsi K, Chang-Claude J, Goode EL, Moysich KB; Australian Ovarian Cancer Study. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Arce A, Ziogas A, Taylor T, Wang Z, Yourk V, Liu J, Wu J, McEligot AJ, Anton-Culver H, Meyskens FL. Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light KB, A; Australian Ovarian Cancer Study Group, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Ness RB, Edwards RP, Jensen A, Kj\u00e6r SK, H\u00f8gdall E, Berchuck A, Cramer DW, Terry CL, Wu AH, Pike MC, Webb PM.Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. Br J Cancer. 2017 Apr Bogdanova NV, Hall P, Li J, Khusnutdinova E, Bermisheva M, Kristensen V, Borresen-Dale AL, Investigators N, Peto J, Dos Santos Silva I, Couch FJ, Olson JE, Hillemans P, Park-Simon TW, Brauch H, F, Giles GG, Milne MK, Nevanlinna H. Phelan KB, Tyrer JP, Kar SP, Lawrenson K, Winham A, Riggan S, Beesley J, McGuffog L, Soucy P, Dicks E, Lee A, Barrowdale D, Lecarpentier J, Leslie G, Aalfs CM, Aben A, Bruinsma F, Brunet J, Buecher B, Butzow R, Buys SS, Caldes T, Caligo MA, Campbell I, Cannioto R, Carney ME, Cescon T, Chan SB, Chang-Claude J, Chung WK, Claes KBM, Conner Cook LS, Cook J, Cramer DW, Cunningham JM, D'Aloisio AA, Daly MB, Damiola F, Damirovna SD, Dansonka-Mieszkowska A, Dao F, Davidson R, DeFazio A, Delnatte C, Doheny KF, Diez T, Eeles R, Eilber U, Ejlertsen B, Ekici AB, Ellis S, Elvira M; EMBRACE Study, Eng KH, Engel C, Evans DG, Fasching Ferguson J, Garc\u00eda MJ, Garcia-Barberan V, Gehrig Giles R, Glendon G, Godwin AK, Goldgar DE, Goranova T, Gore M, Greene MH, Gronwald J, Gruber S, Hahnen E, Haiman CA, H\u00e5kansson N, Hamann U, Hansen TVO, Harrington PA, Harris HR, Hauke J; HEBON Study, Hein A, Henderson A, Hildebrandt MAT, P, Hodgson S, H\u00f8gdall A, Jakubowska A, James P, Janavicius R, Jernetz M, Jensen A, Jensen UB, John EM, Johnatty S, Jones ME, Kannisto P, N, Larson MC, Lazaro C, ND, Marchand L, Lee JW, Lele SB, Leminen A, Leroux D, Lester J, Lesueur F, Levine DA, Liang D, Liebrich C, Lilyquist J, Lipworth L, Lissowska J, Lu LFAG, May T, Mazoyer McNeish I, Meijers-Heijboer H, Meindl A, Menon U, Mensenkamp AR, Merritt MA, Milne RL, Mitchell G, Modugno F, Moes-Sosnowska J, Moffitt E, O'Malley DM, Ong KR, Onland-Moret NC; OPAL study Orr A, Palli D, Papi L, Park-Simon Pike MC, Piskorz AM, Poblete SR, Pocza J, Rappaport-Fuerhauser C, Rennert G, Rhiem K, Rice P, Richardson A, Robson M, Rodriguez GC, C, Romm Siddiqui N, Side LE, Sieh W, Singer CF, Sobol H, Song H, Southey AJ, L, Tan YY, Taylor JA, Tea MK, Teixeira MR, Teo SH, Terry KL, Thompson PJ, Thomsen Thull DL, AE, Tone A, Trabert B, RC, Trichopoulou A, Tung N, Tworoger SS, van Altena AM, Van Den Berg D, van der Hout AH, van der Luijt RB, Van Heetvelde M, Van Nieuwenhuysen E, van Rensburg Vanderstichele I, Vierkant RA, Vijai J, Vratimos A, Walker L, Walsh C, Wand D, Wang-Gohrke S, Wappenschmidt B, Webb PM, Weinberg Woo M, Wu X, Wu AH, Yang H, Yannoukakos D, Ziogas A, Zorn AN, Couch FJ, Berchuck A, Chenevix-Trench G, Goode EL, Sellers TA, Gayther SA, Antoniou AC, Pharoah PDP.Identification of 12 new susceptibility loci for different histotypes Nielsen TS, Webb PM, Nagle CM, DeFazio A; Australian Ovarian Cancer Study Group, H\u00f8gdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, Edwards R, Matsuo K, Hosono S, Goode EL, Whittemore Sieh W, Rothstein J, SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike M, AW, Sutphen R, Chang-Claude J, Risch HA, Kjaer SK; Ovarian Cancer Association Consortium. Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer. 2017 Jun 1;140(11):2422-2435. doi: 10.1002/ijc.30600. Epub 2017 Jan 24.PMID:28063166 VM, Villanueva C, Chang J, Ziogas A, Bristow RE. Impact of community disadvantage and air pollution burden on geographic disparities of ovarian cancer survival in California. Environ Res. CB, Berwick M, Thomas NE, Kanetsky PA, Jones LW; GEM Study Group.No association between prediagnosis exercise and survival in patients with high-risk primary melanoma: A population-based study. abstract available.PMID:28397350 236. Liu G, Lee S, Lee AW, Wu AH, Bandera EV, Jensen A, Anne Rossing M, Moysich KB, Chang- Claude J, Doherty J, Gentry-Maharaj A, Kiemeney L, Gayther SA, Modugno F, Massuger U, A, Pharoah PD, Risch H, Leigh Pearce C, Mukherjee B. Robust Tests for Additive Gene-Environment Interaction in Case- Control Studies Using Gene-Environment J Epidemiol. 14. ahead of print]PMID: 28633381 237. Park HL, Chang J, Lal G, Lal K, Ziogas A, Anton-Culver H. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.Clin Breast Cancer. 2017 H, Lee E, Neuhausen SL, Anton-Culver H, Reynolds P, Nelson DO, Ziogas A, Van Den Berg D, Deapen DM, Bernstein L, Schumacher FR. Genome-Wide Testing of Exonic Variants and Breast Cancer Risk in the California Epidemiol P, Diergaarde B, Zsiros E, Kelemen LE, K\u00f6bel M, Steed SJ, Fasching PA, Beckmann MW, Risch HA, Rossing MA, Doherty Chang-Claude J, Goodman MT, D\u00f6rk T, Edwards R, Modugno F, Ness RB, Matsuo K, Mizuno M, Karlan BY, Goode EL, Kj\u00e6r A, Pearce CL, AH, Kupryjanczyk J, Jensen A, Webb PM, Moysich KB; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group.History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiol Kar S, Lindstr\u00f6m S, Hui S, Lema\u00e7on A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, Wang CM; ABCTB Adlard J, Agata S, Ahmed S, Ahsan H, Aittom\u00e4ki K, Al-Ejeh F, Allen J, Ambrosone CI, Andrulis IL, Anton-Culver H, Antonenkova Barkardottir RB, D, Baynes C, MW, H, Paillerets Brewer Broberg P, Brooks-Wilson A, Brunet J, Br\u00fcning T, Burwinkel B, Buys SS, Byun J, Cai Q, Cald\u00e9s T, Caligo MA, Campbell I, Canzian F, Caron A, Chanock SJ, X, TD, Chiquette Christiansen H, Claes KBM, Clarke CL, Conner T, DM, Cook J, Cordina- Duverger E, Cornelissen S, Coupier I, Cox A, Cox DG, Cross SS, Cuk K, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, Davidson R, De Leeneer K, Devilee P, Dicks Dugu\u00e9 PA, Dumont M, Dunning AM, Durcan L, Dwek M, Dworniczak B, Eccles Fasching PA, Faust O, Flyger H, Foulkes WD, Friedman E, Fritschi L, Frost Gammon Gehrig Georgoulias V, Gerdes AM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, Gonz\u00e1lez-Neira A, Goodfellow P, Greene MH, Aln\u00e6s GIG, Grip M, Gronwald J, Grundy A, Gschwantler-Kaulich D, Gu\u00e9nel P, Guo N, U, JM, CS; HEBON, Hein A, Helbig S, Henderson A, Heyworth J, Hicks B, Hillemanns P, Hodgson S, Hogervorst FB, Hollestelle A, Hooning MJ, Hoover B, Hopper JL, Hu C, Huang G, Hulick PJ, Humphreys K, Hunter DJ, Imyanitov EN, Isaacs C, Iwasaki M, Izatt L, Jakubowska A, James P, Janavicius R, Janni W, Jensen UB, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Konstantopoulou D, K, Lasset C, Lazaro C, Le Marchand L, Lecarpentier J, Lee A, Lee E, Lee JW, Lee MH, Lejbkowicz F, Lesueur F, Li J, Lilyquist J, Lincoln A, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Loud JT, Lubinski J, Luccarini Lush M, MacInnis RJ, Maishman T, Makalic E, Kostovska IM, Malone KE, Manoukian S, Manson JE, Margolin S, Martens JWM, Martinez ME, Matsuo K, Mavroudis D, Mazoyer S, McLean C, Meijers-Heijboer H, Men\u00e9ndez P, Meyer J, Miao H, Miller A, Miller N, Mitchell G, Montagna M, Muir K, Mulligan RL, Olswold Oosterwijk JC, Orr N, Osorio A, Pankratz VS, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Lloyd R, Pedersen IS, Peissel B, Peixoto A, Perez JIA, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Pinchev M, Plaseska-Karanfilska D, Poppe B, Porteous ME, Prentice N, Prokofieva D, Pugh E, Pujana MA, Pylk\u00e4s K, Rack B, Radice P, Rahman N, Rantala J, Rappaport-Fuerhauser C, Rennert G, Rennert HS, Rhenius V, Rhiem K, Richardson A, Rodriguez GC, Romero A, Romm J, Rookus MA, Rudolph A, Ruediger T, Saloustros E, Sanders J, DP, Sangrajrang DF, Schoemaker MJ, Sch\u00fcrmann P, Schwentner Scott C, Scott RJ, Seal S, Senter L, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng X, Shimelis H, Shrubsole MJ, Shu XO, Side LE, Singer Spinelli Spurdle RM, Tan YY, Taylor JA, Tejada MI, Tengstr\u00f6m M, Teo SH, Terry MB, Tessier DC, Teul\u00e9 A, Th\u00f6ne K, L, Torres D, Tranchant M, Truong T, Tucker K, Tung N, Tyrer J, Ulmer HU, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, Rensburg EJ, Varesco L, Varon-Mateeva Viel A, Vijai J, Vincent D, Vollenweider J, Walker L, Wang Z, Wang-Gohrke S, Wappenschmidt B, Weinberg CR, AH, Xia L, Yang XR, Yannoukakos D, Zaffaroni D, Zheng W, Zhu B, Ziogas A, Ziv E, Zorn KK, Gago-Dominguez M, Mannermaa A, Olsson H, Teixeira MR, Stone J, Offit K, Ottini L, Park SK, Thomassen M, Hall Antoniou AC, Simard J.Identification of ten variants associated with risk of estrogen-receptor-negative cancer. Nat Genet. Oct Michailidou K, Lindstr\u00f6m S, Dennis J, Beesley J, Hui S, Kar S, Lema\u00e7on A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, Wang Z, Allen J, Keeman R, Eilber U, French JD, Qing Chen X, Fachal McCue K, McCart Reed AE, Ghoussaini M, Carroll JS, Jiang X, Finucane H, Adams M, Adank MA, Ahsan H, Aittom\u00e4ki Q, Cald\u00e9s T, Canzian F, Carracedo A, Carter BD, Castelao JE, Chan TL, David Cheng TY, Seng Chia K, Choi JY, Christiansen H, Clarke CL; NBCS Collaborators, Coll\u00e9e M, Conroy DM, Cordina-Duverger E, Cornelissen Cox DG, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, D\u00f6rk Dos-Santos-Silva I, Dumont M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Elvira M, Engel C, Eriksson M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher H, MS, DE, A, Grip N, SN, Hartikainen JM, Hartman M, Hein A, Heyworth DN, Hollestelle A, MJ, Hoover RN, Hopper JL, Hou MF, Hsiung CN, Huang G, Humphreys K, Ishiguro J, Ito H, Iwasaki M, Iwata H, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang Y, Kerin MJ, Khan S, Khusnutdinova E, Kiiski Kosma VM, Kristensen VN, Kr\u00fcger U, Kwong A, Lambrechts D, Le Marchand L, Lee E, Lee MH, Lee JW, Neng Lee C, Lejbkowicz F, Li J, Lilyquist J, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Lophatananon A, Lubinski J, Luccarini C, Lux MP, Ma ESK, MacInnis RJ, Maishman T, Makalic E, Malone KE, Kostovska IM, Mannermaa A, Manoukian S, Manson JE, Margolin S, Mariapun S, Martinez ME, Matsuo K, Mavroudis D, McKay J, McLean C, Meijers-Heijboer H, Meindl A, Men\u00e9ndez P, Menon U, Meyer J, Miao H, Miller N, Taib NAM, Muir K, Mulligan AM, Mulot C, Neuhausen SF, Noh DY, Nordestgaard BG, Norman A, Olopade OI, Olson JE, Olsson H, Olswold C, Orr N, Pankratz VS, Park SK, Park-Simon TW, Lloyd R, Perez JIA, Peterlongo P, Peto J, Phillips KA, Pinchev M, Plaseska-Karanfilska D, Prentice R, Presneau N, Prokofyeva D, Pugh E, Pylk\u00e4s K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, T, Scott RJ, Scott C, Seal S, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng G, Sherman ME, Shrubsole MJ, Shu XO, Smeets Surowy H, Swerdlow A, Tamimi R, Taylor JA, Tengstr\u00f6m M, Teo SH, Beth Terry M, Tessier DC, Thanasitthichai S, Th\u00f6ne K, Tollenaar RAEM, Tomlinson CC, Tsugane S, Ulmer HU, Ursin G, Untch M, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, van der Kolk L, van der Luijt RB, Vincent D, Vollenweider J, Waisfisz Q, Wang-Gohrke S, Weinberg CR, Wendt AS, Wildiers H, Willett W, Winqvist R, Wolk A, Wu AH, Xia L, Yamaji T, Yang XR, Har Yip C, Yoo KY, Yu JC, Zheng W, Zheng Y, Zhu B, Ziogas A, Ziv E; ABCTB Amos CI, Couch FJ, Pharoah PDP, Chang-Claude J, Hall P, Hunter M, Schmidt Simard J, Kraft P, Easton DF. Association analysis identifies 65 new breast cancer 2017 A, Anton-Culver H. Cancer risk in different generations of Middle Eastern immigrants to California, 1988-2013. Int J Cancer. 2017 Dec Beesley J, Kar S, Lindstr\u00f6m S, Hui S, Lema\u00e7on A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, Wang CM; ABCTB Adlard J, Agata S, Ahmed S, Ahsan H, Aittom\u00e4ki K, Al-Ejeh F, Allen J, Ambrosone CI, Andrulis IL, Anton-Culver H, Antonenkova Barkardottir RB, D, Baynes C, MW, H, Paillerets Brewer Broberg P, Brooks-Wilson A, Brunet J, Br\u00fcning T, Burwinkel B, Buys SS, Byun J, Cai Q, Cald\u00e9s T, Caligo MA, Campbell I, Canzian F, Caron A, Chanock SJ, X, TD, Chiquette Christiansen H, Claes KBM, Clarke CL, Conner T, DM, Cook J, Cordina- Duverger E, Cornelissen S, Coupier I, Cox A, Cox DG, Cross SS, Cuk K, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, Davidson R, De Leeneer K, Devilee P, Dicks Dugu\u00e9 PA, Dumont M, Dunning AM, Durcan L, Dwek M, Dworniczak B, Eccles Fasching PA, Faust O, Flyger H, Foulkes WD, Friedman E, Fritschi L, Frost Gammon Gehrig Georgoulias V, Gerdes AM, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, Gonz\u00e1lez-Neira A, Goodfellow P, Greene MH, Aln\u00e6s GIG, Grip M, Gronwald J, Grundy A, Gschwantler-Kaulich D, Gu\u00e9nel P, Guo N, U, JM, CS; HEBON, Hein A, Helbig S, Henderson A, Heyworth J, Hicks B, Hillemanns P, Hodgson S, Hogervorst FB, Hollestelle A, Hooning MJ, Hoover B, Hopper JL, Hu C, Huang G, Hulick PJ, Humphreys K, Hunter DJ, Imyanitov EN, Isaacs C, Iwasaki M, Izatt L, Jakubowska A, James P, Janavicius R, Janni W, Jensen UB, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Konstantopoulou D, K, Lasset C, Lazaro C, Le Marchand L, Lecarpentier J, Lee A, Lee E, Lee JW, Lee MH, Lejbkowicz F, Lesueur F, Li J, Lilyquist J, Lincoln A, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Loud JT, Lubinski J, Luccarini Lush M, MacInnis RJ, Maishman T, Makalic E, Kostovska IM, Malone KE, Manoukian S, Manson JE, Margolin S, Martens JWM, Martinez ME, Matsuo K, Mavroudis D, Mazoyer S, McLean C, Meijers-Heijboer H, Men\u00e9ndez P, Meyer J, Miao H, Miller A, Miller N, Mitchell G, Montagna M, Muir K, Mulligan RL, Olswold Oosterwijk JC, Orr N, Osorio A, Pankratz VS, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Lloyd R, Pedersen IS, Peissel B, Peixoto A, Perez JIA, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Pinchev M, Plaseska-Karanfilska D, Poppe B, Porteous ME, Prentice N, Prokofieva D, Pugh E, Pujana MA, Pylk\u00e4s K, Rack B, Radice P, Rahman N, Rantala J, Rappaport-Fuerhauser C, Rennert G, Rennert HS, Rhenius V, Rhiem K, Richardson A, Rodriguez GC, Romero A, Romm J, Rookus MA, Rudolph A, Ruediger T, Saloustros E, Sanders J, DP, Sangrajrang DF, Schoemaker MJ, Sch\u00fcrmann P, Schwentner Scott C, Scott RJ, Seal S, Senter L, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng X, Shimelis H, Shrubsole MJ, Shu XO, Side LE, Singer Spinelli Spurdle RM, Tan YY, Taylor JA, Tejada MI, Tengstr\u00f6m M, Teo SH, Terry MB, Tessier DC, Teul\u00e9 A, Th\u00f6ne K, L, Torres D, Tranchant M, Truong T, Tucker K, Tung N, Tyrer J, Ulmer HU, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, Rensburg EJ, Varesco L, Varon-Mateeva Viel A, Vijai J, Vincent D, Vollenweider J, Walker L, Wang Z, Wang-Gohrke S, Wappenschmidt B, Weinberg CR, AH, Xia L, Yang XR, Yannoukakos D, Zaffaroni D, Zheng W, Zhu B, Ziogas A, Ziv E, Zorn KK, Gago-Dominguez M, Mannermaa A, Olsson H, Teixeira MR, Stone J, Offit K, Ottini L, Park SK, Thomassen M, Hall M, Schmidt MK, Antoniou AC, Simard J. Identification of ten variants associated with risk of Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kj\u00e6r SK, H\u00f8gdall SA, McLaughlin JR, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Terry KL; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group. Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Prev. A, Ziogas A, Anton-Culver H. Negative Valence Life Events Promote Breast Cancer Development. Clin Breast Cancer. 2017 Nov 1. P, Webb PM, MacGregor S; Ovarian Cancer Association Consortium. Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J F, Ziogas A. An age-dependent interaction between sex and geographical UV index in melanoma risk. J Am LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM; Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM; African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol. 2017 Dec FL, Anton-Culver H, F. Case- Study of the Genetic Variability in Reactive Oxygen Species-Metabolizing Enzymes in Melanoma Risk. Silverman Demetriou A, Yakut C, Nimri O, Pavlou P, \u00d6zg\u00fcr S, Ziogas A, Stevens L, Ward K, Anton Culver H. Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and Izmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program. Turk J Gastroenterol. 2018 Jan;29(1):36-44. doi: Anton-Culver H, Norden-Krichmar T. Identification of a gene expression signature predicting survival in oral cavity squamous cell carcinoma using Monte Carlo cross validation. Oral Oncol. 2018 Mar;78:72-79. doi: CM, Ewing A, Pearce CL, Zheng W; Australian Ovarian Study Group, Chenevix-Trench PA, MW, Rossing MA, Doherty JA, Wicklund KG, Chang- Claude J, Jung AY, Moysich KB, Odunsi Goodman Wilkens LM, F, RB, RP, JL, Heitz F, du Bois A, Harter P, S, Rimel BJ, SK, Hildebrandt MAT, Wu X, Lu KH, Liang D, Levine DA, Bisogna M, J, H\u00f8gdall CK, Lundvall L, Song H, Tyrer JP, Campbell I, Eccles D, Paul J, Glasspool R, Siddiqui N, Whittemore AS, Sieh W, McGuire V, Rothstein JH, Narod SA, Phelan C, Risch HA, McLaughlin A, Menon U, SA, A, Budzilowska A, Rzepecka IK, Webb PM; Ovarian Cancer Association Consortium. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer. 2018 Mar doi: 10.1038/s41416-018-0011-3. [Epub ahead of print] LC, Risch H, Terry KL, M Webb P, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Manichaikul A, Abbott SE, Camacho F, Jordan SJ, Nagle CM; Australian Ovarian Cancer Study Group, Anne Rossing M, Doherty JA, Modugno F, Moysich K, Ness R, Berchuck A, Cook L, Le N, Brooks-Wilson A, Sieh W, Whittemore A, McGuire V, Rothstein J, Anton-Culver H, Ziogas A, Pearce CL, Tseng C, Pike M, Schildkraut JM; African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol. 2018 Mar 23. doi: 10.1093/ije/dyy054. [Epub ahead of print] PubMed PMID: 29584862. JOURNAL ARTICLES, Peer Reviewed 1. Taylor W, Guirgis HA, Stewart WK. Investigations of a population exposed to organomercurial seed dressings, Archives of Environmental Health 19:505, 1969. 2. Lynch HT, Krush AJ, Guirgis HA. Genetic factors in families with combined gastrointestinal and breast cancer, American Journal Gastroenterology 59:31 40, 1973. Lynch HT, Guirgis HA, Swartz MW, Lynch JS, Krush AJ, Kaplan AR. Genetics and colon cancer, Archives of Surgery 106:669 675, 1973. 4. Lynch HT, Guirgis HA. Carcinoembryonic antigen in families. Journal of the American Medical Association 224:1042, 1973. 5. Lynch HT, Guirgis HA. Cancer resistance, Part I and Part II. Nebraska Medical Journal, 1973. 1974 May; 59(5): 156-61. 1974 June; Albert S, Brennan M, Lynch J, Kraft C, Pocekay D, Vaughns C, Kaplan AR. Familial association of carcinoma of the breast and ovary. Surg. Gynec. Obstet. 138:717 724, 1974. HA, Albert S, Brennan M. Familial breast cancer in a normal population. Cancer 34:2080 2086, 1974. 8. Lynch HT, Thomas RJ, Terasaki PI, Ting A, Guirgis HA, Kaplan AR, Lynch JR, Kraft C. HL A in cancer family \"N\". Cancer 36(4):1315 1320, 1975. 9. Lynch HT, Guirgis HA, Lynch JF. Cancer of the colon: Socioeconomic variables in a community, American Journal of Epidemiology 102(2):119 127, 1975. 10. Lynch HT, Thomas RJ, Guirgis HA, Lynch JF. Clues to cancer risk: Biological markers, American Family Physician 11:153 158, March 1975. 11. Lynch HT, Guirgis HA, Brodkey FD, Maloney K, Lynch P, Rankin L, Lynch JF. Early age of onset in familial breast cancer: Genetic and cancer control implications, Archives of Surgery 111:126 131, February 1976. 12. Lynch HT, Guirgis HA, Brodkey F, Lynch J, Maloney K, Rankin L, Mulcahy GM. Genetic heterogeneity and familial carcinoma of the breast, Surgery 142:693 699, 1976. 13. Lynch HT, Mulcahy GM, Lynch P, Guirgis H, Brodkey F, Lynch J, Maloney K, Rankin L. Genetic factors in breast cancer: A survey, Pathology Annals 899:77 101, 1976. 14. Lynch HT, Brodkey FD, Lynch P, Lynch J, Maloney K, Rankin L, Kraft C, Swartz M, Westercamp T, Guirgis H. Familial risk and cancer control, Journal of the American Medical Association 236:582 584, 1976. 15. Lynch HT, Saldivar VA, Guirgis HA, Terasaki PI, Bardawil WA, Harris RE, Lynch JF, Thomas R. Familial Hodgkin's disease and associated cancer: A clinical pathologic study, Cancer 38(5):2033 2041, 1976. 16. Stewart WK, Guirgis HA, Sanderson J, Taylor W. Urinary mercury excretion and proteinuria in pathology laboratory staff, British Journal of Industrial Medicine 34:26 31, 1977. 17. Lynch HT, Guirgis HA, Lynch PM, Lynch JF, Harris RE. Familial cancer syndromes: A survey, Cancer 39:1867 1881, 1977. 18. Lynch HT, Harris RE, Lynch PM, Guirgis HA, Lynch JF, Bardawil WA. Role of heredity in multiple primary cancers, Cancer 40:1849 1854, 1977. 19. Lynch HT, Harris RE, Bardawil WA, Lynch PM, Guirgis HA, Swartz MJ, Lynch JF. Management of hereditary site specific colon cancer, Archives of Surgery. 112:170 174, 1977. 20. Guirgis HA, Lynch HT, Mate T, Harris RE, Wells I, Caha L, Anderson J, Maloney K, Rankin L. Aryl hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls, Oncology 33:105 109, 1977. 21. Lynch HT, Harris RE, Organ CH, Jr, Guirgis HA, Lynch PM, Lynch JF, Nelson EJ. The surgeon, genetics, and cancer control: The cancer family syndrome, Annals of Surgery 185:435 440, 1977. 22. Lynch HT, Organ CH, Jr, Harris RE, Guirgis HA, Lynch PM, Lynch JF. Familial cancer: Implications for surgical management of high risk patients, Surgery 83:104 113, 1978. 23. Lynch HT, Harris RE, Guirgis HA, Maloney K, Carmody LL, Lynch JF. Familial association of breast/ovarian carcinoma, Cancer 41:1543 1549, 1978. 24. Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF. Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal and adrenal cortical carcinoma, Cancer 41:2055 2064, 1978. H, Lynch HT, Harris R, Vandevoorde J. Carcinoembryonic antigen (CEA) in the cancer family syndrome, Cancer 42:1574 1578, 1978. 26. Lynch HT, Bardawil WA, Harris RE, Lynch PM, Guirgis HA, Lynch JF. Multiple primary cancers and prolonged survival: Familial colonic and endometrial cancers, American Society of Colon and Rectal Surgery 4:165 168, 1978. 27. Guirgis HA, Lynch HT, Harris RE, Vandevoorde JP. Genetic and communicable effects on carcinoembryonic antigen (CEA) expressivity in the cancer family syndrome, Cancer Research 38:2523 2528, 1978. 28. Harris RE, Lynch HT, Guirgis HA. Familial breast cancer: Risk to the contralateral breast, Journal of the National Cancer Institute 60:955 960, 1978. 29. Fishman J, Fukushima D, O'Conner J, Rosenfeld RS, Lynch HT, Lynch JF, Guirgis H, Maloney K. Plasma hormone profiles of young women at risk for familial breast cancer, Cancer Research 38:4006 4011, 1978. 30. Guirgis HA, Lynch HT, Harris RE, Vandevoorde P. Immunochemical biological markers and hereditary cancer risk, Scandinavian Journal of Immunology 8:647 652, 1978. 31. Lynch HT, Guirgis H, Childhood cancer and the SBLA syndrome, Medical Hypotheses 5:15 22, 1979. 32. Lubiniecki AS, Lynch HT, Blattner WA, Guirgis H. Increased expression of SV40 T antigen and cell division in skin fibroblast cell lines derived from a family at high risk of carcinoma (family G of Warthin), Journal of Cancer Research and Clinical Oncology 103:127 133, 33. Anton-Guirgis inhalation in asthma, Journal of Asthma, 21: 108, 1984. 34. Anton-Guirgis H, Culver BD, Kurosaki T, Elston RC. A study of multiple in twins, Acta Geneticae Medicae et Gemellologiae, 34:3 4, 1985. 35. Kleinman S, Anton-Guirgis H, Culver BD, Taylor TH, Prince H, Kaplan H. Anti HTLV III Elisa and Western Blot Testing in a blood donor population: Implications for donor notification. Vox Sanguinis, 51:143 147, 1986. 36. McEwen E, Anton-Guirgis H. The medical communication of deaf patients, The Journal of Family Practice Vol. 26, No. 2, 1988. 37. Anton-Culver H, Culver B, Kurosaki T. Immune response in shipyard workers having x-ray abnormalities consistent with asbestos exposure, British Journal of Industrial Medicine 45:464 468, 1988. 38. Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB. Incidence of lung cancer by histologic type from a population based registry, Cancer Research 48:6580 6583, 1988. 39. Anton-Culver H. Epidemiologic assessment of cancer risk: Applications from the Cancer Surveillance Program of Orange County, Journal of the American College of Toxicology 8:933-940, 1989. 40. Anton-Guirgis H, Culver BD Kurosaki T. An epidemiologic study of asbestos-related chest x ray changes to identify work areas of high risk in a shipyard population, Applied Industrial Hygiene 4:110 118, 1989. 41. Kaisch K, Anton-Culver H. Psychological and social consequences of HIV exposure: Homosexuals in Southern California, Psychology and Health 3:63-75, 1989. 42. Anton-Culver H. Smoking and other risk factors associated with the stage and age at diagnosis of colon and rectum cancers, Cancer Detection and Prevention 15:345-350, 1991 43. Gardin, JM, Wong, ND, Bommer, Lobodzinski, S, Anton-Culver H, Manolio TA. design of a multicenter investigation of free-living elderly subjects: the cardiovascular health study, Journal of the American Society of Echocardiography, 5:63-72, 1992. 44. Anton-Culver A. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study, American Journal of Obstetrics and Gynecology, 166(5): 1507-1514, 1992 and Letter to the Editor, 168(5):1646-1647, 1992 45. Anton-Culver H, Lee-Feldstein A, Taylor T. Occupation and bladder cancer risk, American Journal of Epidemiology 136:89-94, 1992. 46. Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung cancer risk associated with cigarette smoking, International Journal of Cancer 54:44-48, 1993. 47. Higgins MW, Enright PL, Kronmal RA, Schenker MB, Anton-Culver H, Lyles M. Smoking and lung function in elderly men and women, the cardiovascular health study, Journal of the American Medical Association 269: (21)2741-48, 1993. 48. Anton-Culver H, Lee-Feldstein A, Taylor TH, The association of bladder cancer risk with ethnicity, gender and smoking, AEP 3:429-433, 1993. 49. Davis D, Bradlow HL, Wolff T, Hoel DG, Anton-Culver H. Medical Hypothesis: Xenoestrogenic exposures as preventable cause of breast cancer, Environmental Health Perspectives 101(5): 372-377, 1993. 50. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival: delivery systems and medical outcomes, Journal of the American Medical Association 271:1163-1168, 1994, and reply: Breast Cancer: Treatment Differences and Survival, Journal of the American Medical Association 272:1166, 1994. 51. Monk BJ, Burger R, Van Ostrand K, Aquino L, Greep N, Silk E, Kolin M, Anton-Culver H, Manetta A. One-visit program for the prevention of cervical cancer in a high-risk population, Gynecologic Oncology 54:105, 1994. 52. Melbye M, Cote TR, Kessler L, Gail M, Biggar RJ, Lemp G, West D, Singleton J, Young J, Kerndt P, Deapen D, Ginzberg M, Anton-Culver H, Lieb S, Hopkins R, Williams B, Liff J, Morgan D, Parkin W. High incidence of anal cancer among AIDS patients. Lancet 343: 636-639, 1994. 53. Plummer SJ, Santibanez-Koref M, Kurosaki T, H, Casey G.A Germline 2.35kb deletion of p53 genomic DNA creating a specific loss of oligomerization domain inherited in a Li-Fraumeni syndrome family, Oncogene 9:3273-3280, 1994. 54. Goldman LR, Anton-Culver H, Kharazzi M, Blake E. Banking of human tissue for biomonitoring and exposure assessment: utility for environmental epidemiology and surveillance. Environmental Health Perspectives 103(S3): 31-34, 1995. 55. Wong N, Gardin J, Kurosaki T, Anton-Culver H, Sidney S, Roseman J, Gidding S. Echocardiographic left ventricular systolic function and volumes in young adults: distribution and factors influencing variability, American Heart Journal 129: 571-77, 1995. 56. Gardin J, Siscovick D, Anton-Culver H, Lynch JC, Smith VE, Klopfenstein HS, Bommer WJ, Fried L, O'Leary D, Manolio TA. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly: the Cardiovascular Health Study, Circulation 91(6):1739-1748, 1995. 57. Gardin J, Wagenknecht L, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wong ND, Manolio TA. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women: the CARDIA study, Circulation 92(3): 380-387, 1995. 58. Anton-Culver H. Cancer prevention strategies: use of cancer prevention research registries, Environmental Health Perspectives 103(S8):237-239, 1995. 59. Delfino RJ, Anton-Culver H, Saltzstein SL. Gender-related differences of thoracic versus abdominal malignant mesothelioma, Cancer Detection and Prevention 19(4): 301-307, 1995. 60. Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J, Casey G. Detection of BRCA1 mutations by the protein truncation test. Human Molecular Genetics 4(10): 1989-1991, 1995. 61. Monk BJ, Burger R, Van Ostrand K, Aquino L, Greep N, Silk E, Kolin M, Anton-Culver H, Manetta A. A single visit program for cervical cancer prevention in a high-risk population, Obstetrics and Gynecology 86(4 Pt 1):491-8, 1995. 62. Paczek A, Gardin Anton-Culver Kurosaki D. Comparison of m-mode and two-dimensional echocardoigraphic algorithms used to estimate left ventricular mass: the CARDIA study, Journal of the American Society of Echocardiography 8(6):780-792, 1995. 63. Anton-Culver H, Kurosaki T, Taylor T, Gildea M, Brunner D, Bringman D. Validation of Family History of Breast Cancer and Identification of the BRCA1 and Other Syndromes Using a Population-Based Cancer Registry, Genetic Epidemiology 13:193-205, 1996. 64. Disaia PJ, Grosen E, Kurosaki T, Gildea M, Cowan B, Anton-Culver H. Hormone replacement therapy in breast cancer survivors: a cohort study, American Journal of Obstetrics and Gynecology 174(5): 1494-1498, 1996. 65. Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP. Human Papillomavirus Type 18: Association With Poor Prognosis in Early Stage Cervical Cancer, Journal of the National Cancer Institute 88(19): 1361-1368, 1996. 66. Barker D, Almeida E, Casey G, Fain P, Liao S Y, Masunaka I, Noble B, Kurosaki T, Anton-Culver H. BRCA1 R841W: A strong candidate for a common mutation with moderate phenotype, Genetic Epidemiology 13: 595 604, 1996. 67. Jonas HA, RA, Psaty BM, Manolio TA, Meilahn EN, Tell JA, Anton-Culver H. Current estrogen progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study. Annals of Epidemiology 6(4):314 23, 1996. 68. Love SM, Rabson AS, Anton-Culver H, Clayton EW, Miller DS, Ravdin PM, Travers H, Barr PA, Liu E, Pinn VW, et al. Correspondence re: Mills SE, Kempson RL, Fechner RE, et al.: Guardians of the wax and the patient. Modern Pathology 8:699, 1995 [letter]; and Modern Pathology, 9(4):457, 1996. 69. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. American Journal of Human Genetics 60(2): 313 319, 1997. 70. Price TR, Manolio TA, Kronmal RA, Kittner S, Yue NC, Robbins J, Anton-Culver H, O'Leary DH. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 28(6):1158 64, 1997. 71. Re A, Taylor TH, DiSaia PJ, Anton-Culver H. Risk for breast and colorectal cancers subsequent to cancer of the endometrium in a population based case series. Gynecologic Oncology 66(2):255 7, 1997. 72. Theuer CP, Kurosaki T, Taylor TH, Anton-Culver H. Unique features of gastric carcinoma in the young: a population based analysis. Cancer 83(1):25 33, 1998. 73. Delfino RJ, Ferrini RL, Taylor TH, Howe S, Anton-Culver H. Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California, American Journal of Preventive Medicine 14: 96-102, 1998. 74. Bentley JR, Delfino, RJ, Taylor TH, Howe S, Anton-Culver H. Differences in breast cancer stage at diagnosis between non-Hispanic white and Hispanic populations, San Diego County 1988-1993, Breast Cancer Research and Treatment 50: 1-9, 1998. 75. Howe SL, Delfino RJ, Taylor TH, Anton-Culver H. The risk of invasive cervical cancer among Hispanics: evidence for targeted preventive interventions. Preventive Medicine 27:674-680, 1998. 76. Theuer CP; Anton-Culver H. Important prognostic factor in patients with gastric cancer [letter]. Western Journal of Medicine 169(4):254, 1998. 77. Janezic SA, Ziogas A, Krumroy Plummer SJ, Cohen P, Gildea M, D, Haile R, Casey G, Anton-Culver H. Germline BRCA1 alterations in a population-based series of ovarian cancer cases. Human Molecular Genetics 8(5):889-897, 1999. 78. Brewster WR, DiSaia PJ, Monk BJ, Ziogas Yamada SD, Anton-Culver H. Young age as a prognostic factor in cervical cancer: results of a population based study. American Journal of Obstetrics and Gynecology 180(6 Pt 1):1464 7, 1999. 79. Astin JA, Anton-Culver H, Schwartz C, Shapiro DH, McQuade J, Breuer A, Taylor T, Lee H, Kurosaki T. Sense of control and adjustment to breast cancer: the importance of balancing control coping styles. Behavioral Medicine 25:3, 1999. 80. Boyer-Chammard AB, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detection and RD, Das Gupta Weger J, Wahlberg S, Fox EA, Peel D, Ziogas A, Garber JE, Syngal S, Anton-Culver H, and Li FP. Germ-line msh6 mutations in colorectal cancer families. Cancer 1999. 82. Theuer CP, Nastanski F, Brewster WR, Butler JA, Anton-Culver H. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. American Surgeon, 65(10):915 21, 1999. 83. Ziogas A, Gildea M, Cohen P, Bringman D, Taylor T, Seminara D, Barker D, Casey G, Haile R, Liao S-Y, Thomas D, Noble B, Kurosaki T, and Anton-Culver H. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention 9: 103-111, 2000. 84. Delfino RJ, Sinha R, Smith C, West J, White E, Lin HJ, Liao S-Y, Gim JS-Y, Ma HL, Butler J, Anton-Culver H. Breast cancer, heterocyclic meat and 2 genotype. Gildea ME, Ziogas A. Characteristics of BRCA1 mutations in a population-based series of breast & ovarian cancer. European Journal of Cancer 36; 1200-08, June 2000. 86. Delfino RJ, Smith C, West J, White E, Lin HJ, Liao S-Y, Gim JSY, Ma HL, Butler J, Anton-Culver H. Breast cancer, passive and active cigarette smoking, and N-acetyltranferase 2 genotype. Pharmacogenetics July 2000 (10):461-469. 87. Taylor TH, Anton-Culver H. Let's leave the date out of the name of the standard population. (Correspondence.) Journal of the National Cancer Institute 92 (2000):1269-70. 88. Peel D, Ziogas A, Fox E, Gildea M, Laham B, Clements E, Kolodner R, Anton-Culver H. Epidemiologic, genetic, and molecular characterization of HNPCC families from a population based series of colorectal cancer. Journal of the National Cancer Institute 92 (2000):1517-22. 89. Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-Culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer, November 1, 2000: 89 (9):1883-1892. 90. Theuer CP, Taylor TH, Anton-Culver H. Letter. Correspondence: Screening for Colorectal Cancer. New England Journal of Medicine 343 (22); November 30, 2000: 1625. 91. DiSaia PJ, Brewster WR, Ziogas A, Anton-Culver H. Breast cancer survival and hormone replacement therapy: a cohort analysis. American Journal of Clinical Oncology Dec 2000, 23 (6):541-5. 92. Brewster WR, Monk A, Anton-Culver ML. Intent-to-treat analysis of stage Ib and IIa cervical cancer in the Untied States: Radiotherapy or Surgery 1988-1995. Obstetrics & Gynecology 97(2), February Theuer CP, WR, CE, Anton-Culver H. Racial and Ethnic Colorectal Cancer Patterns Affect the Utility of Colorectal Cancer Screening in the United States. Gastroenterology. March 2001; 120: 848-856. 94. Peel DJ, Anton-Culver H. Response to Hemminki (Correspondence regarding Peel et. al, Characterization of HNPCC families from a population based series of cases, published JNCI Reports 2000; 92(18):1517-1522.): Journal of the National Cancer Institute, vol. 93, no. 8, April 18, 2001: 651-652. 95. Semenza JC, Ziogas A, Largent J, Peel D, Anton-Culver H. Gene-environment interactions in renal cell carcinoma. American Journal of Epidemiology 153(9):851-859, 2000 May 1. 96. Anton-Culver H, Peel D, Ziogas A. Proportion of HNPCC in the general population, Response to Evans (Correspondence regarding Peel et. al, Characterization of HNPCC families from a population based series of cases, published JNCI Reports 2000; 92(18):1517-1522.) Journal of the National Cancer Institute, vol. 93, no. 9, May 2, 2001: 717-718. 97. Keefe KA, Schell MJ, Brewer C, McHale Brewster W, Chapman McMeeken YM, FL, Berman ML. double-blind, Phase III trial using oral beta-carotene supplementation JC, H. The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy. Am Surg 2001 Dec; 7(12):1157-61. 99. Speer SA, Semenza Jan C, Kurosaki T, Anton-Culver H. Risk Factors for Acute Myeloid Leukemia and Multiple Myeloma: A Combination of Geographic Information System and Case-Control Studies. J Environ Health, March 2002:64(7); 9-15. 100. Diamond C, Taylor T, Anton-Culver H. Characteristics and survival of patients with non-Hodgkin's lymphoma with and without Acquired Immunodeficiency Syndrome. Published on line in Hematological Oncology May 8, http://www3.interscience.wiley.com/cgi-bin/issuetoc?ID=82002594 101. Brewster WR, Anton-Culver Ziogas A, Largent J, Howe S, Hubbell FA, Manetta A. Recruitment strategies for cervical cancer prevention study. Gynecological Oncology. 2002 May 85(2):250-254. 102. MR, Stewart Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Reynolds P, Ross RK, Wright W, Ziogas A. Recent diet and breast cancer risk: the California Teachers Study. Cancer Cause Control. 2002 June; 13(5):407-415. 103. Irene L. Andrulis, Hoda Anton-Culver, Jeanne Beck, Betsy Bove, Jeff Boyd, Saundra Buys, Andrew Godwin, John Hopper, Frederick Li, Susan L. Neuhausen, Hilmi Ozcelik, David Peel, Jan Vijg and Alice S.Whittemore for the Cooperative Family Registry for Breast Cancer Studies. Comparison of DNA- and RNA-based Methods for Detection of Truncating BRCA1 Mutations. Human Mutation. 2002 July; 20(1):65-73. 104. Bernstein L, Allen L, Anton-Culver H, Deapen D, Horn-Ross P, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A. High breast cancer rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control. 2002 September; 13(7):625-635. 105. Hoggatt KJ, Bernstein L, Reynolds P, Anton-Culver H, Deapen D, Peel D, Pinder R, Ross RK, West DW, Wright W, Ziogas A, Horn-Ross PL. Correlates of vitamin supplement use in the United States: Data from the California Teachers Study cohort. Cancer Cause Control. 2002 October; 13(8): 735-740. 106. Semenza J, Delfino cancer Cancer Control. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. American Journal of Preventive Medicine, 24(2): 190-198; Feb 2003. 108. Parikh-Patel A, Allen MA, Wright WE, and the California Teachers Study Steering Committee. Validation of self-reported cancers in the California Teachers Study. American Journal of Epidemiology 157(6), 539-545, 2003 March 15. 109. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper J, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Tang Olah Anton-Culver Warner Lubinski Gronwald O-P, J, Lalloo F, Evans DG, Easton DF. Average risks of breast and ovarian cancer associated with mutations in BRCA1 or BRCA2 detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics. 2003 May; 72(5): 1117-1130. Epub 2003 April 3. 110. Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum Olsen Group. ATM variants 7271T>G and IVS10-6T4 among women with unilateral and ilateral breast cancer. British Journal of Cancer 89, 1513-1516, 2003 October 20. 111. Marshall SF, Deapen D, Allen M, Anton-Culver H, Bernstein L, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Ross R, West D, Ziogas A. Validating California Teachers Study self-reports of recent hospitalization: comparison with California hospital discharge data. American Journal of Epidemiology. 2003 November 15; 158(10): 1012-1020. 112. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin c, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S. The Cancer Genetics Network: Recruitment Results and Pilot Studies. Community Genetics 2003; 6(3): 171-177. 113. Taylor TH, Bringman B, Anton-Culver H. Excluded cases and the age-standardized incidence rate implications for cancer-registry data standards. Journal of Registry Management, 30(3), 84-89, 2003. 114. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, orn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A. Active smoking, household passive smoking, and breast cancer: evidence from the California teachers study. Journal of the National Cancer Institute 96, 29-37, 2004. 115. Horn-Ross PL, Canchola AJ, West DW, Stewart SL, Bernstein L, Deapen D, Pinder R, Ross RK, Anton-Culver H, Peel D, Ziogas A, Reynolds P, Wright W. Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort. Cancer Epidemiology Biomarkers Prev 2004 Mar, 13:405-11 116. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice P, Thompson WD, WECARE study. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res 2004, 6:R199-214 117. Meyskens FL, Farmer PJ, Anton-Culver H. Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res. 2004 Apr 15, 10:2581-3 118. Brewster WR, Hubbell FA, Largent J, Ziogas A, Ganiats T, Anton-Culver H, Manetta A. Feasibility of a cervical cancer screening program. Plenary Presentation Western Association of Gynecologic Oncologists (WAGO), Thirty Third Annual Meeting, Monterey, CA; 119. Theurer CP, Taylor TH, Brewster WR Anton-Culver H. Should colon cancer screening guidelines account for race and ethnicity? American Society of Clinical Oncology, New Orleans LA June 2004, 22 : 1022 120. Reynolds P, Hurley SE, Hoggatt K, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, West D, Wright W, Ziogas A, Horn-Ross PL. Correlates of active and passive smoking in the California Teachers Study cohort. Journal of Womens Health (Larchmt) 2004 Sep; 13(7):778-90. 121. Reynolds P, Hurley SE, Goldberg DE, Yerabati S, Gunier RB, Hertz A, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A. Residential proximity to agricultural pesticide use and incidence of breast cancer in the California Teachers Study cohort. Environ Res 2004 Oct; 96(2):206-18. 122. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A. Regional variations in breast cancer among California Teachers. Epidemiology 2004 November, Vol15, (6):746-54. 123. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, FP, AS, Seminara D, and the Breast Cancer Family Registry. The Breast Cancer family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004, 6:R375-R389. 124. Begg CB, Hummer A, Mujumdar U, M, GEM Study Group. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004 Nov, 15:957-65 125. McEligot AJ, Wenzel L, Largent J, Ziogas A, Anton-Culver H. Factors associated with complementary and alternative medicine (CAM): Use among breast cancer patients with and without a family history of breast or ovarian cancer, Journal of Cancer Integrative Medicine, Winter 2004; Volume 2, Number 1, pages Arthur G, Becerra Phan PC, Anton-Culver H. Forthal DN. Autologous Antibody to Breast Cancer in Healthy Multiparous Women.2004 127. Chang KJ, Parasher G, Christie C, Largent J, Anton-Culver H. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups. Cancer. 2005 Jan 15, 103:349-57. 128. Meyskens FL, Farmer PJ, Anton-Culver H. Diet in case-control study. Cancer Epidemiol Biomarkers Prev. 2005 14:293. SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris C, Bowman E, Clayman GL, Lippman SM, Lee JJ, Zheng W, Balmain A. T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis 2005 Aug, 26:1368-73. Epub 2005, Mar 31. 130. Hurley SE, Reynolds P, Goldberg DE, Hertz A, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A, Horn-Ross PL. Residential mobility in the California Teachers Study: implications for geographic differences in disease rates. Soc Sci Med. 2005 Apr, 60(7):1547-55. 131. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau Boardman LA, Seminara D. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005 1979-85 132. Largent J, Ziogas A, Anton-Culver H. Effect of Reproductive factors on stage and hormones receptor status on early onset breast cancer. Breast Cancer Research, 2005, 7:R541-R554 (16 May 2005) 133. Diamond C, Taylor TH, Aboumrad T, Bringman D, Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005 May, 32:314-20. 134. Wenzel L, DeAlba D, Krebs LU, Anton-Culver H, Berkowitz R, Aziz N. Quality of life in long-term cervical cancer survivors. Gynecol Oncol 2005, May, 97:310-7. 135. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK. Nonsteroidal anti- inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst. 2005 Jun 1; 97(11):805-12. 136. Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, RA, Duffy D, Chenevix-Trench G. BRAF Polymorphism and the risk of ovarian cancer of low malignant potential. Gynecological Oncology 2005 Jun, 97:807-12. 137. Wodarz D, Anton-Culver H. Dynamical interactions between multiple cancers. Cell Cycle 2005 Jun, 4:764-71. 138. Antoniou AC, Pharoah PD, Narod A, Pasini B, Radice Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, C, Peto J, Lalloo F, Evans DG, Easton DF. Breast and ovarian cancer risks to carriers the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 2005 Jul, 42: 602-3. 139. Shin, BY, Rozek, L., Paxton, L., Peel, D., Anton-Culver, H., Rennert, G., Goodfellow, P., Gruber, S., Lipkin Endometrial Cancer Patients\" Dis. of the Colon and Rectum 2005 Sep, 48:1723-7 140. Sogn JA, Anton-Culver H, Singer DS. Meeting report: NCI think tanks in cancer biology. Cancer Res 2005 Oct 15, 65:9117-20. 141. Begg CB, Orlow I, Hummer AJ, Rebbeck TR, Mitra N, Busam K, From L, Berwick M, Genes Environment and Melanoma Study Group. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005 Oct 19, 97:1507-15 142. Millikan RC, Hummer A, Begg C, Player J, De Cotr\u00e9t AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Mujumdar U, and Berwick, M for the GEM Study Group. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis. 2006 610-18. WR, Hubbell FA, Largent J, Ziogas A, Lin F, Howe S, Ganiats TG, Anton-Culver H, Manetta A. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial. JAMA 2005 Nov 2, 294:2182-7. 144. Zell, JA, Ou, S-HI, Ziogas, A, Anton-Culver, H. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. Journal of Clinical Oncology 2005 Nov 20; 23(33): 8396-405. 145. Diamond C, Taylor TH, Aboumrad H. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 2006 Jan 1, 106:128-35 146. Theuer CP, Taylor TH, Brewster WR, and affect the cost-effectiveness of colorectal cancer screening. J Natl Med Assoc 2006 Jan, 98:51-7 147. Crawford NPS, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Research 2006, 8:R16 (21 March 2006) 148. Begg CB, Hummer AJ, Mujumdar, BK, Kricker Millikan RP, Dwyer T, Rebbeck TR, Busam K, From L, and Berwick M for the GEM Study Group. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol. 2006 June; 35(3): 756-64. Epub 2006 March 23. 149. Diamond C, Taylor TH, Im T, Miradi M, Anton-Culver H. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy. Hematol Oncol 2006 Apr 10. 150. Taylor TH, Bringman D, Anton-Culver H. Malignancies following in situ cervical cancer in Hispanic Americans and non-Hispanic whites. Gynecol Oncol 2006 Jul 18. 151. Diamond C, Taylor TH, Im T, Miradi M, Wallace M, Anton-Culver H. Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma. Curr HIV Res 2006 Jul, 4:375-8 152. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006 Aug 3. 153. Zell JA, Ou SH, Ziogas A, Anton-Culver H. Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis. Ann Oncol 2006 Aug, 17:1255-62. 154. Berwick M, Orlow I, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, GEM Study Group. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer 2006 15:1520-5. 155. Kanetsky PA, Rebbeck LD, Millikan RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, and Berwick M, for the Genes Environment and Melanoma Study Group. Population-Based Study of Natural Vairation in the Melanocortin-1 Receptor Gene and Melanoma. Cancer Res 2006 Sept 15; 66(18): 9330-7. 156. Diamond C, Taylor TH, Im T, Anton-Culver H. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS. Leuk Lymphoma 2006 Sep, 47:1822-9. 157. Ou SH, Zell J, Ziogas A, Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 2007 Jan, 18:29-35. Epub 2006 October 23. 158. Raz DJ, Zell JA, Karnezis AN, Odisho A, Ignatius Ou SH, Jablons DM; Misclassification of bronchioloalveolar carcinoma with cytologic of lung cancer. J Thorac Oncol 2006 Nov, 1:943-8. 159. Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM. Analysis of co-aggregation of cancer based on registry data. Community Genet 2006, 9:87-92. 160. McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer 2006, 55:132-40. 161. Kricker A, Armstrong BK, Goumas C, Litchfield M, CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Culver RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Zanetti R, and Berwick M for the GEM Study Group. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007 April; 18(3): 295-304. Epub 2007 January 6. 162. Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, Stram DO, West DW, Wright W, Ziogas A, Horn-Ross PL. Diet and Risk of Ovarian Cancer in the California Teachers Study Cohort. Am J Epidemiology. 2007 Jan 8. 163. Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, R, T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M. CDKN2A Germline Mutations in Individuals with Dermatol. 2007 May; H, Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Int J Cancer 2007 Feb 1, 120:459-68. 165. Chang ET, Canchola AJ, Lee VS, Clarke CA, Purdie DM, Reynolds P, Bernstein L, Stram DO, Anton-Culver H, Deapen D, Mohrenweiser H, Peel D, Pinder R, Ross RK, West DW, Wright W, Ziogas A, Horn-Ross PL. Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control 2007 Feb, 18:91-103. 166. Dallal CM, Sullivan-Halley J, Ross RK, Wang Y, Deapen D, Horn-Ross PL, Reynolds P, Stram DO, Clarke CA, Anton-Culver H, Ziogas A, Peel D, West DW, Wright W, Bernstein L; Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med 2007 Feb 26, 167:408-15. 167. Diamond C, Taylor TH, Im T, Wallace M, Saven A, Anton-Culver H How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma? Cancer Causes Control 2007 CL, Anton-Culver H, Yunis C, Gardin JM; and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol 2007, Mar 15, 99:830-4. 169. Mai PL, Sullivan-Halley J, Ursin G, Stram DO, Deapen D, Villaluna D, Horn-Ross PL, Clarke CA, Reynolds P, Ross RK, West DW, Anton-Culver H, Ziogas A, Bernstein L; Physical activity and colon cancer risk among women in the California Teachers Study. Cancer Epidemiol Biomarkers Prev 2007 Lipkin SM, Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev 2007 Mar, 16:546-52. 171. Largent JA, Capanu Bernstein L, Langholz B, Mellemkaer L, Malone KE, Begg CB, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL, Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiology Biomarkers Prev; 2007 May, 16:906-11. 172. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM, Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007 Jul, 132:193-9. 173. Ou SH, Zell JA, Ziogas A, Anton-Culver H, Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 2007 Oct 1, 110:1532-41. 174. Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis Strong LC, Berry DA, S, Dutson D, Kerber R, Peshkin BN, DM, Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 2007 Oct 2, 147:441-50. 175. Templeman C, Marshall SF, Ursin G, Horn-Ross PL, Clarke CA, Allen M, Deapen D, Ziogas A, Reynolds P, Cress R, Anton-Culver H, West D, Ross RK, Bernstein L, Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 2007 Oct 3. 176. Ou SH, Zell JA, Ziogas A, and Anton-Culver H, IB non-small-cell lung cancer (NSCLC) is dependent on tumor size. Chest 2007 Oct 9. 177. Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes WL, S, Lowy DR, Anton-Culver H, Hunter KW, Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 2007 Nov 30, 3:e214. 178. Zell JA, Ignatius Ou SH, Ziogas A, Anton-Culver H, Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry. J Thorac Oncol 2007 Dec, 2:1078-85. 179. Satram-Hoang S, Ziogas A, Anton-Culver H, Risk of second primary cancer in men with breast cancer.Breast Cancer Res 2007, 9:R10. 180. Meyskens FL, Farmer PJ, Yang S, Anton-Culver H New perspectives on melanoma pathogenesis and chemoprevention. Recent Results Cancer Res 2007, JA, McEligot AJ, Ziogas A, Holcombe RF, Anton-Culver H, Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer 2007, 59:36-45. 182. Zell JA, Ou SH, Ziogas A, Anton-Culver H, Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary Cancer 2008 Jan 1, 112:136-43. Mobasher M, Ziogas A, H, for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol 2008 Jan 1, 26:66-75. 184. Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD, Shore RE. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. Women's Environment, Cancer and Radiation Epidemiology Study Collaborative Group , Bernstein JL, J Natl Cancer Inst 2, 100:32-40. 185. Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL, Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008 Jan 9, 299:194-201. 186. Yarosh W, Barrientos T, Esmailpour T, Lin L, Carpenter PM, Osann K, Anton-Culver H, Huang T, TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res 2008 Feb 1, 68:693-9. 187. Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Anton-Culver H, Stovall M, Bertelsen L, Haile RW, Bernstein JL, Oral Contraceptives, Postmenopausal Hormones, and Risk of Asynchronous Bilateral Breast Cancer: The WECARE Study Group. J Clin Oncol 2008 Feb 4. 188. Simoneau AR, Gerner R, Ziogas A, Fujikawa-Brooks R, CE, Anton-Culver H, Meyskens FL, The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a Wenzel L, Bowen D, Habbal R, Leighton N, Vu T, Anton-Culver H, Testing targeted approaches to enhance Cancer Genetics Network minority recruitment within Asian populations. Community Genet 2008, 11:234-40. 190. Antoniou AC, Cunningham AP, Peto DG, Radice S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008; Apr 22, 98:1457-66. 191. Ou SH, Zell JA, Ziogas A, Anton-Culver H, Low socioeconomic status is a poor prognostic factor for survival in stage independent of surgical treatment, race, and marital status. Cancer 2008 May 1, 112:2011-20. 192. Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL, WECARE Study Collaborative Group, Dose to the Contralateral Breast from Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE Study. Int J Radiat Oncol Biol Phys 2008 193. Chao JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, H, Accurate classification MLH1/MSH2 variants protein polymorphisms-mismatch repair Hum Mutat 2008 Jun, 29:852-60. 194. Barton JC, Leiendecker-Foster Reboussin DM, Adams PC, Acton RT, Eckfeldt JH; Hemochromatosis and Iron Overload Screening Study Research Investigators. Collaborators (113) Acton RT, Barton JC, Dixon D, Ferguson S, Jones R, McKnight J, Rivers CA, Tucker D, Ware JC, McLaren CE, McLaren GD, Anton-Culver H, Ton T, Walker AP, Wenzel LB, Ziogas A, Adams PC, Bloch E, Chakrabarti S, Fleischhauer A, Harrison H, Jia K, Larson S, Lin E, Lopez M, Nguyen L, Pepper C, Power T, Speechley M, Sun D, Woelfle D, Harris EL, Aickin M, Baker E, Erwin M, Holup J, Lloyd C, Press N, Press RD, Reiss J, Ritenbaugh C, Uchida E, Vogt T, Yim FW, O, M, Harrison BW, Lewis-Jack O, Murray RF, McDonald-Pinkett S, Rock S, Leiendecker-Foster Wang X, Reboussin DM, Snively BM, Anderson R, Bostic E, Craven BL, Ellis S, Furberg C, Griffin J, Hall M, Harris D, Henkin L, Jackson S, Jewett T, King MD, Lohman K, Lovato L, Michaleckyj J, Palla S, Parks T, Passmore L, Phatak P, Rich S, Ruggiero A, Vitolins M, Wolgast G, Zaccaro D, Sholinsky P, Bookman E, Chang H, Fabsitz R, Jaquish C, Manolio T, O'Neill L, Thomson E, MacCluer J Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS 18(8):831-8. B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, Bernstein JL. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res. 2008 Aug 15;68(16):6486-91.PMID: 18701470 196. De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, Bracho A, Arias C, Manetta A Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev 2008; Aug, 17:2163-8. 197. Glaser SL, Clarke CA, Keegan TH, Chang ET, Shema SJ, Craig FE, Digiuseppe RF, Ambinder RF. Racial/ethnic variation in EBV-Positive classical Hodgkin lymphoma in California populations. Int J Cancer 2008; Oct 1, 123:1499-507. 198. Neklason DW, Kerber RA, JT, Schildkraut Evans JP, Tomlinson GE, Strong LC, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten Mineau GP, Burt RW. Anton-Culver H, familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res 2008; Nov 1, 68:8993-7. 199. Zell JA, Honda J, Ziogas A, Anton-Culver H. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev 2008; Nov, 17:3134-40. 200. McLaren Barton JC, Reboussin DM, Gordeuk Acton JH; Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators. Collaborators (114) Acton RT, Barton JC, Dixon D, Ferguson S, Jones R, McKnight J, Rivers CA, Tucker D, Ware JC, McLaren CE, McLaren GD, Anton-Culver H, Ton T, Walker AP, Wenzel LB, Ziogas A, Adams PC, Bloch E, Chakrabarti S, Fleischhauer A, Harrison H, Jia K, Larson S, Lin E, Lopez M, Nguyen L, Pepper C, Power T, Speechley M, Sun D, Woelfle D, Harris EL, Aickin M, Baker E, Erwin M, Holup J, Lloyd C, Press N, Press RD, Reiss J, Ritenbaugh C, Uchida E, Vogt T, Yim FW, Fadojutimi-Akinsiku M, Castro O, White-Coleman D, Gerald M, Harrison B, Lewis-Jack O, Murray RF, McDonald-Pinkett S, Rock A, Romagoza S, Leiendecker-Foster X, Reboussin DM, Snively BM, Anderson R, Balasubramanyam A, Bostic E, Craven BL, Ellis S, Furberg C, Griffin J, Hall M, Harris D, Henkin L, Jackson S, Jewett T, King MD, Lohman K, Lovato L, Michaleckyj J, Palla S, Parks T, Passmore L, Phatak PD, Rich S, Ruggiero A, Vitolins M, Wolgast G, Zaccaro D, Sholinsky P, Bookman E, Chang H, Cooper K, Fabsitz R, Jaquish C, Manolio T, O'Neill L, Thompson E. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, Chenevix-Trench G, Chang-Claude J, SK, Hogdall CK, Hopkins MP, Jenison EL, Blaakaer J, Lurie G, McGuire V, Menon U, Moysich KB, Vandenberg D, Vierkant RA, Wang-Gohrke S, Webb PM, Whittemore AS, Wu AH, Ziogas A, Berchuck A, Schildkraut JM, Ovarian Cancer Association Consortium , Australian Cancer Study (Ovarian Cancer Group) , Australian Ovarian Cancer Study Group. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev JG, Salem R, Haque R, Anton-Culver H, Abstracting height and weight from medical records, and breast cancer pathologic factors. Cancer Causes Control 2008; Dec, 19:1217-26. 203. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode JC, JM, Berchuck A, Brewster W, Galitovskiy V, Chenevix-Trench G, Australian Cancer Study, Australian Ovarian Cancer Study Group. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 2009; Jan 27, 100:412-20. 204. Lu Y. Sullivan-Halley J, Cozen W, Chang ET, Henderson K, Ma H, Deapen D, Clarke C, Reynolds P, Neuhausen SL, Anton-Culver H, Ursin G, West D, Bernstein L., Family history of hematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study. Br J Cancer 2009; Feb 10, 100:524-6. 205. Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, AS, X, Haile RW, Boice JD Jr; Begg C, Capanu M, Liang X, Reiner AS, Orlow I, Layne T, Bernstein L, Donnelly-Allen L, Olsen JH, Andersson M, Bertelsen L, Guldberg P, Lynch CF, DeWall RW, Langholz BM, Thomas DC, Diep AT, Xue S, Zhou N, Liu Y, Ter-Karapetova E, Thompson WD, Stovall M, Smith S, Concannon P, Teraoka S, Olson ER, Morrison VA, Cerosaletti KM, Navarro L, Wright J. Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol. 2009 Apr 15; 169(8):962-8. Epub 2009 Feb 11. knight@lunenfeld.ca 206. Zell JA. Tsang WY, Taylor TH, Mehta RS, Anton-Culver H. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Breast Cancer Res 2009; 11:R9 207. Yu Z., Garner C, Ziogas A, Anton-Culver H, Schaid DJ. Bioinformatics 10:63. Dunning AM, Healey AT, Scollen S, Vega A, Rodr\u00edguez R, Barbosa-Morais NL, , Low YL, Bingham S, , Haiman CA, Le L, MEC , Broeks A, Group , Change-Claude J, Flesch-Janys D, MARIE , FJ, SASBAC , Kang D, Yoo KY, SEBCS , Shen of with 18:1131-9. Iversen Berchuck A, Marks JR, Lissowska J, B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Van Den Berg D, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, Gayther SA, Ramus SJ, Jacobs I, SS, Calingaert B, Chanock S, Sherman M, Garcia-Closas M, Australian Ovarian Cancer Study Group. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009; Mar 15, 69:2349-57. 210. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, Eccles D, Evans DG, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Stratton MR, Rahman N, Jacobs K, Prentice R, Anderson GL, Rajkovic A, Curb JD, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson Thun E, SEARCH , Kang D, Yoo KY, Noh DY, Ahn SH, Devilee P, van Asperen Margolin S, Mannermaa A, Kosma VM, Kataja V, Olson JE, Wang X, Fredericksen Z, Giles GG, Severi G, Baglietto L, English MJ, van den Ouweland AM, Oldenburg RA, Schutte M, Hall P, Czene K, Liu J, Li Y, Cox A, Elliott G, Brock I, Reed MW, Shen CY, Yu JC, Hsu GC, Chen ST, Anton-Culver H, Ziogas A, Andrulis IL, Knight JA, kConFab , Australian Ovarian Cancer Study Group , Beesley J, Goode EL, Couch F, Chenevix-Trench G, Hoover RN, Ponder BA, AM, 17q23.2. Nat Genet 2009; May, 41:585-90. 211. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa Justenhoven C, BG, Flyger HL, Peto J, Fletcher O, Silva I, Fasching PA, Beckmann MW, Strick R, MC, Hopper JL, Apicella Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter Hankinson Seynaeve C, Vreeswijk J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Dietz Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Australian Ovarian Cancer Study Group , Garcia-Closas M, Breast Cancer Association Consortium. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2009; May, 18:1610-6. 212. Kent EE, Sender LS, Largent JA, Anton-Culver H. Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors.Cancer Causes Control 2009 Jun 4. 213. Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, Gentry-Maharaj A, Jacobs IJ, Webb PM, Beesley J, Chen X, Australian Cancer (Ovarian) Study , Australian Ovarian Cancer Study Group , Rossing MA, Doherty JA, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Ness RB, Moysich K, Goode EL, Vierkant RA, Cunningham JM, Anderson PD, Ovarian Cancer Association Consortium (OCAC). Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet Jun Heikkinen CR, Meindl A, Schmutzler G, MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Sch\u00fcrmann P, Bremer M, Hillemanns P, P, Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Liu J, Li Y, Ahmed S, Dunning AM, Maranian M, Giles GG, Severi G, Baglietto L, English DR, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Turnbull C, Hines S, Renwick A, Rahman N, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo Mannermaa A, Kataja V, Kosma J, LA, Chang-Claude J, Wang-Gohrke S, Shen CY, Wang HC, Yu JC, Chen ST, Bermisheva M, Nikolaeva T, Khusnutdinova E, Humphreys MK, Morrison J, Platte R, Easton DF, Breast Cancer Association Consortium. Risk of receptor-positive -negative breast cancer and single-nucleotide Natl Cancer H, Ramus SJ, Tyrer J, Bolton KL, Chang-Claude J, Cramer DW, DiCioccio R, D\u00f6rk T, Goode EL, T, Baglietto L, Beckmann MW, Beesley J, J, Carney ME, Chanock S, Chen Z, Cunningham JM, Dicks E, Doherty JA, D\u00fcrst M, Ekici AB, Fenstermacher D, Fridley BL, Giles G, ME, Vivo I, Hillemanns Hogdall C, Hogdall E, Iversen IJ, Jakubowska A, Li D, Lissowska J, Lubi?ski J, Lurie G, McGuire V, McLaughlin J, Medrek K, Moorman PG, Moysich K, Narod SS, Van Den DJ, Vierkant RA, Wang-Gohrke S, Webb PM, Wilkens LR, Wu AH, Yang H, Brewster W, Ziogas A, Australian Cancer (Ovarian) Study , Australian Ovarian Cancer Study Group , Ovarian Cancer Association Consortium , Houlston R, Tomlinson I, Whittemore AS, Rossing MA, Ponder Pearce CL, Ness RB, Menon U, SA. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009 Sep, 41:996-1000. 216. Zell JA, Ziogas A, Ignatenko N, Honda J, Qu N, Bobbs AS, Neuhausen SL, Gerner EW, Anton-Culver H. Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival. Clin Cancer Res 2009 Oct 1, 15:6208-16. 217. McEligot AJ, Mouttapa M, Ziogas A, Anton-Culver H. Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer. Cancer Epidemiology 33 (2009) 419-423. Epub 2009 Oct 14. 218. Zell JA, Ziogas A., Bernstein L, Clarke CA, Deapen D, Largent JA, anti-inflammatory drugs: effects on mortality diagnosis. Cancer. 2009 Dec 15; 115(24):5662-71.PMID: 19827153 [PubMed - indexed for MEDLINE] Related citations. 219. Mitsuhashi M, Peel D, Ziogas A, and Anton-Culver H. Enhanced expression of radiation-induced leukocyte CDKN1A mRNA in multiple primary breast cancer patients: potential new marker of cancer susceptibility. Biomark Insights. 2009 Dec 22; 4:201-9. 220. Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj H; Australian Ovarian Cancer Study Management Group; Australian Cancer Study (Ovarian Cancer), Pearce CL; Ovarian Cancer Association Consortium (OCAC). ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):245-50. 221. Diamond C, Taylor TH, Anton-Culver H. Quality of life, characteristics and survival of patients with HIV and lymphoma. Qual Life Res. 2010 Jan 8. JN, Langhoz B, Largetn J, Mellemkjaer Bernstein L, Lynch CF, Borg A, Concannon P, Teraoka RW; WECARE Study Collaborative Group, and Bernstein JL. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control. 2010 June; 21(6):839-46. Epub 2010 Feb 4. 223. Reding Langholz BM, Bernstein L, Haile AS, Capanu M, Molone KE, and the WECARE Collaborative Study Group. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2): 491-498. Epub 2010 Feb 5. 224. Link NJ, Maurer E, Largent J, Kent E, Morris RA, Sender LS, and Anton-Culver H. Kids, Adolescents, and Young Adults Cancer Study\u2014A Methodologic Approach in Cancer Epidemiology Research. Journal of Cancer Epidemiology. Volume 2009, Article ID 354257, Methodology Report. Epub 2010 Feb 10. 225. Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen X, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Hein R, Green AC, Lissowska J, Carney ME, Lurie G, Wilkens LR, Ness RB, Pearce CL, Wu AH, Van Den Berg DJ, Stram DO, Terry KL, Whiteman DC, Whittemore, AS, DiCioccio RA, McGuire V, Doherty Rossing MA, Anton-Culver H, Ziogas A, Hogdall I, PDP, ES, Marks JR, Pike Goodman MT, Schildkraut JM, Chenevix-Trench Berchuck A, and Sellers TA. Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: the Ovarian Cancer Association Consortium. Cancer Epidemiol, Biomarkers Feb; M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein Diep Gatti RA, M, Orlow I, Liang X, Reiner AS, Layne TM, Bernstein L, Donnelly-Allen L, Olsen JH, Andersson M, Bertelsen L, Guldberg P, L, AL, Jansen L, Anton-Culver H, Largent J, Gatti A, Lynch CF, DeWall J, Haile RW, Langholz B, Thomas DC, Xue S, Zhou N, Diep AT, Ter-Karapetova E, Thompson WD, Stovall M, Buchholz T, Smith SA, Concannon P, Teraoka SN, Olson ER, Ramchurren N. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center New York Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst. 2010 Apr 7; Chang-Claude J, Hein Wang-Gohrke VM, Kataja V; The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Beesley J, Chen X, Chenevix-Trench G, Couch FJ, Olson JE, Fredericksen ZS, Wang J, Sherman ME, Bolton KL, Hall P, Czene K, Cox A, Brock IW, Elliott GC, Reed MW, Estrogen Receptor-Negative Breast J Natl Cancer Inst. 2010 Mar 22. PMID: 20308648 228. Malone Begg Haile Concannon P, Tellhed Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkj\u00e6r L, CF, Boice JD Jr, Anton-Culver H, Bernstein JL. Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 Apr 5. PMID: 20368571 229. Chen R, Crispin DA, Pan S, Hawley S, McIntosh MW, May D, Anton-Culver H, Ziogas A, Bronner MP, and Brentnall TA. Pilot Study of Blood Biomarker Candidates for Detection of Pancreatic Cancer. Pancreas. 2010 May 7. 230. Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A, and Anton-Culver H. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control. 2010 June 6. 231. Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen d, Largent JA, Neuhausen SL, Stram DO, Ursin G, and Anton-Culver H. Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study. Cancer Prev Res (Phila Pa). 2010 Jul; 3(7): 865-75. Epub 2010 Jun 15. 232. Kent EE, Morris RA, Largent JA, Ziogas A, Sender LS, and Anton-Culver H. Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma. Journal of Cancer Epidemiology. 2010; 824691. Epub 2010 Jun 22. 233. Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM; Australian Cancer Study (Ovarian Cancer) Study Group, Kobel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G; Australian Ovarian Cancer Study Group, Cramer SK, Lurie G, Menon U, Moorman PG, SJ, Song D, Vierkant RA, S, Whittemore AS, Wilkens LR, Wu AH, Schildkraut JM, Sellers TA, Goode EL; Ovarian Cancer Association Consortium. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2010 Jul; Anton-Culver H, Engstrom P, Greenberg ER, and Meyskens F. Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the American society for preventive oncology international cancer prevention interest group. Cancer Epidemiol Jul; S, Duffy DL, Spurdle AB, Defazio A, Gava N, Webb PM; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer), Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude Terry H, JM, PG, CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G; Ovarian Cancer Association Consortium. Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer I, PA, Zulka R, Hufnagel G, and Bahan KK. A Pilot Study of Male Breast Cancer in the Veterans Affairs Healthcare System. J Environ Pathol Toxicol Oncol. 2010; Zanetti R, Rosso T, Goumas C, Kanetsky PA, Begg CB, Orlow I, Wilcox H, Paine S, and Berwick M. Association of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis. Cancer Epidemiol Biomarkers Prev. 2010 Aug 27. 238. Fletcher O, Johnson N, dos Santos Silva I, Orr N, Ashworth A, Nevanlinna H, Heikkinen T, Aittom\u00e4ki A, G, MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Sch\u00fcrmann P, Waltes R, Bremer M, P, Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Humphreys K, Liu J, Ahmed S, L, English DR, Ben\u00edtez Arias JI, Pita G, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo Mannermaa A, Kataja V, Kosma J; Breast Cancer Association Consortium. Missense variants in ATM in 26, 101 breast cancer cases and 29, 843 controls. Cancer Epidemiol Biomarkers Prev. 2010 Sep; 19(9):2143-51. Ramus SJ, Notaridou M, Lawrenson LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman D\u00f6rk T, Nevanlinna H, RB, E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, J, Bolton KL, D, A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC; The Wellcome Trust Case-Control Consortium, Beesley J, Webb PM; The Australian Cancer Study (Ovarian Cancer); The Australian Ovarian Cancer Study Group; the Ovarian Cancer Association Consortium (OCAC), Chen X, Ekici Thiel Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, D\u00fcrst M, Antonenkova K, TA, Gayther SA, and Pharoah PD. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet. 2010 Sep 19. 240. Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Palmieri Moorman PG, J, Iversen ES, BL, Kruger-Kjaer J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Hillemanns P, D\u00fcrst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen P, Stefansson X; the Australian Ovarian Cancer Study Group; the Australian Cancer Study (Ovarian Cancer); on behalf of the Ovarian Cancer Association Consortium, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet. 2010 Sep 19. 241. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet Park Y, MJ. Body-Mass Index and Mortality among 1.46 Million White Adults. N Engl J Med. 2010 Dec 2; 363(23):2211-9. 242. Katz MH, Taylor TH, Al-Refaie WB, Hanna MH, Imagawa DK, Anton-Culver H, Zell JA. Adenosquamous versus Andocarcinoma Gastrointest Surg. 2011 Epub 2010 Nov 17. 243. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittom\u00e4ki K, Heikkil\u00e4 S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van 't Veer LJ, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Severi G, Lambrechts D, Vandorpe Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, D\u00f6rk T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, Arias Rodr\u00edguez PM, Zamora Ben\u00edtez Ko M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel Margolin Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, D, Pharoah P, Sherman ME, Garcia-Closas M. Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies. J Natl Cancer Inst. 2011 Feb 2; 103(3):250-63. Epub 2010 244. Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benitez J, Arias Perez JI, Zamora MP, Malats N, Dos Santos Silva I, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman P, Andrulis IL, Glendon G, Knight JA, Weerasooriya N, Cox A, Reed MW, Cross SS, Dunning AM, Ahmed S, Shah M, Brauch H, Ko YD, Bruning T, Genica Network T, Lambrechts Reumers J, Smeets A, Wang-Gohrke S, Hall P, Czene K, Liu J, Irwanto AK, Chenevix-Trench G, Holland H, Kconfab Investigators T, Aocs Investigators T, L, John EM, West DW, Whittemore AS, Vachon C, Olson JE, Fredericksen Z, Kosel M, Hein R, Vrieling A, Flesch-Janys D, Heinz J, M, PD, Garcia-Closas M, Goode EL, Chang-Claude J. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the Breast Cancer Association Consortium: a combined case-control study. Breast Cancer Res. 2010 Dec 31; 12(6): R110. 245. Bessonova L, Marshall SF, Ziogas A, Largent J, Bernstein L, Henderson KD, Ma H, West DW, Anton-Culver H. The association of body mass index with mortality in the California Teachers Study. Int J Cancer. 2011 Jan 4. 246. Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver HA. Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2011 Jan 7. 247. Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj H; Australian Ovarian Cancer Study Management Group; Australian Cancer Study (Ovarian Cancer), Pearce CL; Ovarian Cancer Association Consortium (OCAC). ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers PMC2863004. 248. Diamond C, Taylor TH, Anton-Culver H. Quality of life, characteristics and survival of patients with HIV and lymphoma. Qual Life Res. 2010 Mar; M, Peel Enhanced Expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility. Biomark Insights. 2009 Dec 22; 4:201-9. Largent J, Mellemkjaer Bernstein L, Lynch CF, Borg A, Concannon P, Teraoka RW; WECARE Study Collaborative Group, Bernstein JL. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control. 2010 Jun; 21(6):839-46. Epub 2010 Feb 4. PubMed PMID: 251. AS, Capanu M, Malone KE; WECARE Collaborative Study Group. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8. Epub 2010 Feb 5. PubMed PMID: 20135344; PubMed Central PMCID: PMC2903659. 252. Phelan EL, Vierkant Fridley BL, Beesley Webb DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Hein R, Green AC, Lissowska J, Carney ME, Lurie G, Wilkens LR, Ness RB, Pearce CL, Wu AH, Van Den Berg DJ, Stram DO, Terry KL, Whiteman DC, Whittemore AS, DiCioccio RA, McGuire V, Doherty Rossing MA, H, A, PD, ES, Marks JR, Pike MT, Schildkraut JM, Chenevix-Trench G, Berchuck A, Sellers TA; Ovarian Cancer Association Consortium, Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Stovall M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein Diep Gatti RA, Concannon P; WECARE Study Collaborative Group. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst. 2010 Apr 7; 102(7):475-83. Epub Chang-Claude J, Hein Wang-Gohrke VM, V; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Beesley J, Chen X, Chenevix-Trench G, Couch FJ, Olson JE, Fredericksen ZS, Wang J, Sherman ME, Bolton KL, Hall P, Czene K, Cox A, Brock IW, Elliott GC, Reed MW, estrogen receptor-negative Natl Cancer Inst. 2010 5; 102(9):650-62. Epub PubMed 20308648; PubMed PMC2864289. 255. Malone Concannon P, Tellhed Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkjaer L, CF, Boice JD Jr, Anton-Culver H, Bernstein JL. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 PMID: 20368571; PubMed Central PMCID: PMC2881721. 256. Chen R, Crispin DA, Pan S, Hawley S, McIntosh MW, May D, Anton-Culver H, Ziogas A, Bronner MP, Brentnall TA. Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas. 2010 Oct; PubMed PMID: 20467349. JA, Bernstein Marshall Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A, Anton-Culver H. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control. 2010 Oct; 21(10):1615-24. Epub 2010 Jun 6. PubMed PMCID: PMC2941047. 258. Zell JA, Ziogas Bernstein L, Clarke Deapen D, Largent JA, Neuhausen SL, Stram DO, Ursin G, Anton-Culver H. Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study. Cancer Prev Res (Phila). 2010 Jul; 3(7):865-75. Epub PubMed Central PMCID: PMC2931369. 259. Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM; Australian Cancer Study (Ovarian Cancer) Study Group, K\u00f6bel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G; Australian Ovarian Cancer Study Group, Cramer SK, Lurie G, Menon U, Moorman PG, SJ, Song D, Vierkant RA, S, Whittemore AS, Wilkens LR, Wu AH, Schildkraut JM, Sellers TA, Goode EL; Ovarian Cancer Association Consortium. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1822-30. PMC3013232. 260 Johnatty Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude Terry H, JM, PG, CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer). Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility PMC2900295. 261. Kent EE, Morris RA, Largent JA, Ziogas A, Sender LS, Anton-Culver H. Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma. J Cancer Epidemiol. 2010; 2010:824691. Central PMCID: PMC2905919. 262. Thomas From L, Busam Goumas C, Kanetsky PA, CB, Orlow I, H, Paine S, Berwick M; Genes, Environment, and Melanoma Study Group. Associations of cumulative sun exposure and phenotypic characteristics with histologic 20802019; PubMed Central PMCID: PMC2976811. 263. Fletcher O, Johnson N, dos Santos Silva I, Orr N, Ashworth A, Nevanlinna H, Heikkinen T, Aittom\u00e4ki A, G, MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Sch\u00fcrmann P, Waltes R, Bremer M, P, Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Humphreys K, Liu J, Ahmed S, L, English DR, Ben\u00edtez Arias JI, Pita G, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo Mannermaa A, Kataja V, Kosma J; Association Consortium. Missense variants in ATM in 26,101 breast cancer cases Chenevix-Trench Song H, Ramus SJ, Notaridou M, Lawrenson LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman D\u00f6rk T, Nevanlinna H, RB, E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC; Wellcome Trust Case-Control Consortium, Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group; Ovarian Cancer Association Consortium (OCAC), Chen X, Ekici Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, D\u00fcrst M, Antonenkova S, Sellers TA, Gayther SA, Pharoah PD; Ovarian Cancer Association Consortium (OCAC). A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet. 2010 Oct;42(10):874-9. Epub Central Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Palmieri Moorman PG, J, Iversen ES, BL, Kruger-Kjaer J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Hillemanns P, D\u00fcrst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen P, Stefansson X; Australian Ovarian Cancer Study Group; Australian. 266. Cancer Study (Ovarian Cancer); Ovarian Cancer Association Consortium, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet. 2010 Oct; 42(10):880-4. Epub 2010 Sep 19. PubMed PMID: 20852633; PubMed Central PMCID: PMC3125495. 267. Katz MH, Taylor TH, Al-Refaie WB, Hanna MH, Imagawa DK, Anton-Culver H, Zell JA. Adenosquamous versus adenocarcinoma Gastrointest PMC3023036. 268. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet Park Y, MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010 Dec 2; 363(23):2211-9. Erratum in: EL, H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittom\u00e4ki K, Heikkil\u00e4 S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van 't Veer LJ, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Severi G, Lambrechts D, Vandorpe Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, D\u00f6rk T, Bremer M, Meyer A, Karstens JH, Ay Park-Simon TW, Hillemanns Rodr\u00edguez M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel Margolin Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, D, Pharoah P, Sherman ME, Garcia-Closas M. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011 Feb 2; 103(3):250-63. Epub 270. Milne AB, FJ, Ben\u00edtez J, Arias P\u00e9rez JI, Zamora MP, Malats N, Dos Santos Silva I, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman P, Andrulis IL, Glendon G, Knight JA, Weerasooriya N, Cox A, Reed MW, Cross SS, Dunning AM, Ahmed S, Shah M, Brauch Ko Hall P, Czene K, J, John EM, West DW, Whittemore AS, Vachon C, Olson JE, Fredericksen Z, Kosel M, Hein R, Vrieling A, Flesch-Janys J, MW, Heusinger PD, Garc\u00eda-Closas M, Goode EL, Chang-Claude J. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res. 2010; 12(6):R110. Epub 2010 Dec PubMed PMID: 21194473; PMC3046455. 271. Bessonova L, Marshall SF, Ziogas A, Largent J, Bernstein L, Henderson KD, Ma H, West DW, Anton-Culver H. The association of body mass index with mortality in the California Teachers Study. Int J Cancer. 2011 Nov 15; 129(10):2492-501.doi: 10.1002/ijc.25905. Epub 2011 Apr 8. PubMed PMID: 21207419. Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver H. Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer. Cancer Epidemiol Biomarkers Prev. 2011 Feb; PA, Zulka R, Hufnagel G, Bahan KK. A pilot study of male breast cancer in the Veterans Affairs healthcare system. J Environ S, Marshall SF, Karao?lano?lu O, Anbarcio?lu Z, \u00dc\u00e7\u00fcnc\u00fc N, Akin \u00dc, \u00d6zen E, \u00d6zg\u00fcl N, Anton-Culver H, Tuncer M. Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev. 2010; 11(6):1731-9. PubMed PMID: 21338224. 275. Orlow I, Roy P, Reiner AS, Yoo S, Patel H, Paine S, Armstrong BK, Kricker A, Marrett Gallagher RP, Dwyer T, Busam K, From L, Begg CB, Berwick M; for the GEM Study Group. Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer. 2011 Mar 1. doi: 10.1002/ijc.26023. of Butzow R, Caldes T, Caligo MA, Campbell I, Chang-Claude J, Chen YA, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Despierre E, Doherty JA, Ekici AB, Easton D; Fenstermacher O; GEMO Study Collaborators, Gentry-Maharaj A, Godwin AK, Goode EL, Goodman MT, Gross J, Hansen TV, Harnett P, Rookus M; HEBON Investigators, Heikkinen of BRCA1/2, Kelemen LE, Kiemeney LA, C, Le ND, Leminen A, Leunen K, Levine DA, Y, Lundvall Macgregor S, Marees T, Massuger Nathanson L, Ness RB, Nevanlinna H, Nickels S, Osorio A, Paul J, Pearce CL, Phelan CM, Pike MC, Radice P, Rossing MA, Schildkraut JM, Sellers TA, H, DO, R, Lindblom A; AH, Ziogas A, Berchuck A, Risch HA; Ovarian Cancer Association Consortium. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res. 2011 Jun 1; 17(11):3742-50. Epub 2011 Mar PMC3107901. 277. Wang Q, Song H, Chenevix-Trench G; Australian Ovarian Cancer Study Group, Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer), Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke Ness JM, Fridley BL, Vierkant RA, Tworoger A, Menon U, Ramus SJ, Rossing MA, Doherty JA, Goodman MT, Carney ME, Lurie G, Wilkens LR, Kj\u00e6r SK, H\u00f8gdall E, Cramer JM, Berchuck A, Cancer Association Consortium. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):1028-31. 21415361; PubMed Central PMCID: PMC3176661. 278. Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, Bronner MP, Ziogas A, Anton-Culver H, Brentnall TA. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011 May 6; 10(5):2359-76. Epub Mar PMC3090497 279. Capanu M, Concannon P, Haile RW, Bernstein Malone KE, Lynch CF, Ziang X, Teraoka SN, Diep AT, Thomas DC, Bernstein JL; Study Begg CB. Assessment of rare BRCA1 and BRCA2 variants of unknown significance Epidemiol. doi: 10.1002/gepi.20587. PMCID: PMC3111904. 280. Broeks A, Sherman ME, Couch Hopper JL, GS, Apicella C, Smith LD, R, Burwinkel B, Marme F, Schneeweiss A, Sinn SE, HP, Br\u00fcning T, R, ZS, Wang X, Giles GG, Baglietto L, Severi G, McLean C, Haiman CA, Marchand L, Kolonel LN, Aln\u00e6s Kristensen B, van Leenders GJ, Hall P, Czene K, Humphreys K, Liu J, Cox A, Connley D, Cramp HE, Cross SS, Balasubramanian AM, Easton DF, Humphreys Lubinski Jakubowska A, Huzarski J, P, Sangrajrang S, Gaborieau V, Shen CY, Hsiung CN, Yu JC, Chen ST, Hsu GC, Hou MF, Huang CS, Anton-Culver H, Ziogas A, Pharoah PD, Garcia-Closas M. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor. Subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2011 Aug 15; 20(16):3289-303. Epub Ovarian Cancer Study Group, Dale LC, Lambrechts Amant F, Despierre JM, Kaye SB, Paul J, B\u00fctzow R, Nevanlinna H, Campbell I, Eccles DM, Karlan BY, Gross J, Walsh C, Pharoah PD, H, Kj\u00e6r Vermeulen SH, Le ND, Brooks-Wilson A, Cook LS, Phelan CM, Cunningham JM, Vachon CM, Vierkant RA, Iversen ES, Berchuck A, Goode EL, Sellers TA, Kelemen LE. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. PLoS One. 2011;6(5):e19642. Epub 2011 May 27. PubMed PMID: Central RK, A, Chenevix-Trench G, Webb PM, Beesley J; Australian Ovarian Cancer Study Group; Australian Cancer Study Group, Goodman MT; Ovarian Cancer Association Consortium Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One. 2011;6(6):e20703. Epub 2011 Jun 6. PubMed DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE. Clinically relevant changes in family history of cancer over time. JAMA. 2011 Jul 13; 306(2):172-8. PubMed PMID: 21750294. 284. Milne RL, Goode EL, Garc\u00eda-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora P, Cox A, Brock IW, Elliot G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC, Huang CS, Hou MF, Nordestgaard BG, Bojesen SE, S, P, Manoukian S, Barile M, L, John EM, Hoover RN, Fletcher O, Gibson LJ, Dos Santos Silva I, Peto J, Nickels S, Flesch-Janys D, Anton-Culver H, Ziogas A, Sawyer E, Tomlinson I, Kerin M, Miller N, Schmidt MK, Broeks B, Jakubowska A, Lubinski J, Jaworska K, Durda K, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Kraft P, Lindstrom S, Chen X, Beesley J, Hamann U, Harth K, Jukkola-Vuorinen A, Grip M, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Khusnutdinova E, Bermisheva M, Prokofieva D, Farahtdinova A, Olson JE, Wang X, Humphreys MK, Wang Q, Chenevix-Trench G; for the kConFab Investigators and the AOCS Group, Easton DF. Confirmation of 5p12 as a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Cancer Epidemiol Biomarkers 285. Berwick M, Begg CB, Armstrong BK, Reiner AS, Thomas NE, Cook LS, Orlow I, Kanetsky PA, Lee-Taylor J. Interaction of CDKN2A and Sun Exposure in the Etiology of Melanoma in the General Population. J Invest Dermatol. 2011 Aug 11. Doi: 10.1038/jid.2011.235. Strick R, Peto J, Dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, H, BG, J, Zamora Brenner H, M\u00fcller H, Arndt V, Rahman N, Turnbull C, S, A, H, Justenhoven C, T; Hein Wang-Gohrke D\u00f6rk T, Sch\u00fcrmann P, Bremer M, Hillemanns P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Marie Mulligan A, O'Malley FP, Brinton Sherman ME, Lissowska P, Czene K, Cox IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Ding SL, Hsu HM, Yu JC, Anton-Culver H, Ziogas A, Ashworth A, Swerdlow A, Jones M, Orr N, Trentham-Dietz A, Egan K, Newcomb P, Titus-Ernstoff L, Easton D, Spurdle AB. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2011 Sep 20. [Epub ahead of 287. Milne Tollenaar Seynaeve C, Hall P, Czene K, Liu J, Irwanto AK, Kang D, Yoo KY, Noh DY, Couch FJ, Olson JE, Wang X, Fredericksen Z, Nordestgaard BG, Bojesen AB, Beckmann MW, Wang-Gohrke S, Shen CY, Yu JC, Hsu HM, Wu PE, Giles GG, Severi G, Baglietto L, English DR, Cox A, Brock I, Elliott G, Reed MW, Beesley J, Chen X, Investigators K; AOCS Group, Fletcher O, Gibson L, dos Santos Silva I, Peto J, Frank B, Heil J, Meindl A, Chang-Claude J, Hein R, Vrieling A, Flesch-Janys D, Southey MC, Smith L, and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet. 2011 Oct; 48(10):698-702. Ahnen Schildkraut JM, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Burt RW. Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer. 2011 Fasching Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, Dos Santos Silva I, Gibson L, Sawyer E, Tomlinson I, Kerin MJ, Chanock S, Lissowska Hein R, Wang-Gohrke S, D\u00f6rk J, Chenevix-Trench G, Chen X, Peterlongo P, Bonanni B, Bernard L, Manoukian S, Wang X, Cerhan J, Vachon CM, Olson J, Giles GG, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Glendon G, Mulligan AM, Cox A, Brock IW, Elliott G, SS, Pharoah PP, Dunning AM, Pooley KA, Humphreys MK, Wang J, Kang D, Yoo KY, Noh DY, Sangrajrang S, Gabrieau V, Brennan P, McKay J, Anton-Culver H, Ziogas A, Couch FJ, Easton DF. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer. 2011 Oct 27. Doi: 10.1038/bjc.2011.448. [Epub ahead of print] PubMed PMID: 22033276. 1. Taylor W, Guirgis HA, Stewart WK. Investigations of a population exposed to organomercurial seed dressings, Archives of Environmental Health 19:505, 1969. 2. Lynch HT, Krush AJ, Guirgis HA. Genetic factors in families with combined gastrointestinal and breast cancer, American Journal Gastroenterology 59:31 40, 1973. Lynch HT, Guirgis HA, Swartz MW, Lynch JS, Krush AJ, Kaplan AR. Genetics and colon cancer, Archives of Surgery 106:669 675, 1973. 4. Lynch HT, Guirgis HA. Carcinoembryonic antigen in families. Journal of the American Medical Association 224:1042, 1973. 5. Lynch HT, Guirgis HA. Cancer resistance, Part I and Part II. Nebraska Medical Journal, 1973. 1974 May; 59(5): 156-61. 1974 June; Albert S, Brennan M, Lynch J, Kraft C, Pocekay D, Vaughns C, Kaplan AR. Familial association of carcinoma of the breast and ovary. Surg. Gynec. Obstet. 138:717 724, 1974. HA, Albert S, Brennan M. Familial breast cancer in a normal population. Cancer 34:2080 2086, 1974. 8. Lynch HT, Thomas RJ, Terasaki PI, Ting A, Guirgis HA, Kaplan AR, Lynch JR, Kraft C. HL A in cancer family \"N\". Cancer 36(4):1315 1320, 1975. 9. Lynch HT, Guirgis HA, Lynch JF. Cancer of the colon: Socioeconomic variables in a community, American Journal of Epidemiology 102(2):119 127, 1975. 10. Lynch HT, Thomas RJ, Guirgis HA, Lynch JF. Clues to cancer risk: Biological markers, American Family Physician 11:153 158, March 1975. 11. Lynch HT, Guirgis HA, Brodkey FD, Maloney K, Lynch P, Rankin L, Lynch JF. Early age of onset in familial breast cancer: Genetic and cancer control implications, Archives of Surgery 111:126 131, February 1976. 12. Lynch HT, Guirgis HA, Brodkey F, Lynch J, Maloney K, Rankin L, Mulcahy GM. Genetic heterogeneity and familial carcinoma of the breast, Surgery 142:693 699, 1976. 13. Lynch HT, Mulcahy GM, Lynch P, Guirgis H, Brodkey F, Lynch J, Maloney K, Rankin L. Genetic factors in breast cancer: A survey, Pathology Annals 899:77 101, 1976. 14. Lynch HT, Brodkey FD, Lynch P, Lynch J, Maloney K, Rankin L, Kraft C, Swartz M, Westercamp T, Guirgis H. Familial risk and cancer control, Journal of the American Medical Association 236:582 584, 1976. 15. Lynch HT, Saldivar VA, Guirgis HA, Terasaki PI, Bardawil WA, Harris RE, Lynch JF, Thomas R. Familial Hodgkin's disease and associated cancer: A clinical pathologic study, Cancer 38(5):2033 2041, 1976. 16. Stewart WK, Guirgis HA, Sanderson J, Taylor W. Urinary mercury excretion and proteinuria in pathology laboratory staff, British Journal of Industrial Medicine 34:26 31, 1977. 17. Lynch HT, Guirgis HA, Lynch PM, Lynch JF, Harris RE. Familial cancer syndromes: A survey, Cancer 39:1867 1881, 1977. 18. Lynch HT, Harris RE, Lynch PM, Guirgis HA, Lynch JF, Bardawil WA. Role of heredity in multiple primary cancers, Cancer 40:1849 1854, 1977. 19. Lynch HT, Harris RE, Bardawil WA, Lynch PM, Guirgis HA, Swartz MJ, Lynch JF. Management of hereditary site specific colon cancer, Archives of Surgery. 112:170 174, 1977. 20. Guirgis HA, Lynch HT, Mate T, Harris RE, Wells I, Caha L, Anderson J, Maloney K, Rankin L. Aryl hydrocarbon hydroxylase activity in lymphocytes from lung cancer patients and normal controls, Oncology 33:105 109, 1977. 21. Lynch HT, Harris RE, Organ CH, Jr, Guirgis HA, Lynch PM, Lynch JF, Nelson EJ. The surgeon, genetics, and cancer control: The cancer family syndrome, Annals of Surgery 185:435 440, 1977. 22. Lynch HT, Organ CH, Jr, Harris RE, Guirgis HA, Lynch PM, Lynch JF. Familial cancer: Implications for surgical management of high risk patients, Surgery 83:104 113, 1978. 23. Lynch HT, Harris RE, Guirgis HA, Maloney K, Carmody LL, Lynch JF. Familial association of breast/ovarian carcinoma, Cancer 41:1543 1549, 1978. 24. Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF. Genetic and pathologic findings in a kindred with hereditary sarcoma breast cancer, brain tumors, leukemia, lung, laryngeal and adrenal cortical carcinoma, Cancer 41:2055 2064, 1978. H, Lynch HT, Harris R, Vandevoorde J. Carcinoembryonic antigen (CEA) in the cancer family syndrome, Cancer 42:1574 1578, 1978. 26. Lynch HT, Bardawil WA, Harris RE, Lynch PM, Guirgis HA, Lynch JF. Multiple primary cancers and prolonged survival: Familial colonic and endometrial cancers, American Society of Colon and Rectal Surgery 4:165 168, 1978. 27. Guirgis HA, Lynch HT, Harris RE, Vandevoorde JP. Genetic and communicable effects on carcinoembryonic antigen (CEA) expressivity in the cancer family syndrome, Cancer Research 38:2523 2528, 1978. 28. Harris RE, Lynch HT, Guirgis HA. Familial breast cancer: Risk to the contralateral breast, Journal of the National Cancer Institute 60:955 960, 1978. 29. Fishman J, Fukushima D, O'Conner J, Rosenfeld RS, Lynch HT, Lynch JF, Guirgis H, Maloney K. Plasma hormone profiles of young women at risk for familial breast cancer, Cancer Research 38:4006 4011, 1978. 30. Guirgis HA, Lynch HT, Harris RE, Vandevoorde P. Immunochemical biological markers and hereditary cancer risk, Scandinavian Journal of Immunology 8:647 652, 1978. 31. Lynch HT, Guirgis H, Childhood cancer and the SBLA syndrome, Medical Hypotheses 5:15 22, 1979. 32. Lubiniecki AS, Lynch HT, Blattner WA, Guirgis H. Increased expression of SV40 T antigen and cell division in skin fibroblast cell lines derived from a family at high risk of carcinoma (family G of Warthin), Journal of Cancer Research and Clinical Oncology 103:127 133, 33. Anton-Guirgis inhalation in asthma, Journal of Asthma, 21: 108, 1984. 34. Anton-Guirgis H, Culver BD, Kurosaki T, Elston RC. A study of multiple in twins, Acta Geneticae Medicae et Gemellologiae, 34:3 4, 1985. 35. Kleinman S, Anton-Guirgis H, Culver BD, Taylor TH, Prince H, Kaplan H. Anti HTLV III Elisa and Western Blot Testing in a blood donor population: Implications for donor notification. Vox Sanguinis, 51:143 147, 1986. 36. McEwen E, Anton-Guirgis H. The medical communication of deaf patients, The Journal of Family Practice Vol. 26, No. 2, 1988. 37. Anton-Culver H, Culver B, Kurosaki T. Immune response in shipyard workers having x-ray abnormalities consistent with asbestos exposure, British Journal of Industrial Medicine 45:464 468, 1988. 38. Anton-Culver H, Culver BD, Kurosaki T, Osann KE, Lee JB. Incidence of lung cancer by histologic type from a population based registry, Cancer Research 48:6580 6583, 1988. 39. Anton-Culver H. Epidemiologic assessment of cancer risk: Applications from the Cancer Surveillance Program of Orange County, Journal of the American College of Toxicology 8:933-940, 1989. 40. Anton-Guirgis H, Culver BD Kurosaki T. An epidemiologic study of asbestos-related chest x ray changes to identify work areas of high risk in a shipyard population, Applied Industrial Hygiene 4:110 118, 1989. 41. Kaisch K, Anton-Culver H. Psychological and social consequences of HIV exposure: Homosexuals in Southern California, Psychology and Health 3:63-75, 1989. 42. Anton-Culver H. Smoking and other risk factors associated with the stage and age at diagnosis of colon and rectum cancers, Cancer Detection and Prevention 15:345-350, 1991 43. Gardin, JM, Wong, ND, Bommer, Lobodzinski, S, Anton-Culver H, Manolio TA. design of a multicenter investigation of free-living elderly subjects: the cardiovascular health study, Journal of the American Society of Echocardiography, 5:63-72, 1992. 44. Anton-Culver A. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study, American Journal of Obstetrics and Gynecology, 166(5): 1507-1514, 1992 and Letter to the Editor, 168(5):1646-1647, 1992 45. Anton-Culver H, Lee-Feldstein A, Taylor T. Occupation and bladder cancer risk, American Journal of Epidemiology 136:89-94, 1992. 46. Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung cancer risk associated with cigarette smoking, International Journal of Cancer 54:44-48, 1993. 47. Higgins MW, Enright PL, Kronmal RA, Schenker MB, Anton-Culver H, Lyles M. Smoking and lung function in elderly men and women, the cardiovascular health study, Journal of the American Medical Association 269: (21)2741-48, 1993. 48. Anton-Culver H, Lee-Feldstein A, Taylor TH, The association of bladder cancer risk with ethnicity, gender and smoking, AEP 3:429-433, 1993. 49. Davis D, Bradlow HL, Wolff T, Hoel DG, Anton-Culver H. Medical Hypothesis: Xenoestrogenic exposures as preventable cause of breast cancer, Environmental Health Perspectives 101(5): 372-377, 1993. 50. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival: delivery systems and medical outcomes, Journal of the American Medical Association 271:1163-1168, 1994, and reply: Breast Cancer: Treatment Differences and Survival, Journal of the American Medical Association 272:1166, 1994. 51. Monk BJ, Burger R, Van Ostrand K, Aquino L, Greep N, Silk E, Kolin M, Anton-Culver H, Manetta A. One-visit program for the prevention of cervical cancer in a high-risk population, Gynecologic Oncology 54:105, 1994. 52. Melbye M, Cote TR, Kessler L, Gail M, Biggar RJ, Lemp G, West D, Singleton J, Young J, Kerndt P, Deapen D, Ginzberg M, Anton-Culver H, Lieb S, Hopkins R, Williams B, Liff J, Morgan D, Parkin W. High incidence of anal cancer among AIDS patients. Lancet 343: 636-639, 1994. 53. Plummer SJ, Santibanez-Koref M, Kurosaki T, H, Casey G.A Germline 2.35kb deletion of p53 genomic DNA creating a specific loss of oligomerization domain inherited in a Li-Fraumeni syndrome family, Oncogene 9:3273-3280, 1994. 54. Goldman LR, Anton-Culver H, Kharazzi M, Blake E. Banking of human tissue for biomonitoring and exposure assessment: utility for environmental epidemiology and surveillance. Environmental Health Perspectives 103(S3): 31-34, 1995. 55. Wong N, Gardin J, Kurosaki T, Anton-Culver H, Sidney S, Roseman J, Gidding S. Echocardiographic left ventricular systolic function and volumes in young adults: distribution and factors influencing variability, American Heart Journal 129: 571-77, 1995. 56. Gardin J, Siscovick D, Anton-Culver H, Lynch JC, Smith VE, Klopfenstein HS, Bommer WJ, Fried L, O'Leary D, Manolio TA. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly: the Cardiovascular Health Study, Circulation 91(6):1739-1748, 1995. 57. Gardin J, Wagenknecht L, Anton-Culver H, Flack J, Gidding S, Kurosaki T, Wong ND, Manolio TA. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women: the CARDIA study, Circulation 92(3): 380-387, 1995. 58. Anton-Culver H. Cancer prevention strategies: use of cancer prevention research registries, Environmental Health Perspectives 103(S8):237-239, 1995. 59. Delfino RJ, Anton-Culver H, Saltzstein SL. Gender-related differences of thoracic versus abdominal malignant mesothelioma, Cancer Detection and Prevention 19(4): 301-307, 1995. 60. Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J, Casey G. Detection of BRCA1 mutations by the protein truncation test. Human Molecular Genetics 4(10): 1989-1991, 1995. 61. Monk BJ, Burger R, Van Ostrand K, Aquino L, Greep N, Silk E, Kolin M, Anton-Culver H, Manetta A. A single visit program for cervical cancer prevention in a high-risk population, Obstetrics and Gynecology 86(4 Pt 1):491-8, 1995. 62. Paczek A, Gardin Anton-Culver Kurosaki D. Comparison of m-mode and two-dimensional echocardoigraphic algorithms used to estimate left ventricular mass: the CARDIA study, Journal of the American Society of Echocardiography 8(6):780-792, 1995. 63. Anton-Culver H, Kurosaki T, Taylor T, Gildea M, Brunner D, Bringman D. Validation of Family History of Breast Cancer and Identification of the BRCA1 and Other Syndromes Using a Population-Based Cancer Registry, Genetic Epidemiology 13:193-205, 1996. 64. Disaia PJ, Grosen E, Kurosaki T, Gildea M, Cowan B, Anton-Culver H. Hormone replacement therapy in breast cancer survivors: a cohort study, American Journal of Obstetrics and Gynecology 174(5): 1494-1498, 1996. 65. Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP. Human Papillomavirus Type 18: Association With Poor Prognosis in Early Stage Cervical Cancer, Journal of the National Cancer Institute 88(19): 1361-1368, 1996. 66. Barker D, Almeida E, Casey G, Fain P, Liao S Y, Masunaka I, Noble B, Kurosaki T, Anton-Culver H. BRCA1 R841W: A strong candidate for a common mutation with moderate phenotype, Genetic Epidemiology 13: 595 604, 1996. 67. Jonas HA, RA, Psaty BM, Manolio TA, Meilahn EN, Tell JA, Anton-Culver H. Current estrogen progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study. Annals of Epidemiology 6(4):314 23, 1996. 68. Love SM, Rabson AS, Anton-Culver H, Clayton EW, Miller DS, Ravdin PM, Travers H, Barr PA, Liu E, Pinn VW, et al. Correspondence re: Mills SE, Kempson RL, Fechner RE, et al.: Guardians of the wax and the patient. Modern Pathology 8:699, 1995 [letter]; and Modern Pathology, 9(4):457, 1996. 69. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. American Journal of Human Genetics 60(2): 313 319, 1997. 70. Price TR, Manolio TA, Kronmal RA, Kittner S, Yue NC, Robbins J, Anton-Culver H, O'Leary DH. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 28(6):1158 64, 1997. 71. Re A, Taylor TH, DiSaia PJ, Anton-Culver H. Risk for breast and colorectal cancers subsequent to cancer of the endometrium in a population based case series. Gynecologic Oncology 66(2):255 7, 1997. 72. Theuer CP, Kurosaki T, Taylor TH, Anton-Culver H. Unique features of gastric carcinoma in the young: a population based analysis. Cancer 83(1):25 33, 1998. 73. Delfino RJ, Ferrini RL, Taylor TH, Howe S, Anton-Culver H. Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California, American Journal of Preventive Medicine 14: 96-102, 1998. 74. Bentley JR, Delfino, RJ, Taylor TH, Howe S, Anton-Culver H. Differences in breast cancer stage at diagnosis between non-Hispanic white and Hispanic populations, San Diego County 1988-1993, Breast Cancer Research and Treatment 50: 1-9, 1998. 75. Howe SL, Delfino RJ, Taylor TH, Anton-Culver H. The risk of invasive cervical cancer among Hispanics: evidence for targeted preventive interventions. Preventive Medicine 27:674-680, 1998. 76. Theuer CP; Anton-Culver H. Important prognostic factor in patients with gastric cancer [letter]. Western Journal of Medicine 169(4):254, 1998. 77. Janezic SA, Ziogas A, Krumroy Plummer SJ, Cohen P, Gildea M, D, Haile R, Casey G, Anton-Culver H. Germline BRCA1 alterations in a population-based series of ovarian cancer cases. Human Molecular Genetics 8(5):889-897, 1999. 78. Brewster WR, DiSaia PJ, Monk BJ, Ziogas Yamada SD, Anton-Culver H. Young age as a prognostic factor in cervical cancer: results of a population based study. American Journal of Obstetrics and Gynecology 180(6 Pt 1):1464 7, 1999. 79. Astin JA, Anton-Culver H, Schwartz C, Shapiro DH, McQuade J, Breuer A, Taylor T, Lee H, Kurosaki T. Sense of control and adjustment to breast cancer: the importance of balancing control coping styles. Behavioral Medicine 25:3, 1999. 80. Boyer-Chammard AB, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detection and RD, Das Gupta Weger J, Wahlberg S, Fox EA, Peel D, Ziogas A, Garber JE, Syngal S, Anton-Culver H, and Li FP. Germ-line msh6 mutations in colorectal cancer families. Cancer 1999. 82. Theuer CP, Nastanski F, Brewster WR, Butler JA, Anton-Culver H. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. American Surgeon, 65(10):915 21, 1999. 83. Ziogas A, Gildea M, Cohen P, Bringman D, Taylor T, Seminara D, Barker D, Casey G, Haile R, Liao S-Y, Thomas D, Noble B, Kurosaki T, and Anton-Culver H. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention 9: 103-111, 2000. 84. Delfino RJ, Sinha R, Smith C, West J, White E, Lin HJ, Liao S-Y, Gim JS-Y, Ma HL, Butler J, Anton-Culver H. Breast cancer, heterocyclic meat and 2 genotype. Gildea ME, Ziogas A. Characteristics of BRCA1 mutations in a population-based series of breast & ovarian cancer. European Journal of Cancer 36; 1200-08, June 2000. 86. Delfino RJ, Smith C, West J, White E, Lin HJ, Liao S-Y, Gim JSY, Ma HL, Butler J, Anton-Culver H. Breast cancer, passive and active cigarette smoking, and N-acetyltranferase 2 genotype. Pharmacogenetics July 2000 (10):461-469. 87. Taylor TH, Anton-Culver H. Let's leave the date out of the name of the standard population. (Correspondence.) Journal of the National Cancer Institute 92 (2000):1269-70. 88. Peel D, Ziogas A, Fox E, Gildea M, Laham B, Clements E, Kolodner R, Anton-Culver H. Epidemiologic, genetic, and molecular characterization of HNPCC families from a population based series of colorectal cancer. Journal of the National Cancer Institute 92 (2000):1517-22. 89. Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-Culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer, November 1, 2000: 89 (9):1883-1892. 90. Theuer CP, Taylor TH, Anton-Culver H. Letter. Correspondence: Screening for Colorectal Cancer. New England Journal of Medicine 343 (22); November 30, 2000: 1625. 91. DiSaia PJ, Brewster WR, Ziogas A, Anton-Culver H. Breast cancer survival and hormone replacement therapy: a cohort analysis. American Journal of Clinical Oncology Dec 2000, 23 (6):541-5. 92. Brewster WR, Monk A, Anton-Culver ML. Intent-to-treat analysis of stage Ib and IIa cervical cancer in the Untied States: Radiotherapy or Surgery 1988-1995. Obstetrics & Gynecology 97(2), February Theuer CP, WR, CE, Anton-Culver H. Racial and Ethnic Colorectal Cancer Patterns Affect the Utility of Colorectal Cancer Screening in the United States. Gastroenterology. March 2001; 120: 848-856. 94. Peel DJ, Anton-Culver H. Response to Hemminki (Correspondence regarding Peel et. al, Characterization of HNPCC families from a population based series of cases, published JNCI Reports 2000; 92(18):1517-1522.): Journal of the National Cancer Institute, vol. 93, no. 8, April 18, 2001: 651-652. 95. Semenza JC, Ziogas A, Largent J, Peel D, Anton-Culver H. Gene-environment interactions in renal cell carcinoma. American Journal of Epidemiology 153(9):851-859, 2000 May 1. 96. Anton-Culver H, Peel D, Ziogas A. Proportion of HNPCC in the general population, Response to Evans (Correspondence regarding Peel et. al, Characterization of HNPCC families from a population based series of cases, published JNCI Reports 2000; 92(18):1517-1522.) Journal of the National Cancer Institute, vol. 93, no. 9, May 2, 2001: 717-718. 97. Keefe KA, Schell MJ, Brewer C, McHale Brewster W, Chapman McMeeken YM, FL, Berman ML. double-blind, Phase III trial using oral beta-carotene supplementation JC, H. The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy. Am Surg 2001 Dec; 7(12):1157-61. 99. Speer SA, Semenza Jan C, Kurosaki T, Anton-Culver H. Risk Factors for Acute Myeloid Leukemia and Multiple Myeloma: A Combination of Geographic Information System and Case-Control Studies. J Environ Health, March 2002:64(7); 9-15. 100. Diamond C, Taylor T, Anton-Culver H. Characteristics and survival of patients with non-Hodgkin's lymphoma with and without Acquired Immunodeficiency Syndrome. Published on line in Hematological Oncology May 8, http://www3.interscience.wiley.com/cgi-bin/issuetoc?ID=82002594 101. Brewster WR, Anton-Culver Ziogas A, Largent J, Howe S, Hubbell FA, Manetta A. Recruitment strategies for cervical cancer prevention study. Gynecological Oncology. 2002 May 85(2):250-254. 102. MR, Stewart Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Reynolds P, Ross RK, Wright W, Ziogas A. Recent diet and breast cancer risk: the California Teachers Study. Cancer Cause Control. 2002 June; 13(5):407-415. 103. Irene L. Andrulis, Hoda Anton-Culver, Jeanne Beck, Betsy Bove, Jeff Boyd, Saundra Buys, Andrew Godwin, John Hopper, Frederick Li, Susan L. Neuhausen, Hilmi Ozcelik, David Peel, Jan Vijg and Alice S.Whittemore for the Cooperative Family Registry for Breast Cancer Studies. Comparison of DNA- and RNA-based Methods for Detection of Truncating BRCA1 Mutations. Human Mutation. 2002 July; 20(1):65-73. 104. Bernstein L, Allen L, Anton-Culver H, Deapen D, Horn-Ross P, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A. High breast cancer rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control. 2002 September; 13(7):625-635. 105. Hoggatt KJ, Bernstein L, Reynolds P, Anton-Culver H, Deapen D, Peel D, Pinder R, Ross RK, West DW, Wright W, Ziogas A, Horn-Ross PL. Correlates of vitamin supplement use in the United States: Data from the California Teachers Study cohort. Cancer Cause Control. 2002 October; 13(8): 735-740. 106. Semenza J, Delfino cancer Cancer Control. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. American Journal of Preventive Medicine, 24(2): 190-198; Feb 2003. 108. Parikh-Patel A, Allen MA, Wright WE, and the California Teachers Study Steering Committee. Validation of self-reported cancers in the California Teachers Study. American Journal of Epidemiology 157(6), 539-545, 2003 March 15. 109. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper J, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Tang Olah Anton-Culver Warner Lubinski Gronwald O-P, J, Lalloo F, Evans DG, Easton DF. Average risks of breast and ovarian cancer associated with mutations in BRCA1 or BRCA2 detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics. 2003 May; 72(5): 1117-1130. Epub 2003 April 3. 110. Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum Olsen Group. ATM variants 7271T>G and IVS10-6T4 among women with unilateral and ilateral breast cancer. British Journal of Cancer 89, 1513-1516, 2003 October 20. 111. Marshall SF, Deapen D, Allen M, Anton-Culver H, Bernstein L, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Ross R, West D, Ziogas A. Validating California Teachers Study self-reports of recent hospitalization: comparison with California hospital discharge data. American Journal of Epidemiology. 2003 November 15; 158(10): 1012-1020. 112. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin c, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S. The Cancer Genetics Network: Recruitment Results and Pilot Studies. Community Genetics 2003; 6(3): 171-177. 113. Taylor TH, Bringman B, Anton-Culver H. Excluded cases and the age-standardized incidence rate implications for cancer-registry data standards. Journal of Registry Management, 30(3), 84-89, 2003. 114. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, orn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A. Active smoking, household passive smoking, and breast cancer: evidence from the California teachers study. Journal of the National Cancer Institute 96, 29-37, 2004. 115. Horn-Ross PL, Canchola AJ, West DW, Stewart SL, Bernstein L, Deapen D, Pinder R, Ross RK, Anton-Culver H, Peel D, Ziogas A, Reynolds P, Wright W. Patterns of alcohol consumption and breast cancer risk in the California Teachers Study cohort. Cancer Epidemiology Biomarkers Prev 2004 Mar, 13:405-11 116. Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice P, Thompson WD, WECARE study. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res 2004, 6:R199-214 117. Meyskens FL, Farmer PJ, Anton-Culver H. Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res. 2004 Apr 15, 10:2581-3 118. Brewster WR, Hubbell FA, Largent J, Ziogas A, Ganiats T, Anton-Culver H, Manetta A. Feasibility of a cervical cancer screening program. Plenary Presentation Western Association of Gynecologic Oncologists (WAGO), Thirty Third Annual Meeting, Monterey, CA; 119. Theurer CP, Taylor TH, Brewster WR Anton-Culver H. Should colon cancer screening guidelines account for race and ethnicity? American Society of Clinical Oncology, New Orleans LA June 2004, 22 : 1022 120. Reynolds P, Hurley SE, Hoggatt K, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, West D, Wright W, Ziogas A, Horn-Ross PL. Correlates of active and passive smoking in the California Teachers Study cohort. Journal of Womens Health (Larchmt) 2004 Sep; 13(7):778-90. 121. Reynolds P, Hurley SE, Goldberg DE, Yerabati S, Gunier RB, Hertz A, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A. Residential proximity to agricultural pesticide use and incidence of breast cancer in the California Teachers Study cohort. Environ Res 2004 Oct; 96(2):206-18. 122. Reynolds P, Hurley S, Goldberg DE, Anton-Culver H, Bernstein L, Deapen D, Horn-Ross PL, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A. Regional variations in breast cancer among California Teachers. Epidemiology 2004 November, Vol15, (6):746-54. 123. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, FP, AS, Seminara D, and the Breast Cancer Family Registry. The Breast Cancer family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004, 6:R375-R389. 124. Begg CB, Hummer A, Mujumdar U, M, GEM Study Group. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004 Nov, 15:957-65 125. McEligot AJ, Wenzel L, Largent J, Ziogas A, Anton-Culver H. Factors associated with complementary and alternative medicine (CAM): Use among breast cancer patients with and without a family history of breast or ovarian cancer, Journal of Cancer Integrative Medicine, Winter 2004; Volume 2, Number 1, pages Arthur G, Becerra Phan PC, Anton-Culver H. Forthal DN. Autologous Antibody to Breast Cancer in Healthy Multiparous Women.2004 127. Chang KJ, Parasher G, Christie C, Largent J, Anton-Culver H. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups. Cancer. 2005 Jan 15, 103:349-57. 128. Meyskens FL, Farmer PJ, Anton-Culver H. Diet in case-control study. Cancer Epidemiol Biomarkers Prev. 2005 14:293. SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris C, Bowman E, Clayman GL, Lippman SM, Lee JJ, Zheng W, Balmain A. T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis 2005 Aug, 26:1368-73. Epub 2005, Mar 31. 130. Hurley SE, Reynolds P, Goldberg DE, Hertz A, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, West D, Wright WE, Ziogas A, Horn-Ross PL. Residential mobility in the California Teachers Study: implications for geographic differences in disease rates. Soc Sci Med. 2005 Apr, 60(7):1547-55. 131. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau Boardman LA, Seminara D. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005 1979-85 132. Largent J, Ziogas A, Anton-Culver H. Effect of Reproductive factors on stage and hormones receptor status on early onset breast cancer. Breast Cancer Research, 2005, 7:R541-R554 (16 May 2005) 133. Diamond C, Taylor TH, Aboumrad T, Bringman D, Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005 May, 32:314-20. 134. Wenzel L, DeAlba D, Krebs LU, Anton-Culver H, Berkowitz R, Aziz N. Quality of life in long-term cervical cancer survivors. Gynecol Oncol 2005, May, 97:310-7. 135. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK. Nonsteroidal anti- inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst. 2005 Jun 1; 97(11):805-12. 136. Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, RA, Duffy D, Chenevix-Trench G. BRAF Polymorphism and the risk of ovarian cancer of low malignant potential. Gynecological Oncology 2005 Jun, 97:807-12. 137. Wodarz D, Anton-Culver H. Dynamical interactions between multiple cancers. Cell Cycle 2005 Jun, 4:764-71. 138. Antoniou AC, Pharoah PD, Narod A, Pasini B, Radice Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald H, Nevanlinna H, Syrj\u00e4koski K, Kallioniemi OP, Thompson D, C, Peto J, Lalloo F, Evans DG, Easton DF. Breast and ovarian cancer risks to carriers the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 2005 Jul, 42: 602-3. 139. Shin, BY, Rozek, L., Paxton, L., Peel, D., Anton-Culver, H., Rennert, G., Goodfellow, P., Gruber, S., Lipkin Endometrial Cancer Patients\" Dis. of the Colon and Rectum 2005 Sep, 48:1723-7 140. Sogn JA, Anton-Culver H, Singer DS. Meeting report: NCI think tanks in cancer biology. Cancer Res 2005 Oct 15, 65:9117-20. 141. Begg CB, Orlow I, Hummer AJ, Rebbeck TR, Mitra N, Busam K, From L, Berwick M, Genes Environment and Melanoma Study Group. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005 Oct 19, 97:1507-15 142. Millikan RC, Hummer A, Begg C, Player J, De Cotr\u00e9t AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Mujumdar U, and Berwick, M for the GEM Study Group. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis. 2006 610-18. WR, Hubbell FA, Largent J, Ziogas A, Lin F, Howe S, Ganiats TG, Anton-Culver H, Manetta A. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial. JAMA 2005 Nov 2, 294:2182-7. 144. Zell, JA, Ou, S-HI, Ziogas, A, Anton-Culver, H. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. Journal of Clinical Oncology 2005 Nov 20; 23(33): 8396-405. 145. Diamond C, Taylor TH, Aboumrad H. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 2006 Jan 1, 106:128-35 146. Theuer CP, Taylor TH, Brewster WR, and affect the cost-effectiveness of colorectal cancer screening. J Natl Med Assoc 2006 Jan, 98:51-7 147. Crawford NPS, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Research 2006, 8:R16 (21 March 2006) 148. Begg CB, Hummer AJ, Mujumdar, BK, Kricker Millikan RP, Dwyer T, Rebbeck TR, Busam K, From L, and Berwick M for the GEM Study Group. A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol. 2006 June; 35(3): 756-64. Epub 2006 March 23. 149. Diamond C, Taylor TH, Im T, Miradi M, Anton-Culver H. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy. Hematol Oncol 2006 Apr 10. 150. Taylor TH, Bringman D, Anton-Culver H. Malignancies following in situ cervical cancer in Hispanic Americans and non-Hispanic whites. Gynecol Oncol 2006 Jul 18. 151. Diamond C, Taylor TH, Im T, Miradi M, Wallace M, Anton-Culver H. Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma. Curr HIV Res 2006 Jul, 4:375-8 152. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H. Hypertension, diuretics and breast cancer risk. J Hum Hypertens 2006 Aug 3. 153. Zell JA, Ou SH, Ziogas A, Anton-Culver H. Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis. Ann Oncol 2006 Aug, 17:1255-62. 154. Berwick M, Orlow I, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, GEM Study Group. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer 2006 15:1520-5. 155. Kanetsky PA, Rebbeck LD, Millikan RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, and Berwick M, for the Genes Environment and Melanoma Study Group. Population-Based Study of Natural Vairation in the Melanocortin-1 Receptor Gene and Melanoma. Cancer Res 2006 Sept 15; 66(18): 9330-7. 156. Diamond C, Taylor TH, Im T, Anton-Culver H. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS. Leuk Lymphoma 2006 Sep, 47:1822-9. 157. Ou SH, Zell J, Ziogas A, Anton-Culver H. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol 2007 Jan, 18:29-35. Epub 2006 October 23. 158. Raz DJ, Zell JA, Karnezis AN, Odisho A, Ignatius Ou SH, Jablons DM; Misclassification of bronchioloalveolar carcinoma with cytologic of lung cancer. J Thorac Oncol 2006 Nov, 1:943-8. 159. Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM. Analysis of co-aggregation of cancer based on registry data. Community Genet 2006, 9:87-92. 160. McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutr Cancer 2006, 55:132-40. 161. Kricker A, Armstrong BK, Goumas C, Litchfield M, CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Culver RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Zanetti R, and Berwick M for the GEM Study Group. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007 April; 18(3): 295-304. Epub 2007 January 6. 162. Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, Stram DO, West DW, Wright W, Ziogas A, Horn-Ross PL. Diet and Risk of Ovarian Cancer in the California Teachers Study Cohort. Am J Epidemiology. 2007 Jan 8. 163. Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, R, T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M. CDKN2A Germline Mutations in Individuals with Dermatol. 2007 May; H, Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Int J Cancer 2007 Feb 1, 120:459-68. 165. Chang ET, Canchola AJ, Lee VS, Clarke CA, Purdie DM, Reynolds P, Bernstein L, Stram DO, Anton-Culver H, Deapen D, Mohrenweiser H, Peel D, Pinder R, Ross RK, West DW, Wright W, Ziogas A, Horn-Ross PL. Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control 2007 Feb, 18:91-103. 166. Dallal CM, Sullivan-Halley J, Ross RK, Wang Y, Deapen D, Horn-Ross PL, Reynolds P, Stram DO, Clarke CA, Anton-Culver H, Ziogas A, Peel D, West DW, Wright W, Bernstein L; Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med 2007 Feb 26, 167:408-15. 167. Diamond C, Taylor TH, Im T, Wallace M, Saven A, Anton-Culver H How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma? Cancer Causes Control 2007 CL, Anton-Culver H, Yunis C, Gardin JM; and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol 2007, Mar 15, 99:830-4. 169. Mai PL, Sullivan-Halley J, Ursin G, Stram DO, Deapen D, Villaluna D, Horn-Ross PL, Clarke CA, Reynolds P, Ross RK, West DW, Anton-Culver H, Ziogas A, Bernstein L; Physical activity and colon cancer risk among women in the California Teachers Study. Cancer Epidemiol Biomarkers Prev 2007 Lipkin SM, Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev 2007 Mar, 16:546-52. 171. Largent JA, Capanu Bernstein L, Langholz B, Mellemkaer L, Malone KE, Begg CB, Haile RW, Lynch CF, Anton-Culver H, Wolitzer A, Bernstein JL, Reproductive history and risk of second primary breast cancer: the WECARE study. Cancer Epidemiology Biomarkers Prev; 2007 May, 16:906-11. 172. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM, Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007 Jul, 132:193-9. 173. Ou SH, Zell JA, Ziogas A, Anton-Culver H, Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 2007 Oct 1, 110:1532-41. 174. Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis Strong LC, Berry DA, S, Dutson D, Kerber R, Peshkin BN, DM, Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 2007 Oct 2, 147:441-50. 175. Templeman C, Marshall SF, Ursin G, Horn-Ross PL, Clarke CA, Allen M, Deapen D, Ziogas A, Reynolds P, Cress R, Anton-Culver H, West D, Ross RK, Bernstein L, Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 2007 Oct 3. 176. Ou SH, Zell JA, Ziogas A, and Anton-Culver H, IB non-small-cell lung cancer (NSCLC) is dependent on tumor size. Chest 2007 Oct 9. 177. Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes WL, S, Lowy DR, Anton-Culver H, Hunter KW, Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 2007 Nov 30, 3:e214. 178. Zell JA, Ignatius Ou SH, Ziogas A, Anton-Culver H, Validation of the proposed International Association for the Study of Lung Cancer non-small cell lung cancer staging system revisions for advanced bronchioloalveolar carcinoma using data from the California Cancer Registry. J Thorac Oncol 2007 Dec, 2:1078-85. 179. Satram-Hoang S, Ziogas A, Anton-Culver H, Risk of second primary cancer in men with breast cancer.Breast Cancer Res 2007, 9:R10. 180. Meyskens FL, Farmer PJ, Yang S, Anton-Culver H New perspectives on melanoma pathogenesis and chemoprevention. Recent Results Cancer Res 2007, JA, McEligot AJ, Ziogas A, Holcombe RF, Anton-Culver H, Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer 2007, 59:36-45. 182. Zell JA, Ou SH, Ziogas A, Anton-Culver H, Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary Cancer 2008 Jan 1, 112:136-43. Mobasher M, Ziogas A, H, for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol 2008 Jan 1, 26:66-75. 184. Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD, Shore RE. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. Women's Environment, Cancer and Radiation Epidemiology Study Collaborative Group , Bernstein JL, J Natl Cancer Inst 2, 100:32-40. 185. Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL, Variation of breast cancer risk among BRCA1/2 carriers. JAMA 2008 Jan 9, 299:194-201. 186. Yarosh W, Barrientos T, Esmailpour T, Lin L, Carpenter PM, Osann K, Anton-Culver H, Huang T, TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases. Cancer Res 2008 Feb 1, 68:693-9. 187. Figueiredo JC, Bernstein L, Capanu M, Malone KE, Lynch CF, Anton-Culver H, Stovall M, Bertelsen L, Haile RW, Bernstein JL, Oral Contraceptives, Postmenopausal Hormones, and Risk of Asynchronous Bilateral Breast Cancer: The WECARE Study Group. J Clin Oncol 2008 Feb 4. 188. Simoneau AR, Gerner R, Ziogas A, Fujikawa-Brooks R, CE, Anton-Culver H, Meyskens FL, The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a Wenzel L, Bowen D, Habbal R, Leighton N, Vu T, Anton-Culver H, Testing targeted approaches to enhance Cancer Genetics Network minority recruitment within Asian populations. Community Genet 2008, 11:234-40. 190. Antoniou AC, Cunningham AP, Peto DG, Radice S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008; Apr 22, 98:1457-66. 191. Ou SH, Zell JA, Ziogas A, Anton-Culver H, Low socioeconomic status is a poor prognostic factor for survival in stage independent of surgical treatment, race, and marital status. Cancer 2008 May 1, 112:2011-20. 192. Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL, WECARE Study Collaborative Group, Dose to the Contralateral Breast from Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE Study. Int J Radiat Oncol Biol Phys 2008 193. Chao JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, H, Accurate classification MLH1/MSH2 variants protein polymorphisms-mismatch repair Hum Mutat 2008 Jun, 29:852-60. 194. Barton JC, Leiendecker-Foster Reboussin DM, Adams PC, Acton RT, Eckfeldt JH; Hemochromatosis and Iron Overload Screening Study Research Investigators. Collaborators (113) Acton RT, Barton JC, Dixon D, Ferguson S, Jones R, McKnight J, Rivers CA, Tucker D, Ware JC, McLaren CE, McLaren GD, Anton-Culver H, Ton T, Walker AP, Wenzel LB, Ziogas A, Adams PC, Bloch E, Chakrabarti S, Fleischhauer A, Harrison H, Jia K, Larson S, Lin E, Lopez M, Nguyen L, Pepper C, Power T, Speechley M, Sun D, Woelfle D, Harris EL, Aickin M, Baker E, Erwin M, Holup J, Lloyd C, Press N, Press RD, Reiss J, Ritenbaugh C, Uchida E, Vogt T, Yim FW, O, M, Harrison BW, Lewis-Jack O, Murray RF, McDonald-Pinkett S, Rock S, Leiendecker-Foster Wang X, Reboussin DM, Snively BM, Anderson R, Bostic E, Craven BL, Ellis S, Furberg C, Griffin J, Hall M, Harris D, Henkin L, Jackson S, Jewett T, King MD, Lohman K, Lovato L, Michaleckyj J, Palla S, Parks T, Passmore L, Phatak P, Rich S, Ruggiero A, Vitolins M, Wolgast G, Zaccaro D, Sholinsky P, Bookman E, Chang H, Fabsitz R, Jaquish C, Manolio T, O'Neill L, Thomson E, MacCluer J Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS 18(8):831-8. B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, Bernstein JL. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res. 2008 Aug 15;68(16):6486-91.PMID: 18701470 196. De Alba I, Anton-Culver H, Hubbell FA, Ziogas A, Hess JR, Bracho A, Arias C, Manetta A Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev 2008; Aug, 17:2163-8. 197. Glaser SL, Clarke CA, Keegan TH, Chang ET, Shema SJ, Craig FE, Digiuseppe RF, Ambinder RF. Racial/ethnic variation in EBV-Positive classical Hodgkin lymphoma in California populations. Int J Cancer 2008; Oct 1, 123:1499-507. 198. Neklason DW, Kerber RA, JT, Schildkraut Evans JP, Tomlinson GE, Strong LC, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten Mineau GP, Burt RW. Anton-Culver H, familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res 2008; Nov 1, 68:8993-7. 199. Zell JA, Honda J, Ziogas A, Anton-Culver H. Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev 2008; Nov, 17:3134-40. 200. McLaren Barton JC, Reboussin DM, Gordeuk Acton JH; Hemochromatosis and Iron Overload Screen (HEIRS) Study Research Investigators. Collaborators (114) Acton RT, Barton JC, Dixon D, Ferguson S, Jones R, McKnight J, Rivers CA, Tucker D, Ware JC, McLaren CE, McLaren GD, Anton-Culver H, Ton T, Walker AP, Wenzel LB, Ziogas A, Adams PC, Bloch E, Chakrabarti S, Fleischhauer A, Harrison H, Jia K, Larson S, Lin E, Lopez M, Nguyen L, Pepper C, Power T, Speechley M, Sun D, Woelfle D, Harris EL, Aickin M, Baker E, Erwin M, Holup J, Lloyd C, Press N, Press RD, Reiss J, Ritenbaugh C, Uchida E, Vogt T, Yim FW, Fadojutimi-Akinsiku M, Castro O, White-Coleman D, Gerald M, Harrison B, Lewis-Jack O, Murray RF, McDonald-Pinkett S, Rock A, Romagoza S, Leiendecker-Foster X, Reboussin DM, Snively BM, Anderson R, Balasubramanyam A, Bostic E, Craven BL, Ellis S, Furberg C, Griffin J, Hall M, Harris D, Henkin L, Jackson S, Jewett T, King MD, Lohman K, Lovato L, Michaleckyj J, Palla S, Parks T, Passmore L, Phatak PD, Rich S, Ruggiero A, Vitolins M, Wolgast G, Zaccaro D, Sholinsky P, Bookman E, Chang H, Cooper K, Fabsitz R, Jaquish C, Manolio T, O'Neill L, Thompson E. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, Chenevix-Trench G, Chang-Claude J, SK, Hogdall CK, Hopkins MP, Jenison EL, Blaakaer J, Lurie G, McGuire V, Menon U, Moysich KB, Vandenberg D, Vierkant RA, Wang-Gohrke S, Webb PM, Whittemore AS, Wu AH, Ziogas A, Berchuck A, Schildkraut JM, Ovarian Cancer Association Consortium , Australian Cancer Study (Ovarian Cancer Group) , Australian Ovarian Cancer Study Group. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev JG, Salem R, Haque R, Anton-Culver H, Abstracting height and weight from medical records, and breast cancer pathologic factors. Cancer Causes Control 2008; Dec, 19:1217-26. 203. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode JC, JM, Berchuck A, Brewster W, Galitovskiy V, Chenevix-Trench G, Australian Cancer Study, Australian Ovarian Cancer Study Group. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 2009; Jan 27, 100:412-20. 204. Lu Y. Sullivan-Halley J, Cozen W, Chang ET, Henderson K, Ma H, Deapen D, Clarke C, Reynolds P, Neuhausen SL, Anton-Culver H, Ursin G, West D, Bernstein L., Family history of hematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study. Br J Cancer 2009; Feb 10, 100:524-6. 205. Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, AS, X, Haile RW, Boice JD Jr; Begg C, Capanu M, Liang X, Reiner AS, Orlow I, Layne T, Bernstein L, Donnelly-Allen L, Olsen JH, Andersson M, Bertelsen L, Guldberg P, Lynch CF, DeWall RW, Langholz BM, Thomas DC, Diep AT, Xue S, Zhou N, Liu Y, Ter-Karapetova E, Thompson WD, Stovall M, Smith S, Concannon P, Teraoka S, Olson ER, Morrison VA, Cerosaletti KM, Navarro L, Wright J. Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol. 2009 Apr 15; 169(8):962-8. Epub 2009 Feb 11. knight@lunenfeld.ca 206. Zell JA. Tsang WY, Taylor TH, Mehta RS, Anton-Culver H. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Breast Cancer Res 2009; 11:R9 207. Yu Z., Garner C, Ziogas A, Anton-Culver H, Schaid DJ. Bioinformatics 10:63. Dunning AM, Healey AT, Scollen S, Vega A, Rodr\u00edguez R, Barbosa-Morais NL, , Low YL, Bingham S, , Haiman CA, Le L, MEC , Broeks A, Group , Change-Claude J, Flesch-Janys D, MARIE , FJ, SASBAC , Kang D, Yoo KY, SEBCS , Shen of with 18:1131-9. Iversen Berchuck A, Marks JR, Lissowska J, B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Van Den Berg D, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, Gayther SA, Ramus SJ, Jacobs I, SS, Calingaert B, Chanock S, Sherman M, Garcia-Closas M, Australian Ovarian Cancer Study Group. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009; Mar 15, 69:2349-57. 210. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, Eccles D, Evans DG, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Stratton MR, Rahman N, Jacobs K, Prentice R, Anderson GL, Rajkovic A, Curb JD, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson Thun E, SEARCH , Kang D, Yoo KY, Noh DY, Ahn SH, Devilee P, van Asperen Margolin S, Mannermaa A, Kosma VM, Kataja V, Olson JE, Wang X, Fredericksen Z, Giles GG, Severi G, Baglietto L, English MJ, van den Ouweland AM, Oldenburg RA, Schutte M, Hall P, Czene K, Liu J, Li Y, Cox A, Elliott G, Brock I, Reed MW, Shen CY, Yu JC, Hsu GC, Chen ST, Anton-Culver H, Ziogas A, Andrulis IL, Knight JA, kConFab , Australian Ovarian Cancer Study Group , Beesley J, Goode EL, Couch F, Chenevix-Trench G, Hoover RN, Ponder BA, AM, 17q23.2. Nat Genet 2009; May, 41:585-90. 211. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa Justenhoven C, BG, Flyger HL, Peto J, Fletcher O, Silva I, Fasching PA, Beckmann MW, Strick R, MC, Hopper JL, Apicella Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter Hankinson Seynaeve C, Vreeswijk J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Dietz Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Australian Ovarian Cancer Study Group , Garcia-Closas M, Breast Cancer Association Consortium. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2009; May, 18:1610-6. 212. Kent EE, Sender LS, Largent JA, Anton-Culver H. Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors.Cancer Causes Control 2009 Jun 4. 213. Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, Gentry-Maharaj A, Jacobs IJ, Webb PM, Beesley J, Chen X, Australian Cancer (Ovarian) Study , Australian Ovarian Cancer Study Group , Rossing MA, Doherty JA, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Ness RB, Moysich K, Goode EL, Vierkant RA, Cunningham JM, Anderson PD, Ovarian Cancer Association Consortium (OCAC). Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet Jun Heikkinen CR, Meindl A, Schmutzler G, MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Sch\u00fcrmann P, Bremer M, Hillemanns P, P, Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Liu J, Li Y, Ahmed S, Dunning AM, Maranian M, Giles GG, Severi G, Baglietto L, English DR, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Turnbull C, Hines S, Renwick A, Rahman N, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo Mannermaa A, Kataja V, Kosma J, LA, Chang-Claude J, Wang-Gohrke S, Shen CY, Wang HC, Yu JC, Chen ST, Bermisheva M, Nikolaeva T, Khusnutdinova E, Humphreys MK, Morrison J, Platte R, Easton DF, Breast Cancer Association Consortium. Risk of receptor-positive -negative breast cancer and single-nucleotide Natl Cancer H, Ramus SJ, Tyrer J, Bolton KL, Chang-Claude J, Cramer DW, DiCioccio R, D\u00f6rk T, Goode EL, T, Baglietto L, Beckmann MW, Beesley J, J, Carney ME, Chanock S, Chen Z, Cunningham JM, Dicks E, Doherty JA, D\u00fcrst M, Ekici AB, Fenstermacher D, Fridley BL, Giles G, ME, Vivo I, Hillemanns Hogdall C, Hogdall E, Iversen IJ, Jakubowska A, Li D, Lissowska J, Lubi?ski J, Lurie G, McGuire V, McLaughlin J, Medrek K, Moorman PG, Moysich K, Narod SS, Van Den DJ, Vierkant RA, Wang-Gohrke S, Webb PM, Wilkens LR, Wu AH, Yang H, Brewster W, Ziogas A, Australian Cancer (Ovarian) Study , Australian Ovarian Cancer Study Group , Ovarian Cancer Association Consortium , Houlston R, Tomlinson I, Whittemore AS, Rossing MA, Ponder Pearce CL, Ness RB, Menon U, SA. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009 Sep, 41:996-1000. 216. Zell JA, Ziogas A, Ignatenko N, Honda J, Qu N, Bobbs AS, Neuhausen SL, Gerner EW, Anton-Culver H. Associations of a polymorphism in the ornithine decarboxylase gene with colorectal cancer survival. Clin Cancer Res 2009 Oct 1, 15:6208-16. 217. McEligot AJ, Mouttapa M, Ziogas A, Anton-Culver H. Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer. Cancer Epidemiology 33 (2009) 419-423. Epub 2009 Oct 14. 218. Zell JA, Ziogas A., Bernstein L, Clarke CA, Deapen D, Largent JA, anti-inflammatory drugs: effects on mortality diagnosis. Cancer. 2009 Dec 15; 115(24):5662-71.PMID: 19827153 [PubMed - indexed for MEDLINE] Related citations. 219. Mitsuhashi M, Peel D, Ziogas A, and Anton-Culver H. Enhanced expression of radiation-induced leukocyte CDKN1A mRNA in multiple primary breast cancer patients: potential new marker of cancer susceptibility. Biomark Insights. 2009 Dec 22; 4:201-9. 220. Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj H; Australian Ovarian Cancer Study Management Group; Australian Cancer Study (Ovarian Cancer), Pearce CL; Ovarian Cancer Association Consortium (OCAC). ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev. 2010 Jan; 19(1):245-50. 221. Diamond C, Taylor TH, Anton-Culver H. Quality of life, characteristics and survival of patients with HIV and lymphoma. Qual Life Res. 2010 Jan 8. JN, Langhoz B, Largetn J, Mellemkjaer Bernstein L, Lynch CF, Borg A, Concannon P, Teraoka RW; WECARE Study Collaborative Group, and Bernstein JL. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control. 2010 June; 21(6):839-46. Epub 2010 Feb 4. 223. Reding Langholz BM, Bernstein L, Haile AS, Capanu M, Molone KE, and the WECARE Collaborative Study Group. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2): 491-498. Epub 2010 Feb 5. 224. Link NJ, Maurer E, Largent J, Kent E, Morris RA, Sender LS, and Anton-Culver H. Kids, Adolescents, and Young Adults Cancer Study\u2014A Methodologic Approach in Cancer Epidemiology Research. Journal of Cancer Epidemiology. Volume 2009, Article ID 354257, Methodology Report. Epub 2010 Feb 10. 225. Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen X, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Hein R, Green AC, Lissowska J, Carney ME, Lurie G, Wilkens LR, Ness RB, Pearce CL, Wu AH, Van Den Berg DJ, Stram DO, Terry KL, Whiteman DC, Whittemore, AS, DiCioccio RA, McGuire V, Doherty Rossing MA, Anton-Culver H, Ziogas A, Hogdall I, PDP, ES, Marks JR, Pike Goodman MT, Schildkraut JM, Chenevix-Trench Berchuck A, and Sellers TA. Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: the Ovarian Cancer Association Consortium. Cancer Epidemiol, Biomarkers Feb; M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein Diep Gatti RA, M, Orlow I, Liang X, Reiner AS, Layne TM, Bernstein L, Donnelly-Allen L, Olsen JH, Andersson M, Bertelsen L, Guldberg P, L, AL, Jansen L, Anton-Culver H, Largent J, Gatti A, Lynch CF, DeWall J, Haile RW, Langholz B, Thomas DC, Xue S, Zhou N, Diep AT, Ter-Karapetova E, Thompson WD, Stovall M, Buchholz T, Smith SA, Concannon P, Teraoka SN, Olson ER, Ramchurren N. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center New York Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst. 2010 Apr 7; Chang-Claude J, Hein Wang-Gohrke VM, Kataja V; The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Beesley J, Chen X, Chenevix-Trench G, Couch FJ, Olson JE, Fredericksen ZS, Wang J, Sherman ME, Bolton KL, Hall P, Czene K, Cox A, Brock IW, Elliott GC, Reed MW, Estrogen Receptor-Negative Breast J Natl Cancer Inst. 2010 Mar 22. PMID: 20308648 228. Malone Begg Haile Concannon P, Tellhed Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkj\u00e6r L, CF, Boice JD Jr, Anton-Culver H, Bernstein JL. Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 Apr 5. PMID: 20368571 229. Chen R, Crispin DA, Pan S, Hawley S, McIntosh MW, May D, Anton-Culver H, Ziogas A, Bronner MP, and Brentnall TA. Pilot Study of Blood Biomarker Candidates for Detection of Pancreatic Cancer. Pancreas. 2010 May 7. 230. Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A, and Anton-Culver H. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control. 2010 June 6. 231. Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen d, Largent JA, Neuhausen SL, Stram DO, Ursin G, and Anton-Culver H. Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study. Cancer Prev Res (Phila Pa). 2010 Jul; 3(7): 865-75. Epub 2010 Jun 15. 232. Kent EE, Morris RA, Largent JA, Ziogas A, Sender LS, and Anton-Culver H. Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma. Journal of Cancer Epidemiology. 2010; 824691. Epub 2010 Jun 22. 233. Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM; Australian Cancer Study (Ovarian Cancer) Study Group, Kobel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G; Australian Ovarian Cancer Study Group, Cramer SK, Lurie G, Menon U, Moorman PG, SJ, Song D, Vierkant RA, S, Whittemore AS, Wilkens LR, Wu AH, Schildkraut JM, Sellers TA, Goode EL; Ovarian Cancer Association Consortium. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2010 Jul; Anton-Culver H, Engstrom P, Greenberg ER, and Meyskens F. Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the American society for preventive oncology international cancer prevention interest group. Cancer Epidemiol Jul; S, Duffy DL, Spurdle AB, Defazio A, Gava N, Webb PM; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer), Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude Terry H, JM, PG, CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G; Ovarian Cancer Association Consortium. Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer I, PA, Zulka R, Hufnagel G, and Bahan KK. A Pilot Study of Male Breast Cancer in the Veterans Affairs Healthcare System. J Environ Pathol Toxicol Oncol. 2010; Zanetti R, Rosso T, Goumas C, Kanetsky PA, Begg CB, Orlow I, Wilcox H, Paine S, and Berwick M. Association of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis. Cancer Epidemiol Biomarkers Prev. 2010 Aug 27. 238. Fletcher O, Johnson N, dos Santos Silva I, Orr N, Ashworth A, Nevanlinna H, Heikkinen T, Aittom\u00e4ki A, G, MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Sch\u00fcrmann P, Waltes R, Bremer M, P, Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Humphreys K, Liu J, Ahmed S, L, English DR, Ben\u00edtez Arias JI, Pita G, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo Mannermaa A, Kataja V, Kosma J; Breast Cancer Association Consortium. Missense variants in ATM in 26, 101 breast cancer cases and 29, 843 controls. Cancer Epidemiol Biomarkers Prev. 2010 Sep; 19(9):2143-51. Ramus SJ, Notaridou M, Lawrenson LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman D\u00f6rk T, Nevanlinna H, RB, E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, J, Bolton KL, D, A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC; The Wellcome Trust Case-Control Consortium, Beesley J, Webb PM; The Australian Cancer Study (Ovarian Cancer); The Australian Ovarian Cancer Study Group; the Ovarian Cancer Association Consortium (OCAC), Chen X, Ekici Thiel Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, D\u00fcrst M, Antonenkova K, TA, Gayther SA, and Pharoah PD. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet. 2010 Sep 19. 240. Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Palmieri Moorman PG, J, Iversen ES, BL, Kruger-Kjaer J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Hillemanns P, D\u00fcrst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen P, Stefansson X; the Australian Ovarian Cancer Study Group; the Australian Cancer Study (Ovarian Cancer); on behalf of the Ovarian Cancer Association Consortium, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet. 2010 Sep 19. 241. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet Park Y, MJ. Body-Mass Index and Mortality among 1.46 Million White Adults. N Engl J Med. 2010 Dec 2; 363(23):2211-9. 242. Katz MH, Taylor TH, Al-Refaie WB, Hanna MH, Imagawa DK, Anton-Culver H, Zell JA. Adenosquamous versus Andocarcinoma Gastrointest Surg. 2011 Epub 2010 Nov 17. 243. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittom\u00e4ki K, Heikkil\u00e4 S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van 't Veer LJ, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Severi G, Lambrechts D, Vandorpe Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, D\u00f6rk T, Bremer M, Meyer A, Karstens JH, Ay A, Park-Simon TW, Hillemanns P, Arias Rodr\u00edguez PM, Zamora Ben\u00edtez Ko M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel Margolin Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, D, Pharoah P, Sherman ME, Garcia-Closas M. Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies. J Natl Cancer Inst. 2011 Feb 2; 103(3):250-63. Epub 2010 244. Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benitez J, Arias Perez JI, Zamora MP, Malats N, Dos Santos Silva I, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman P, Andrulis IL, Glendon G, Knight JA, Weerasooriya N, Cox A, Reed MW, Cross SS, Dunning AM, Ahmed S, Shah M, Brauch H, Ko YD, Bruning T, Genica Network T, Lambrechts Reumers J, Smeets A, Wang-Gohrke S, Hall P, Czene K, Liu J, Irwanto AK, Chenevix-Trench G, Holland H, Kconfab Investigators T, Aocs Investigators T, L, John EM, West DW, Whittemore AS, Vachon C, Olson JE, Fredericksen Z, Kosel M, Hein R, Vrieling A, Flesch-Janys D, Heinz J, M, PD, Garcia-Closas M, Goode EL, Chang-Claude J. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the Breast Cancer Association Consortium: a combined case-control study. Breast Cancer Res. 2010 Dec 31; 12(6): R110. 245. Bessonova L, Marshall SF, Ziogas A, Largent J, Bernstein L, Henderson KD, Ma H, West DW, Anton-Culver H. The association of body mass index with mortality in the California Teachers Study. Int J Cancer. 2011 Jan 4. 246. Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver HA. Risk of a Second Breast Cancer Associated with Hormone-Receptor and HER2/neu Status of the First Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2011 Jan 7. 247. Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Hogdall E, Kjaer SK, Hogdall C, Goode Chanock S, Lissowska J, Song H, Pharoah PD, Shah M, Perkins B, McGuire V, Whittemore AS, Di Cioccio RA, Gentry-Maharaj H; Australian Ovarian Cancer Study Management Group; Australian Cancer Study (Ovarian Cancer), Pearce CL; Ovarian Cancer Association Consortium (OCAC). ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers PMC2863004. 248. Diamond C, Taylor TH, Anton-Culver H. Quality of life, characteristics and survival of patients with HIV and lymphoma. Qual Life Res. 2010 Mar; M, Peel Enhanced Expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility. Biomark Insights. 2009 Dec 22; 4:201-9. Largent J, Mellemkjaer Bernstein L, Lynch CF, Borg A, Concannon P, Teraoka RW; WECARE Study Collaborative Group, Bernstein JL. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control. 2010 Jun; 21(6):839-46. Epub 2010 Feb 4. PubMed PMID: 251. AS, Capanu M, Malone KE; WECARE Collaborative Study Group. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat. 2010 Sep; 123(2):491-8. Epub 2010 Feb 5. PubMed PMID: 20135344; PubMed Central PMCID: PMC2903659. 252. Phelan EL, Vierkant Fridley BL, Beesley Webb DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Hein R, Green AC, Lissowska J, Carney ME, Lurie G, Wilkens LR, Ness RB, Pearce CL, Wu AH, Van Den Berg DJ, Stram DO, Terry KL, Whiteman DC, Whittemore AS, DiCioccio RA, McGuire V, Doherty Rossing MA, H, A, PD, ES, Marks JR, Pike MT, Schildkraut JM, Chenevix-Trench G, Berchuck A, Sellers TA; Ovarian Cancer Association Consortium, Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Stovall M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein Diep Gatti RA, Concannon P; WECARE Study Collaborative Group. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst. 2010 Apr 7; 102(7):475-83. Epub Chang-Claude J, Hein Wang-Gohrke VM, V; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Beesley J, Chen X, Chenevix-Trench G, Couch FJ, Olson JE, Fredericksen ZS, Wang J, Sherman ME, Bolton KL, Hall P, Czene K, Cox A, Brock IW, Elliott GC, Reed MW, estrogen receptor-negative Natl Cancer Inst. 2010 5; 102(9):650-62. Epub PubMed 20308648; PubMed PMC2864289. 255. Malone Concannon P, Tellhed Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkjaer L, CF, Boice JD Jr, Anton-Culver H, Bernstein JL. Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol. 2010 PMID: 20368571; PubMed Central PMCID: PMC2881721. 256. Chen R, Crispin DA, Pan S, Hawley S, McIntosh MW, May D, Anton-Culver H, Ziogas A, Bronner MP, Brentnall TA. Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas. 2010 Oct; PubMed PMID: 20467349. JA, Bernstein Marshall Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A, Anton-Culver H. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control. 2010 Oct; 21(10):1615-24. Epub 2010 Jun 6. PubMed PMCID: PMC2941047. 258. Zell JA, Ziogas Bernstein L, Clarke Deapen D, Largent JA, Neuhausen SL, Stram DO, Ursin G, Anton-Culver H. Meat consumption, nonsteroidal anti-inflammatory drug use, and mortality among colorectal cancer patients in the California Teachers Study. Cancer Prev Res (Phila). 2010 Jul; 3(7):865-75. Epub PubMed Central PMCID: PMC2931369. 259. Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM; Australian Cancer Study (Ovarian Cancer) Study Group, K\u00f6bel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G; Australian Ovarian Cancer Study Group, Cramer SK, Lurie G, Menon U, Moorman PG, SJ, Song D, Vierkant RA, S, Whittemore AS, Wilkens LR, Wu AH, Schildkraut JM, Sellers TA, Goode EL; Ovarian Cancer Association Consortium. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1822-30. PMC3013232. 260 Johnatty Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude Terry H, JM, PG, CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer). Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility PMC2900295. 261. Kent EE, Morris RA, Largent JA, Ziogas A, Sender LS, Anton-Culver H. Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma. J Cancer Epidemiol. 2010; 2010:824691. Central PMCID: PMC2905919. 262. Thomas From L, Busam Goumas C, Kanetsky PA, CB, Orlow I, H, Paine S, Berwick M; Genes, Environment, and Melanoma Study Group. Associations of cumulative sun exposure and phenotypic characteristics with histologic 20802019; PubMed Central PMCID: PMC2976811. 263. Fletcher O, Johnson N, dos Santos Silva I, Orr N, Ashworth A, Nevanlinna H, Heikkinen T, Aittom\u00e4ki A, G, MW, Southey MC, Smith L, Spurdle AB, Hopper JL, Couch FJ, Olson JE, Wang X, Fredericksen Z, Sch\u00fcrmann P, Waltes R, Bremer M, P, Asperen CJ, Tollenaar RA, Seynaeve C, Hall P, Czene K, Humphreys K, Liu J, Ahmed S, L, English DR, Ben\u00edtez Arias JI, Pita G, Nordestgaard BG, Bojesen SE, Flyger H, Kang D, Yoo Mannermaa A, Kataja V, Kosma J; Association Consortium. Missense variants in ATM in 26,101 breast cancer cases Chenevix-Trench Song H, Ramus SJ, Notaridou M, Lawrenson LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman D\u00f6rk T, Nevanlinna H, RB, E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC; Wellcome Trust Case-Control Consortium, Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group; Ovarian Cancer Association Consortium (OCAC), Chen X, Ekici Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, D\u00fcrst M, Antonenkova S, Sellers TA, Gayther SA, Pharoah PD; Ovarian Cancer Association Consortium (OCAC). A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet. 2010 Oct;42(10):874-9. Epub Central Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, Wu AH, Brewster W, Anton-Culver H, Ziogas A, Narod SA, Levine DA, Kaye SB, Brown R, Paul J, Flanagan J, Sieh W, McGuire V, Whittemore AS, Campbell I, Gore ME, Lissowska J, Yang HP, Medrek K, Gronwald J, Lubinski J, Jakubowska A, Palmieri Moorman PG, J, Iversen ES, BL, Kruger-Kjaer J, Hogdall E, Hogdall C, Gross J, Karlan BY, Ness RB, Edwards RP, Odunsi K, Moyisch KB, Baker JA, Modugno F, Heikkinenen T, Hillemanns P, D\u00fcrst M, Runnebaum I, Thompson PJ, Carney ME, Goodman MT, Lurie G, Wang-Gohrke S, Hein R, Chang-Claude J, Rossing MA, Cushing-Haugen KL, Doherty J, Chen P, Stefansson X; Australian Ovarian Cancer Study Group; Australian. 266. Cancer Study (Ovarian Cancer); Ovarian Cancer Association Consortium, Johnatty SE, Webb PM, Beesley J, Chanock S, Garcia-Closas variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet. 2010 Oct; 42(10):880-4. Epub 2010 Sep 19. PubMed PMID: 20852633; PubMed Central PMCID: PMC3125495. 267. Katz MH, Taylor TH, Al-Refaie WB, Hanna MH, Imagawa DK, Anton-Culver H, Zell JA. Adenosquamous versus adenocarcinoma Gastrointest PMC3023036. 268. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet Park Y, MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010 Dec 2; 363(23):2211-9. Erratum in: EL, H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittom\u00e4ki K, Heikkil\u00e4 S, Figueroa J, Brinton L, Hall P, Czene K, Humphreys K, Darabi H, Liu J, Van 't Veer LJ, van Leeuwen FE, Andrulis IL, Glendon G, Knight JA, Severi G, Lambrechts D, Vandorpe Paridaens R, Smeets A, Neven P, Wildiers H, Wang X, Olson JE, Cafourek V, Fredericksen Z, Kosel M, Vachon C, Cramp HE, Connley D, Cross SS, Balasubramanian SP, Reed MW, D\u00f6rk T, Bremer M, Meyer A, Karstens JH, Ay Park-Simon TW, Hillemanns Rodr\u00edguez M, Miller N, McInerney N, Anton-Culver H, Ziogas A, Shen CY, Hsiung CN, Wu PE, Yang SL, Yu JC, Chen ST, Hsu GC, Haiman CA, Henderson BE, Le Marchand L, Kolonel Margolin Hankinson SE, Hunter DJ, Tamimi R, Sangrajrang S, Brennan P, D, Pharoah P, Sherman ME, Garcia-Closas M. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011 Feb 2; 103(3):250-63. Epub 270. Milne AB, FJ, Ben\u00edtez J, Arias P\u00e9rez JI, Zamora MP, Malats N, Dos Santos Silva I, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman P, Andrulis IL, Glendon G, Knight JA, Weerasooriya N, Cox A, Reed MW, Cross SS, Dunning AM, Ahmed S, Shah M, Brauch Ko Hall P, Czene K, J, John EM, West DW, Whittemore AS, Vachon C, Olson JE, Fredericksen Z, Kosel M, Hein R, Vrieling A, Flesch-Janys J, MW, Heusinger PD, Garc\u00eda-Closas M, Goode EL, Chang-Claude J. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res. 2010; 12(6):R110. Epub 2010 Dec PubMed PMID: 21194473; PMC3046455. 271. Bessonova L, Marshall SF, Ziogas A, Largent J, Bernstein L, Henderson KD, Ma H, West DW, Anton-Culver H. The association of body mass index with mortality in the California Teachers Study. Int J Cancer. 2011 Nov 15; 129(10):2492-501.doi: 10.1002/ijc.25905. Epub 2011 Apr 8. PubMed PMID: 21207419. Bessonova L, Taylor TH, Mehta RS, Zell JA, Anton-Culver H. Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer. Cancer Epidemiol Biomarkers Prev. 2011 Feb; PA, Zulka R, Hufnagel G, Bahan KK. A pilot study of male breast cancer in the Veterans Affairs healthcare system. J Environ S, Marshall SF, Karao?lano?lu O, Anbarcio?lu Z, \u00dc\u00e7\u00fcnc\u00fc N, Akin \u00dc, \u00d6zen E, \u00d6zg\u00fcl N, Anton-Culver H, Tuncer M. Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev. 2010; 11(6):1731-9. PubMed PMID: 21338224. 275. Orlow I, Roy P, Reiner AS, Yoo S, Patel H, Paine S, Armstrong BK, Kricker A, Marrett Gallagher RP, Dwyer T, Busam K, From L, Begg CB, Berwick M; for the GEM Study Group. Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer. 2011 Mar 1. doi: 10.1002/ijc.26023. of Butzow R, Caldes T, Caligo MA, Campbell I, Chang-Claude J, Chen YA, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Despierre E, Doherty JA, Ekici AB, Easton D; Fenstermacher O; GEMO Study Collaborators, Gentry-Maharaj A, Godwin AK, Goode EL, Goodman MT, Gross J, Hansen TV, Harnett P, Rookus M; HEBON Investigators, Heikkinen of BRCA1/2, Kelemen LE, Kiemeney LA, C, Le ND, Leminen A, Leunen K, Levine DA, Y, Lundvall Macgregor S, Marees T, Massuger Nathanson L, Ness RB, Nevanlinna H, Nickels S, Osorio A, Paul J, Pearce CL, Phelan CM, Pike MC, Radice P, Rossing MA, Schildkraut JM, Sellers TA, H, DO, R, Lindblom A; AH, Ziogas A, Berchuck A, Risch HA; Ovarian Cancer Association Consortium. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res. 2011 Jun 1; 17(11):3742-50. Epub 2011 Mar PMC3107901. 277. Wang Q, Song H, Chenevix-Trench G; Australian Ovarian Cancer Study Group, Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer), Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke Ness JM, Fridley BL, Vierkant RA, Tworoger A, Menon U, Ramus SJ, Rossing MA, Doherty JA, Goodman MT, Carney ME, Lurie G, Wilkens LR, Kj\u00e6r SK, H\u00f8gdall E, Cramer JM, Berchuck A, Cancer Association Consortium. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):1028-31. 21415361; PubMed Central PMCID: PMC3176661. 278. Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, Bronner MP, Ziogas A, Anton-Culver H, Brentnall TA. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011 May 6; 10(5):2359-76. Epub Mar PMC3090497 279. Capanu M, Concannon P, Haile RW, Bernstein Malone KE, Lynch CF, Ziang X, Teraoka SN, Diep AT, Thomas DC, Bernstein JL; Study Begg CB. Assessment of rare BRCA1 and BRCA2 variants of unknown significance Epidemiol. doi: 10.1002/gepi.20587. PMCID: PMC3111904. 280. Broeks A, Sherman ME, Couch Hopper JL, GS, Apicella C, Smith LD, R, Burwinkel B, Marme F, Schneeweiss A, Sinn SE, HP, Br\u00fcning T, R, ZS, Wang X, Giles GG, Baglietto L, Severi G, McLean C, Haiman CA, Marchand L, Kolonel LN, Aln\u00e6s Kristensen B, van Leenders GJ, Hall P, Czene K, Humphreys K, Liu J, Cox A, Connley D, Cramp HE, Cross SS, Balasubramanian AM, Easton DF, Humphreys Lubinski Jakubowska A, Huzarski J, P, Sangrajrang S, Gaborieau V, Shen CY, Hsiung CN, Yu JC, Chen ST, Hsu GC, Hou MF, Huang CS, Anton-Culver H, Ziogas A, Pharoah PD, Garcia-Closas M. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor. Subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2011 Aug 15; 20(16):3289-303. Epub Ovarian Cancer Study Group, Dale LC, Lambrechts Amant F, Despierre JM, Kaye SB, Paul J, B\u00fctzow R, Nevanlinna H, Campbell I, Eccles DM, Karlan BY, Gross J, Walsh C, Pharoah PD, H, Kj\u00e6r Vermeulen SH, Le ND, Brooks-Wilson A, Cook LS, Phelan CM, Cunningham JM, Vachon CM, Vierkant RA, Iversen ES, Berchuck A, Goode EL, Sellers TA, Kelemen LE. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. PLoS One. 2011;6(5):e19642. Epub 2011 May 27. PubMed PMID: Central RK, A, Chenevix-Trench G, Webb PM, Beesley J; Australian Ovarian Cancer Study Group; Australian Cancer Study Group, Goodman MT; Ovarian Cancer Association Consortium Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One. 2011;6(6):e20703. Epub 2011 Jun 6. PubMed DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE. Clinically relevant changes in family history of cancer over time. JAMA. 2011 Jul 13; 306(2):172-8. PubMed PMID: 21750294. 284. Milne RL, Goode EL, Garc\u00eda-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora P, Cox A, Brock IW, Elliot G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC, Huang CS, Hou MF, Nordestgaard BG, Bojesen SE, S, P, Manoukian S, Barile M, L, John EM, Hoover RN, Fletcher O, Gibson LJ, Dos Santos Silva I, Peto J, Nickels S, Flesch-Janys D, Anton-Culver H, Ziogas A, Sawyer E, Tomlinson I, Kerin M, Miller N, Schmidt MK, Broeks B, Jakubowska A, Lubinski J, Jaworska K, Durda K, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Kraft P, Lindstrom S, Chen X, Beesley J, Hamann U, Harth K, Jukkola-Vuorinen A, Grip M, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Khusnutdinova E, Bermisheva M, Prokofieva D, Farahtdinova A, Olson JE, Wang X, Humphreys MK, Wang Q, Chenevix-Trench G; for the kConFab Investigators and the AOCS Group, Easton DF. Confirmation of 5p12 as a Susceptibility Locus for Progesterone-Receptor-Positive, Lower Grade Cancer Epidemiol Biomarkers 285. Berwick M, Begg CB, Armstrong BK, Reiner AS, Thomas NE, Cook LS, Orlow I, Kanetsky PA, Lee-Taylor J. Interaction of CDKN2A and Sun Exposure in the Etiology of Melanoma in the General Population. J Invest Dermatol. 2011 Aug 11. Doi: 10.1038/jid.2011.235. Strick R, Peto J, Dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, H, BG, J, Zamora Brenner H, M\u00fcller H, Arndt V, Rahman N, Turnbull C, S, A, H, Justenhoven C, T; Hein Wang-Gohrke D\u00f6rk T, Sch\u00fcrmann P, Bremer M, Hillemanns P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Marie Mulligan A, O'Malley FP, Brinton Sherman ME, Lissowska P, Czene K, Cox IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Ding SL, Hsu HM, Yu JC, Anton-Culver H, Ziogas A, Ashworth A, Swerdlow A, Jones M, Orr N, Trentham-Dietz A, Egan K, Newcomb P, Titus-Ernstoff L, Easton D, Spurdle AB. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2011 Sep 20. [Epub ahead of 287. Milne Tollenaar Seynaeve C, Hall P, Czene K, Liu J, Irwanto AK, Kang D, Yoo KY, Noh DY, Couch FJ, Olson JE, Wang X, Fredericksen Z, Nordestgaard BG, Bojesen AB, Beckmann MW, Wang-Gohrke S, Shen CY, Yu JC, Hsu HM, Wu PE, Giles GG, Severi G, Baglietto L, English DR, Cox A, Brock I, Elliott G, Reed MW, Beesley J, Chen X, Investigators K; AOCS Group, Fletcher O, Gibson L, dos Santos Silva I, Peto J, Frank B, Heil J, Meindl A, Chang-Claude J, Hein R, Vrieling A, Flesch-Janys D, Southey MC, Smith L, and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet. 2011 Oct; 48(10):698-702. Ahnen Schildkraut JM, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Burt RW. Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer. 2011 Fasching Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, Dos Santos Silva I, Gibson L, Sawyer E, Tomlinson I, Kerin MJ, Chanock S, Lissowska Hein R, Wang-Gohrke S, D\u00f6rk J, Chenevix-Trench G, Chen X, Peterlongo P, Bonanni B, Bernard L, Manoukian S, Wang X, Cerhan J, Vachon CM, Olson J, Giles GG, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylk\u00e4s K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Glendon G, Mulligan AM, Cox A, Brock IW, Elliott G, SS, Pharoah PP, Dunning AM, Pooley KA, Humphreys MK, Wang J, Kang D, Yoo KY, Noh DY, Sangrajrang S, Gabrieau V, Brennan P, McKay J, Anton-Culver H, Ziogas A, Couch FJ, Easton DF. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer. 2011 Oct 27. Doi: 10.1038/bjc.2011.448. [Epub ahead of print] PubMed PMID: 22033276. Grants CURRENT AWARDS (Partial Listing) Safeway Foundation, ATHENA Breast Health Network (2009-2014) Beckman Research Institute- City of Hope, NIH National Cancer Institute, California Teacher Study (CTS), Site PI, Hoda Anton-Culver, Ph.D. with PI, (2012-2016) LVS (2013-2014) Professional Societies American Asociation of Cancer Research (AACR) American Society of Preventive Oncology (ASPO) American College of Epidemiology (ACE) American Society of Human Genetics (ASHG) Society of Epidemiology Research (SER) Graduate Programs Cellular and Molecular Biosciences Epidemiology Research Centers Genetic Epidemiology Research Institute Link to this profile [https://faculty.uci.edu/profile/?facultyId=2911](https://faculty.uci.edu/profile/?facultyId=2911) "}